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1. Summary 
The ubiquitination of proteins is a crucial and reversible post-translational modification in 
eukaryotes, which influences all cellular processes. Various types of ubiquitin polymers exist 
that differ in the linkage of the individual ubiquitin molecules. The seven lysine (Lys) residues 
within the ubiquitin molecule as well as its N-terminal methionine (Met1) can be linked to the 
C-terminus of another ubiquitin molecule by specific enzymes. Attached to protein 
substrates, different linkage-specific polyubiquitin chains exert distinct functions. For 
instance, Lys48- and Lys63-linked ubiquitin chains regulate protein stability and activity, 
respectively. Met1-linked ubiquitin chains, also referred to as linear chains, have attracted 
attention in the last decade since they play an important role in the activation of inflammatory 
signaling pathways. Met1-linked ubiquitin chains are synthesized by the linear ubiquitin chain 
assembly complex (LUBAC), with HOIP/RNF31 as the catalytic subunit.  
Recently, OTULIN was identified as the deubiquitinating enzyme (DUB) that specifically 
cleaves Met1-linked ubiquitin chains. OTULIN interacts with LUBAC via the E3 ligase HOIP, 
and thus counteracts LUBAC-mediated generation of linear chains. Moreover, OTULIN acts 
as a general homeostatic control factor that balances cellular amounts of Met1-linked 
ubiquitin.  
 
To better understand the cellular activity of OTULIN, we took a chemical biological approach. 
An activity-based probe (ABP) was designed that covalently couples to the active site of 
OTULIN and thus captures OTULIN in its active conformation. The chemically synthesized 
OTULIN ABP is based on a complete Met1-linked diubiquitin substrate, in which the 
C-terminal glycine (Gly76) of the distal ubiquitin moiety has been substituted with the 
electrophilic non-canonical amino acid dehydroalanine (bio-UbG76Dha-Ub). 
The OTULIN ABP displays strong reactivity toward recombinant and cellular OTULIN. Some 
cross-reactivity was only detected with the DUB USP5 and the ubiquitin-activating (E1) 
enzymes UBA1 and UBA6, confirming the high selectivity for OTULIN. In fact, labeling of 
USP5 and E1 enzymes by the OTULIN ABP was abolished by the removal of the C-terminal 
glycine in the proximal ubiquitin molecule and the resulting OTULIN ABP ?G76 specifically 
labels OTULIN. The OTULIN ABP facilitates the detection of active endogenous OTULIN and 
its enrichment from cell extracts, along with OTULIN-associated protein complexes, such as 
LUBAC.  
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Using mass spectrometric analysis after OTULIN ABP pull-down, we identified Sorting 
Nexin 27 (SNX27) as a new OTULIN interactor. SNX27 is a PDZ (post-synaptic 
density 95/discs large/zonula occludens) domain-containing adaptor protein of the 
endosomal retromer complex, which mediates the fast transport of internalized 
transmembrane proteins, the so called cargos, from early endosomes back to the plasma 
membrane. Co-immunoprecipitations revealed that the OTULIN-SNX27 interaction takes 
place in various cell lines as well as in primary cells. Further, analytical gel filtration indicated 
that the majority of OTULIN and SNX27 form a stable cytosolic complex.  
Structural, biophysical and cellular analyses demonstrated that OTULIN-SNX27 binding 
relies on a C-terminal PDZ-binding motif (PDZbm) in OTULIN, which interacts with the 
canonical cargo-binding site in the SNX27 PDZ domain. Moreover, a second interface was 
identified that contributes to the high affinity and selectivity of the OTULIN-SNX27 interaction. 
Cellular binding studies provided evidence that OTULIN counteracts binding of the retromer 
complex to SNX27. Thus, OTULIN cannot be a cargo for SNX27-dependent sorting 
processes. Functionally, SNX27 has no impact on the hydrolase activity of OTULIN, the 
OTULIN-LUBAC association, or LUBAC-mediated signaling. However, through binding to 
SNX27, OTULIN restricts access for cargos and the retromer complex, and additionally 
prevents endosomal localization of SNX27. Accordingly, OTULIN counteracts fast recycling 
of internalized plasma membrane proteins by the SNX27-retromer complex. While activity of 
OTULIN is critical for controlling the abundance of linear ubiquitin chains, regulation of the 
SNX27-retromer by OTULIN occurs independently from its catalytic hydrolase activity.  
Thus, a chemical biological approach facilitated the characterization of cellular OTULIN 
activity and allowed the identification of a new non-catalytic function of OTULIN in controlling 
endosomal sorting processes. 
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1. Zusammenfassung 
Die Ubiquitinierung von Proteinen ist eine essentielle und reversible post-translationale 
Modifikation in Eukaryoten, die alle zellulären Vorgänge beeinflusst. Es existieren 
verschiedene Arten von Ubiquitin-Polymeren, die sich in der Verknüpfung der einzelnen 
Ubiquitin-Moleküle unterscheiden. Sowohl die sieben Lysin-Reste (Lys) innerhalb des 
Ubiquitin-Moleküls als auch dessen N-terminales Methionin (Met1) können durch spezifische 
Enzyme mit dem C-Terminus eines anderen Ubiquitin-Moleküls verknüpft werden. Gebunden 
an Proteinsubstrate, üben unterschiedliche verbindungsspezifische polyUbiquitin-Ketten 
verschiedene Funktionen aus. So regulieren zum Beispiel Lys48- und Lys63-verknüpfte 
Ubiquitin-Ketten die Protein-Stabilität beziehungsweise die Protein-Aktivität. Met1-verknüpfte 
Ubiquitin-Ketten, welche auch lineare Ketten genannt werden, haben im letzten Jahrzehnt 
große Aufmerksamkeit auf sich gezogen, da sie eine wichtige Rolle bei der Aktivierung 
inflammatorischer Signalwege spielen. Lineare Ubiquitin-Ketten werden durch den ,Linear 
ubiquitin chain assembly complex‘ (LUBAC) mit HOIP/RNF31 als katalytischer Untereinheit 
synthetisiert.  
Kürzlich wurde OTULIN als deubiquitinierendes Enzym (DUB) identifiziert, das spezifisch 
Met1-verknüpfte Ubiquitin-Ketten spaltet. OTULIN interagiert über die E3 Ligase HOIP mit 
LUBAC, und wirkt der LUBAC-vermittelten Bildung linearer Ketten entgegen. Außerdem 
fungiert OTULIN als wesentlicher homöostatischer Kontrollfaktor, der die zelluläre 
Konzentration von Met1-verknüpftem Ubiquitin im Gleichgewicht hält.  
 
Um die zelluläre Aktivität von OTULIN besser zu verstehen, wählten wir einen chemisch-
biologischen Ansatz. Eine aktivitätsbasierte Sonde (,activity-based probe‘, ABP) wurde 
generiert, die kovalent an das aktive Zentrum von OTULIN bindet und OTULIN so in der 
aktiven Konformation arretiert. Die chemisch synthetisierte OTULIN ABP basiert auf einem 
vollständigen Met1-verknüpften diUbiquitin-Substrat, in dem das C-terminale Glycin (Gly76) 
des distalen Ubiquitins durch die elektrophile nicht-kanonische Aminosäure Dehydroalanin 
ersetzt wurde (bio-UbG76Dha-Ub). Die OTULIN ABP zeigt eine starke Reaktivität gegenüber 
rekombinantem und zellulärem OTULIN. Eine gewisse Kreuzreaktivität konnte nur mit dem 
DUB USP5 und den Ubiquitin aktivierenden E1 Enzymen UBA1 und UBA6 festgestellt 
werden, sodass die OTULIN ABP eine hohe Selektivität für OTULIN aufweist. Die geringe 
Kreuzreaktivität der OTULIN ABP gegenüber USP5 und E1 Enzymen wurde durch 
Entfernung des C-terminalen Glycins im proximalen Ubiquitin-Molekül aufgehoben und die 
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hierdurch entstandene OTULIN ABP ?G76 markiert spezifisch das aktive OTULIN. Die 
OTULIN ABP ermöglicht somit die Detektion von aktivem endogenen OTULIN und dessen 
Anreicherung aus Zellextrakten, zusammen mit OTULIN-assoziierten Proteinkomplexen, wie 
dem LUBAC.  
 
Mittels massenspektrometrischer Analyse nach OTULIN ABP Pull-down identifizierten wir 
Sorting Nexin 27 (SNX27) als einen neuen OTULIN-Interaktor. SNX27 ist ein PDZ 
(post-synaptic density 95/discs large/zonula occludens)-Domäne enthaltendes 
Adapterprotein des endosomalen Retromerkomplexes, welches den schnellen Transport 
internalisierter Transmembranproteine (so genannter Cargos) von frühen Endosomen zurück 
zur Plasmamembran vermittelt. Co-Immunopräzipitationen zeigten, dass die OTULIN-SNX27 
Interaktion sowohl in verschiedenen Zelllinien als auch in primären Zellen erfolgt. Überdies 
deutete analytische Gelfiltration darauf hin, dass ein Großteil zellulären OTULINs und 
SNX27‘ einen stabilen zytosolischen Komplex bilden.  
Strukturelle, biophysikalische und zelluläre Analysen zeigten, dass die OTULIN-SNX27 
Bindung auf einem C-terminalen PDZ-Bindemotiv (PDZbm) in OTULIN beruht, welches mit 
der kanonischen Cargo-Bindestelle in der SNX27 PDZ-Domäne interagiert. Außerdem wurde 
eine zweite Interaktionsoberfläche identifiziert, die zur hohen Affinität und Selektivität der 
OTULIN-SNX27 Interaktion beiträgt. 
Zelluläre Bindungsstudien erbrachten den Nachweis, dass OTULIN der Bindung des 
Retromerkomplexes an SNX27 entgegenwirkt. Demnach kann OTULIN kein Cargo für 
SNX27-abhängige Sortiervorgänge sein. Funktional hat SNX27 weder Auswirkungen auf die 
Hydrolase-Aktivität OTULINs, noch auf die OTULIN-LUBAC Interaktion oder die LUBAC-
vermittelte Signalübermittlung. OTULIN hingegen beschränkt durch die Bindung an SNX27 
den Zugang für Cargos und den Retromer-Komplex und verhindert zusätzlich die 
endosomale Lokalisation von SNX27. Dementsprechend wirkt OTULIN dem schnellen 
Rücktransport internalisierter Plasmamembran-Proteine durch den SNX27-Retromer-
Komplex entgegen. Während die Aktivität von OTULIN entscheidend für die Kontrolle der 
Abundanz linearer Ubiquitin-Ketten ist, geschieht die Regulation des SNX27-Retromer-
Komplexes durch OTULIN unabhängig von dessen Hydrolase-Aktivität. So erlaubte der 
chemisch-biologische Ansatz die Charakterisierung der zellulären Aktivität von OTULIN und 
die Identifikation einer neuen nicht-katalytischen Funktion von OTULIN bei der Kontrolle 
endosomaler Sortierungsprozesse. 
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2. Introduction 
2.1 Ubiquitination – a versatile post-translational protein modification 
The post-translational modifier ubiquitin (Ub) is an important regulator of almost every 
cellular process in eukaryotic organisms (Komander and Rape, 2012). This small (8.5 kDa) 
protein consists of 76 amino acids (aa) whose sequence is highly conserved from yeast to 
humans. Its globular structure exhibits an exposed C-terminal tail, which can be covalently 
linked to lysine (Lys) residues in cellular proteins in a post-translational process called 
ubiquitination. Target proteins can become monoubiquitinated at one (monoubiquitination), or 
multiple sites (multi-monoubiquitination), or they can become polyubiquitinated by the 
formation of a polymeric Ub chain on their surface (polyubiquitination) (Figure 2-1A). 
Different Ub modifications affect the fate of a target protein in a variety of ways and function 
as signals for succeeding cellular events (Komander and Rape, 2012). Proteins may, for 
instance, become activated or inhibited, stabilized or destabilized by ubiquitination or provide 
a platform for protein interactions. Thus, cellular processes such as protein degradation or 
endocytosis and signaling pathways leading to the activation of transcription factors can be 
regulated and tightly controlled (Komander and Rape, 2012). 
As well as cellular substrates, Ub itself can become ubiquitinated. All ?-amino groups of the 
seven Lys residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, Lys63) within the Ub 
molecule or the ?-amino group of the N-terminal methionine (Met1) can serve as conjunction 
sites for the C-terminal carboxyl group of another Ub (Figure 2-1B). Thus, eight different 
 
Figure 2-1: Ubiquitin – a versatile post-translational modifier. 
A) Kinds of ubiquitination as post-translational modification: monoubiquitination, multi-monoubiquitination and polyubiquitination. 
B) Ribbon representation of Ub depicted in green (PDB ID: 1ubq) (Vijay-Kumar et al., 1987). The seven Lys residues and the N-
terminal Met are highlighted as these can serve as conjunction sites for another Ub molecule during polyubiquitination. 
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linkages can be formed between two Ub molecules creating a large variety of possible chain 
architectures. In homotypic or linkage-specific Ub chains, the molecules are connected by 
the same linkage type. The most extensively studied linkage-specific chains are Lys48- and 
Lys63-Ub. Lys48-Ub usually denotes target proteins for proteasomal degradation (Chau et 
al., 1989; Hershko and Ciechanover, 1998), whereas Lys63-Ub mostly has non-degradative 
roles and acts as a scaffold in signaling cascades triggering, for example, kinase activation, 
the DNA damage response or intracellular trafficking (Chen and Sun, 2009). Besides these 
typical chains, Met1-linked linear Ub chains have attracted increasing attention in the last 
decade due to their role in NF-?B (nuclear factor kappa B) signaling (Iwai and Tokunaga, 
2009). 
Depending on the linkage type, Ub chains differ in their three-dimensional conformations. 
Lys6-, Lys11- and Lys48-Ub, for instance, exhibit compact structures that are generated by 
non-covalent interactions between the hydrophobic patches of adjacent Ub molecules 
(Bremm et al., 2010; Eddins et al., 2007; Virdee et al., 2010). K63- and Met1-Ub, on the 
other hand, form open chain structures, in which the covalent linkages are the only 
interaction surfaces (Komander et al., 2009b; Varadan et al., 2004). 
Besides the homotypic Ub chains, heterotypic, or branched Ub chains also exist, in which the 
Ub moieties are connected by different linkages, and which considerably increase the 
complexity of Ub modifications (Komander and Rape, 2012). 
2.1.1 Ubiquitin conjugation 
Ub is covalently attached to substrates in a three-step enzymatic process by enzymes 
referred to as E1, E2 and E3s (Figure 2-2). In humans, two E1s named UBA1 and UBA6, 
about 40 E2, and more than 600 E3 enzymes exist. This large number of E2 and E3 
enzymes emphasizes the diversity and complexity of the Ub-mediated signaling network and 
the basic importance of linkage and substrate specificity (Zinngrebe et al., 2014). 
In the first ATP-dependent step of the ubiquitination cascade, the E1 or Ub-activating 
enzyme recognizes the C-terminal di-glycine (di-Gly) motif in the Ub molecule and binds the 
C-terminal carboxyl group of Ub via a high-energy thioester bond. In a second step, the Ub is 
transferred to the active Cys of an E2 or Ub-conjugating enzyme. And finally, an E3 Ub 
ligase catalyzes the Ub transfer onto the target protein, interacting with both E2 and 
substrate (Hershko and Ciechanover, 1998). 
The precise transfer mechanism is dependent on the domain structure of the respective E3 
enzyme (Figure 2-2). HECT (Homologous to the E6AP Carboxyl Terminus) E3s have a 
C-terminal HECT domain with an active Cys residue that takes over the Ub from the E2~Ub 
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intermediate before attaching it to the substrate. RING (Really Interesting New Gene) E3 
ligases catalyze the direct Ub transfer from the E2 onto the substrate by bringing both into 
very close proximity. The third subfamily of RING-between-RING (RBR) E3 enzymes carries 
a RING domain (RING1) followed by an in-between-RING (IBR) and a second RING domain 
(RING2). The RING1 domain initially binds the E2~Ub complex as is the case with classical 
RING E3s. Then, however, the Ub is transferred to a catalytic Cys in the RING2 domain 
before becoming attached to the substrate. This mechanism is called the RING-HECT hybrid 
mechanism and is characteristic of the E3 ligases Parkin, HHARI and HOIP (Rotin and 
Kumar, 2009; Smit et al., 2012; Zinngrebe et al., 2014). 
 
In the ubiquitination process, E3 enzymes mediate substrate specificity and sometimes 
linkage specificity of polyUb chains, whereas E2 enzymes mostly determine linkage 
specificity and the length of generated Ub chains (Ye and Rape, 2009; Zinngrebe et al., 
2014). E3 ligases often ubiquitinate themselves and thus affect their own stability and activity 
(Keusekotten et al., 2013; Lorenz, 2018; Zheng and Shabek, 2017).  
Figure 2-2: Ubiquitin conjugation. 
Ubiquitination is a three-step enzymatic process. First, Ub is activated in an ATP-dependent reaction by an E1 enzyme by 
forming an E1~Ub intermediate. Then, the activated Ub is transferred to an E2 enzyme. Finally, E3 enzymes mediate the Ub 
transfer onto the target protein either by bridging the E2-substrate interaction or by serving as E3~Ub intermediate. 
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2.1.2 Ubiquitin recognition by ubiquitin-binding proteins 
Ubiquitin attachment primarily mediates its effects by offering interaction platforms for other 
proteins. Ub can interact non-covalently with other proteins via several surfaces (Figure 
2-3A). The main interaction surface is a hydrophobic area formed by Ile44, Leu8, Val70, and 
His68 (Dikic et al., 2009; Komander and Rape, 2012). This Ile44 patch is flexible around 
Leu8 and mediates the interaction with most Ub-binding proteins. Further important 
interaction surfaces are the hydrophobic Ile36 patch (Ile36, Leu71 and Leu73), the Phe4 
patch (Phe4, Gln2 and Thr12) and the TEK-box (Thr12, Thr14, Glu34, Lys6, and Lys11) 
(Husnjak and Dikic, 2012; Komander and Rape, 2012). 
MonoUb and polyUb are recognized by a plethora of Ub-binding proteins (UBPs). These 
UBPs contain at least one Ub-binding domain (UBD). UBPs are, for example, enzymes that 
are required for conjugation and deconjugation of Ub chains. These enzymes must have the 
ability to interact with Ub to ensure the signaling function of the post-translational modifier. 
 
UBDs can be subdivided into approximately 20 families and their structures differ widely in 
some cases (Dikic et al., 2009; Husnjak and Dikic, 2012). Nevertheless, all UBDs are able to 
interact with the highly conserved Ub surfaces (see Figure 2-3A). Most UBDs recognize the 
Ub Ile44 patch (Beal et al., 1998; Dikic et al., 2009). The Ile36 patch is, among others, 
recognized by some proteins of the Ub chain assembly and disassembly machinery (Hu et 
al., 2002; Kamadurai et al., 2009; Komander and Rape, 2012; Reyes-Turcu et al., 2006). The 
Phe4 patch and the TEK-box provide further interaction surfaces for UBDs (Husnjak and 
Dikic, 2012; Komander and Rape, 2012).  
 
Figure 2-3: Ubiquitin sensing by Ub-binding proteins. 
A) Molecular surface representation of Ub (green) with important recognition patches highlighted in color (PDB ID: 1ubq) (Vijay-
Kumar et al., 1987). 
B) The four UBDs of USP5. The C-terminal di-Gly motif in unanchored Ub chains is recognized and bound by the ZnF-UBP 
domain (S1´ site). This binding is required for the cleavage of Ub chains from the proximal end. The UBP domain (S1 site) 
comprises the active site, whereas two UBA domains bind the distal Ub molecules. 
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Many UBPs possess several UBDs. The deubiquitinating enzyme Ub-specific protease 5 
(USP5), also referred to as isopeptidase T (IsoT), is an interesting example, because it has 
four UBDs (Figure 2-3B): A zinc-finger Ub-binding protein (ZnF-UBP) domain with a deep 
binding pocket (S1´ site) recognizes the highly conserved C-terminal di-Gly motif 
(Gly75-Gly76) of Ub in unanchored chains and thus enables fast hydrolysis of free polymers 
in the cell (Reyes-Turcu et al., 2006). The Ub-binding protein (UBP) domain contains the 
catalytic center (S1 site), and two Ub-associated (UBA) domains (S2 and S3 site) bind the 
distally linked Ub molecules (Reyes-Turcu et al., 2008).  
Many proteins are equipped with specific UBDs, which enable them to distinguish between 
distinct Ub modifications by sensing the specific linkage between two Ub molecules or the 
overall conformation of Ub chains (Dikic et al., 2009; Husnjak and Dikic, 2012). This is, 
among others, an important feature of proteins that act in cellular signaling cascades and link 
specific Ub signals with a downstream effect. The protein NEMO (NF-?B essential modulator, 
IKK?), for instance, binds to Met1-Ub through its UBAN (Ub binding in ABIN and NEMO) 
domain (Ivins et al., 2009; Komander et al., 2009b; Rahighi et al., 2009). More precisely, this 
domain interacts with both the distal Ile44 patch and the proximal Phe4 patch of Met1-diUb, 
providing specificity for the linear linkage (Rahighi et al., 2009). The NEMO UBAN-Met1-Ub 
interaction is important for proper NF-?B activation. Patients carrying a mutation in the 
Met1-Ub binding site of NEMO suffer from ectodermal dysplasia with immune deficiency 
(Hubeau et al., 2011; Rahighi et al., 2009). Interestingly, NEMO is not only recruited to 
Met1-Ub, but is also a substrate for linear ubiquitination (Tokunaga et al., 2009). 
Further examples of UBPs with specific UBDs are the TAK1-binding proteins 2 and 3 
(TAB2/3) that are found in a complex with the transforming growth factor ?-activated kinase 1 
(TAK1). TAB2 and TAB3 contain nuclear protein localization 4 zinc finger (NZF) domains that 
specifically interact with Lys63-linked Ub chains (Kulathu et al., 2009; Sato et al., 2009). This 
interaction recruits TAK1 to Lys63-Ub and induces kinase activation, which is also required 
for NF-?B activation and mitogen-activated protein kinase (MAPK) signaling. 
2.1.3 Ubiquitin deconjugation 
In common with other post-translational modifications (e.g. phosphorylation or acetylation), 
ubiquitination is a reversible and highly dynamic process in cells. The action of E3 ligases is 
counteracted by deubiquitinating enzymes (DUBs) that disassemble Ub chains. This 
degradation prevents continuous activation of cellular signaling pathways and ensures that 
the cellular equilibrium can be restored. Moreover, DUBs process Ub precursor proteins to 
maintain the cellular pool of free Ub. These Ub precursors are encoded by the UBC, UBB, 
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UBA52 and UBA80 genes and are translated either as fusions of three to nine Ub molecules 
or as fusions of one Ub and a ribosomal protein (Komander et al., 2009a). 
In humans, approximately 100 DUBs exist that can be classified into six different families: 
The Ub-specific proteases (USPs), the ovarian tumor domain-containing proteases (OTUs), 
the Ub C-terminal hydrolases (UCHs), the Josephin domain-containing proteases and the 
motif interacting with Ub (MIU)- containing novel DUB family (MINDY) are all Cys proteases 
with a catalytic diad (Cys-His) or triad (Cys-His-Asn/Asp), whereas the zinc-dependent 
JAB1/MPN/MOV34 (JAMM) DUBs are metalloproteases (Mevissen and Komander, 2017). 
Structures of the catalytic DUB domains in unbound (apo) and substrate-bound states, have 
given an insight into DUB reactivities. Some DUBs, like USP7, are inactive in the apo state 
due to a disordered catalytic site. Upon substrate binding, the catalytic residues are 
reorganized and adopt an active configuration (Hu et al., 2002). Other DUBs, like the 
proteasome-associated USP14, already exhibit a functional active site in the apo state, but 
the access to the catalytic pocket is blocked by a structural element, such as a surface loop 
(Hu et al., 2005). 
All DUBs have the ability to interact with the highly conserved hydrophobic surfaces in the Ub 
molecule (see Figure 2-3A), through a primary Ub-binding site, the S1 site in the catalytic 
domain (Mevissen and Komander, 2017). This interaction orients the C-terminus of the distal 
Ub and its linkage towards the catalytic center. Additional substrate or Ub-binding sites 
provide DUBs with specificity and the ability to distinguish between distinct Ub linkages. A 
second Ub-binding site inside or outside of the catalytic domain enables DUBs to bind two 
consecutive Ub molecules in Ub chains. This S1´ site can accommodate the proximal Ub 
only in a particular orientation and thus determines what linkage is within reach of the active 
site (Mevissen and Komander, 2017).  
The extent of linkage specificity varies among the DUB families. All MINDY family members, 
for example, are Lys48-specific (Abdul Rehman et al., 2016) and most OTU DUBs, give 
preference to one particular linkage type or to a small selection of linkages (Mevissen et al., 
2013): Cezanne exclusively disassembles Lys11-Ub (Mevissen et al., 2016), OTUB1 
specifically cleaves Lys48-Ub (Edelmann et al., 2009) and OTULIN is the only known DUB 
that is specific for the cleavage of Met1-Ub (Keusekotten et al., 2013). Usually 
linkage-specific enzymes cannot cleave off the remaining substrate-bound monoUb since 
their minimal substrate is a diUb. In contrast, most USPs unspecifically cleave a broad range 
of Ub linkages (Komander et al., 2009b) and are also capable of removing substrate-bound 
monoUb (Mevissen and Komander, 2017). Even though they are very promiscuous in terms 
of Ub linkages, they often specifically recruit target proteins that they deubiquitinate by 
means of substrate-specific binding sites. It is important to mention that the USP CYLD 
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(Cylindromatosis) is an exception, since it preferentially cleaves Lys63- and Met1-Ub chains 
(Komander et al., 2008; Komander et al., 2009b; Sato et al., 2015). 
In addition, a polyUb chain can be cleaved by DUBs at different sites. In the case of internal 
cleavage by DUBs with so-called endo-activity, modified substrates can quickly become 
deubiquitinated, and the released unanchored polyUb chains have to be processed 
afterwards. Endo-activity is a common feature of DUBs that modulate Ub-mediated signaling, 
as for example CYLD (Komander et al., 2008). If the Ub chain is attacked from the distal end 
by a DUB with exo-activity, monoUb is released at each cleavage step and the complete 
deubiquitination of substrates requires more cleavage steps than complete deubiquitination 
by endopeptidases. Exo-activity is a characteristic of the proteasome-associated DUB 
USP14 (Hu et al., 2005) and the MINDY family (Abdul Rehman et al., 2016). Whether a DUB 
deconjugates polyUb with endo- or exo-activity, mainly depends on the accessibility of the 
catalytic site for the respective chain type. Interestingly, USP21 hydrolyzes Lys6-Ub with 
exo- (Hospenthal et al., 2013), Lys63-Ub with endo-activity (Ye et al., 2012) based on the 
structural conditions of its USP domain. 
Specialized ‘recycling’ DUBs exist for the cleavage of free unattached Ub chains. USP5 
(IsoT), for instance, recognizes and binds the C-terminal di-Gly motif in unanchored Ub 
chains via its ZnF-UBP domain, and efficiently disassembles them from the proximal end, 
regardless of the linkage type (see also section 2.1.2) (Reyes-Turcu et al., 2006). 
DUB abundance, localization and post-translational modifications can additionally influence 
and fine-tune DUB activity and function (Mevissen and Komander, 2017). Some DUBs, such 
as the proteasome-bound USP14, associate with large protein complexes to fulfill their 
function (Borodovsky et al., 2001; Hu et al., 2005). DUBs can also form complexes with E3 
ligases (Elliott et al., 2014; Schaeffer et al., 2014; Sowa et al., 2009), indicating that the 
synthesis and degradation of Ub chains are often closely linked and regulated. 
2.1.4 Ubiquitination in the NF-?B signaling pathway 
Transcription factors of the NF-?B family are crucial for proper functioning of our immune 
system since they regulate the expression of target genes, which induce pro-inflammatory 
immune responses, cell survival, cell proliferation and cell differentiation (Hayden and 
Ghosh, 2012).  
Under unstimulated conditions, NF-?B dimers are bound and retained in the cytoplasm by 
the inhibitor of NF-?B alpha (I?B?). Stimulation of immune receptors, such as cytokine 
receptors, pattern recognition receptors (PRRs) or antigen receptors, by their respective 
ligands triggers activation of the canonical NF-?B signaling pathway. Owing to this activation, 
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I?B? is phosphorylated and subsequently modified with Lys48-linked Ub chains. This 
ubiquitination with Lys48-linked polyUb results in the proteasomal degradation of I?B? and in 
the release of the transcription factors. Free NF-?B dimers can finally translocate into the 
nucleus and induce gene transcription (Hayden and Ghosh, 2012; Liu and Chen, 2011).  
Besides ubiquitination of I?B?, adaptor proteins and E3 ligases are recruited to the receptors 
and form receptor-associated initial complexes upon stimulation of immune receptors. In the 
case of tumor necrosis factor receptor 1 (TNFR1), for example, TRADD (TNFR1-associated 
death domain protein) and the kinase RIPK1 (receptor-interacting serine/threonine protein 
kinase 1), as well as the E3 enzymes cIAP1/2 (cellular inhibitor of apoptosis 1 and 2) and 
TRAF2 (TNF receptor-associated factor 2) represent the receptor-proximal signaling complex 
(Fiil and Gyrd-Hansen, 2014; Hayden and Ghosh, 2012; Lork et al., 2017). This cluster of 
adaptor proteins and enzymes enables ubiquitination of complex components, predominantly 
with Lys63-linked Ub chains, creating a binding platform for additional protein complexes 
(Figure 2-4). 
Among others, the linear Ub chain assembly complex (LUBAC) is also recruited to 
receptor-associated signaling complexes, as it has been shown for TNFR1 and NOD2 
 
Figure 2-4: Ubiquitin-mediated NF-?B activation. 
Engagement of immune receptors by ligands leads to the assembly of receptor-associated signaling complexes composed of 
adaptor proteins, E3 ligases and kinases. These complexes are modified with Lys63-Ub, Met1-Ub and other Ub chain types,
which are recognized and bound by two key kinase complexes. The TAB-TAK1 complex induces MAPK signaling and activates 
the IKK complex. The activated IKK complex phosphorylates I?B? leading to its proteasomal degradation. Released NF-?B
dimers translocate into the nucleus, which together with AP-1 up-regulates target gene expression.  
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(nucleotide-binding oligomerization domain-containing protein 2) (Damgaard et al., 2012; 
Haas et al., 2009). Recruitment of LUBAC results in the additional conjugation of Met1-Ub on 
signaling components, which, along with Lys63-Ub, promotes the attraction and activation of 
two important kinase complexes (Figure 2-4): The I?B kinase (IKK) complex, composed of 
IKK?, IKK? and NEMO (IKK?) is recruited to Met1-Ub via the regulatory subunit NEMO 
(Rahighi et al., 2009), whereas the TAK1-binding proteins TAB2 and TAB3 lead the TAB-
TAK1 complex to Lys63-Ub chains (see section 2.1.2). TAK1 induces downstream MAPK 
signaling and phosphorylates the adjacent IKK? subunit of the IKK complex leading to its 
activation (Zhang et al., 2014). Activated IKK?, in turn, phosphorylates I?B?, which leads to 
the ubiquitination and proteasomal degradation of I?B?, as mentioned above (Hayden and 
Ghosh, 2012). 
2.2 Linear ubiquitin (Met1-Ub) 
Linear Ub, also referred to as Met1-Ub, contrasts strongly with all other Ub chain types, since 
peptide bonds (Figure 2-5A) and not isopeptide bonds (Figure 2-5B) link the Ub molecules to 
one another. This creates a unique chemical and structural surrounding at the linkage sites 
(Figure 2-5). Compared to isopeptide bonds, the peptide bond has limited rotational freedom 
and the Met1 side chain occupies much space next to the carboxyl group (Komander et al., 
2009b). 
 
Figure 2-5: Chemical environment of peptide and isopeptide bonds in Ub chains. 
A) In Met1-Ub, the C-terminal Gly76 of the distal Ub is linked to the ?-amino group of Met1 in the proximal Ub via a peptide 
bond. Met1 and Gln2 side chains are in close vicinity to the peptide bond and limit the rotational freedom of the Ub linkage. 
B) In Lys-linked Ub chains, distal Gly76 is connected to the ?-amino group of a proximal Lys side chain. 
The peptide and isopeptide bonds, respectively, are colored in yellow, amino acid side chains in red. 
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The structural conformation of Met1-Ub is similar to that of Lys63-Ub (Komander et al., 
2009b; Varadan et al., 2004) and just as Lys63-Ub, it is also essential for the regulation of 
various signaling pathways (Shimizu et al., 2015). 
In human cells, two sources exist for Met1-Ub. On the one hand, the UBB and UBC genes 
encode Met1-linked Ub precursors that are composed of three to nine Ub molecules 
(Ozkaynak et al., 1984) and are post-translationally processed by DUBs like USP5 to 
maintain the cellular availability of free Ub (Amerik et al., 1997). On the other hand, Met1-Ub 
is generated by a specific E3 ligase complex, the linear Ub chain assembly complex 
(LUBAC) (Kirisako et al., 2006). Met1-Ub is disassembled by the recently identified 
Met1-specific OTU domain-containing DUB OTULIN (Keusekotten et al., 2013) and by the 
USP CYLD, which is selective for Met1- and Lys63-Ub (Hrdinka et al., 2016; Komander et 
al., 2008; Sato et al., 2015). Some other promiscuous USPs can also hydrolyze Met1-Ub, but 
only with very low efficiency compared to other chain types (Faesen et al., 2011; Komander 
et al., 2009b). DUBs of other families are unreactive towards Met1-Ub (Komander et al., 
2009b; Mevissen et al., 2013).  
Linear Ub is an important regulator of inflammatory and cell death signaling and has been 
linked with Wnt signaling during embryonic development (Rittinger and Ikeda, 2017; Rivkin, 
2013; Sasaki and Iwai, 2015; Shimizu et al., 2015). Deficiencies in the Met1-Ub machinery 
impair the function of the immune system and cause disease (Hrdinka and Gyrd-Hansen, 
2017; Rittinger and Ikeda, 2017). 
2.2.1 LUBAC 
To this day, LUBAC is the only known E3 ligase complex that specifically generates 
Met1-Ub. It is composed of the proteins HOIL-1L (Heme-oxidized IRP2 Ub ligase-1, also 
termed RBCK1 or RNF54), HOIP (HOIL-1-interacting protein, also termed RNF31 or ZIBRA), 
and SHARPIN (Shank-associated RH domain-interacting protein, also termed hSIPL1) 
(Gerlach et al., 2011; Ikeda et al., 2011; Kirisako et al., 2006; Tokunaga et al., 2011). 
Although both HOIP and HOIL-1 are E3 ligases with functional RBR domains, the ability of 
the complex to generate Met1-Ub originates from the catalytic activity of HOIP (Emmerich et 
al., 2013; Stieglitz et al., 2012). Being an RBR E3 ligase, HOIP catalyzes the assembly of 
Met1-Ub by means of a RING/HECT hybrid mechanism (Figure 2-6). After an initial 
interaction between the RING1 domain and the incoming E2-Ub complex, the Ub is taken 
over by Cys885 in the RING2 domain and subsequently connected to the amino-terminus of 
the target Ub (Smit et al., 2012; Stieglitz et al., 2012; Stieglitz et al., 2013). 
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It was shown that LUBAC can at least in vitro form linear chains with various E2 enzymes 
(Kirisako et al., 2006). However, Met1-linkage specificity is not determined by these E2s, but 
is an intrinsic feature of HOIP. It is based on a C-terminal linear Ub chain-determining 
domain (LDD) that forms a structural unit with the RING2 domain. The LDD binds the 
acceptor Ub and brings its N-terminus in close proximity to the donor Ub in the RING2 
domain, thus enabling formation of the peptide bond (Smit et al., 2012; Stieglitz et al., 2013). 
So far, it is unclear whether LUBAC may only generate linear Ub on existing Ub chains or 
whether it is capable of recognizing the target substrate and attaching the first Ub (Emmerich 
et al., 2016; Emmerich et al., 2013; Fujita et al., 2014; Hrdinka et al., 2016; Smit et al., 2012; 
Tokunaga et al., 2009). In vitro isolated HOIP is present in an auto-inhibited state (Stieglitz et 
al., 2012). The binding of HOIL-1 or SHARPIN releases this state and promotes HOIP 
activity (Figure 2-6) (Gerlach et al., 2011; Kirisako et al., 2006; Stieglitz et al., 2012). It is 
known that the binding of only one component is sufficient to promote HOIP activity, the 
exact stoichiometric composition of cellular LUBAC, however, is still unclear. It cannot be 
ruled out that distinct LUBAC complexes with different properties are present in cells. Gel 
filtration analyses of cell extracts revealed that all components associate into a complex with 
an apparent molecular weight of approximately 600 kDa (Kirisako et al., 2006; Tokunaga et 
al., 2011).  
LUBAC stability strongly depends on the prescence of all three sububnits. Loss of a single 
component results in LUBAC destabilization and functional impairment (Boisson et al., 2015; 
Boisson et al., 2012; Ikeda et al., 2011; Tokunaga et al., 2011). 
 
Figure 2-6: HOIP interacts with LUBAC subunits and DUBs. 
HOIP, the catalytic subunit of LUBAC, generates Met1-Ub by a RING-HECT hybrid mechanism. Met1-Ub specificity is mediated 
by the linear Ub chain-determining domain (LDD). HOIP activity requires interaction with the other LUBAC components (HOIL-1 
or SHARPIN). Moreover, HOIP interacts with the Met1-Ub cleaving DUBs OTULIN and CYLD via its PUB domain. Whereas 
OTULIN directly associates with HOIP via a PUB-interacting motif, the HOIP-CYLD interaction is mediated by the bridging factor 
SPATA2. 
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HOIP additionally interacts with the DUBs OTULIN and CYLD (Figure 2-6). OTULIN 
exclusively disassembles linear Ub (Keusekotten et al., 2013), whereas CYLD cleaves both 
Met1-Ub and K63-Ub (Hrdinka et al., 2016; Komander et al., 2009b; Sato et al., 2015). 
OTULIN directly binds to the PUB (peptide:N-glycanase/UBA- or UBX-containing proteins) 
domain of HOIP by means of a PUB-interacting motif (PIM) (Elliott et al., 2014; Schaeffer et 
al., 2014), CYLD, however, is linked to HOIP via the bridging factor SPATA2 
(Spermatogenesis-associated protein 2) (Elliott et al., 2016; Kupka et al., 2016a; Schlicher et 
al., 2016; Wagner et al., 2016). SPATA2 also carries a PIM and engages the same 
PIM-binding pocket in HOIP as OTULIN (Elliott et al., 2016). Therefore, OTULIN and 
SPATA2-CYLD cannot simultaneously form a complex with HOIP, but it remains to be 
defined whether the two distinct LUBAC-DUB complexes are stably associated or whether 
they are subjected to a dynamic exchange (Draber et al., 2015; Elliott et al., 2016).  
The generation of Met1-Ub by LUBAC facilitates the activation of the transcription factor 
NF-?B in response to the stimulation of various immune receptors, like TNFR, IL-1R or TLRs 
(see section 2.1.4) (Ikeda, 2015; Shimizu et al., 2015). Upon stimulation, LUBAC is recruited 
to pre-assembled receptor-associated signaling complexes (Damgaard et al., 2012; Gerlach 
et al., 2011; Haas et al., 2009). Accordingly, all LUBAC subunits comprise NZF domains that 
allow interaction with Met1-Ub and Lys63-Ub (Emmerich et al., 2013; Gerlach et al., 2011; 
Haas et al., 2009; Ikeda et al., 2011; Sato et al., 2011; Shimizu et al., 2016). The NZF 
domain of SHARPIN, for example, is required for LUBAC recruitment to the activated TNFR1 
complex (Shimizu et al., 2016). Integrated in the receptor-associated signaling complexes, 
LUBAC decorates signaling mediators, like RIPKs, NEMO, TNFR1, MYD88 and IRAK1/4, 
with Met1-Ub (Draber et al., 2015; Emmerich et al., 2013; Fiil et al., 2013; Gerlach et al., 
2011; Hrdinka et al., 2016; Tokunaga et al., 2009). 
The HOIP-associated DUBs OTULIN and CYLD counteract LUBAC-mediated NF-?B 
activation (Draber et al., 2015; Elliott et al., 2014; Keusekotten et al., 2013; Schaeffer et al., 
2014; Takiuchi et al., 2014). When HOIP null MEFs are reconstituted with a HOIP PUB 
mutant that cannot interact with OTULIN and CYLD, TNF-induced NF-?B activation is 
enhanced (Takiuchi et al., 2014). Interestingly, LUBAC-associated SPATA2-CYLD is 
recruited to receptor-associated signaling complexes after stimulation of TNFR1 and NOD2, 
whereas minimal or no OTULIN is detected in activated signaling complexes (Draber et al., 
2015; Elliott et al., 2016; Schlicher et al., 2016; Wagner et al., 2016). Nevertheless, OTULIN 
was shown to limit ubiquitination of receptor-associated proteins (Fiil et al., 2013; Hrdinka et 
al., 2016; Keusekotten et al., 2013). Further studies are necessary to elucidate more 
precisely the role of OTULIN in the activated NF-?B signaling pathway. 
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LUBAC not only assembles Met1-Ub on substrates but also on itself (Fiil et al., 2013; Hrdinka 
et al., 2016; Keusekotten et al., 2013). This auto-ubiquitination is controlled by LUBAC-bound 
OTULIN but not by CYLD (Elliott et al., 2014; Hrdinka et al., 2016). The purpose of LUBAC 
auto-ubiquitination is not completely clarified, but it was suggested to affect LUBAC activity 
(Damgaard et al., 2016; Draber et al., 2015; Fiil et al., 2013; Hrdinka et al., 2016). In addition 
to the role of LUBAC in NF-?B-mediated immune signaling, it is also implicated in cell death 
regulation (Sasaki and Iwai, 2015; Shimizu et al., 2015). 
2.2.2 OTULIN – the only known Met1-specific DUB 
In 2013, two groups identified independently the first DUB that exclusively disassembles 
Met1-Ub: On the one hand by studying mutations in mice that lead to embryonic lethality due 
to angiogenic abnormalities (Rivkin, 2013), on the other hand by a bioinformatical screen in 
search of unannotated OTU DUBs (Keusekotten et al., 2013). 
Keusekotten et al. found an OTU domain with complete catalytic triad (Cys129, His339, 
Asn341) in the previously unannotated protein FAM105B and named the protein OTULIN 
(OTU DUB with linear linkage specificity). OTULIN is composed of 352 aa and the highly 
conserved OTU domain that was shown to be sufficient for OTULIN´s Met1-linkage 
specificity spans a large part of the protein (aa 80-352, Figure 2-7A) (Keusekotten et al., 
2013). Structural analyses of this domain revealed that substrate-unbound OTULIN exists in 
an auto-inhibited state, in which the catalytic residues His339 and Cys129 are maintained in 
an inactive conformation by Asp336 (Keusekotten et al., 2013). MonoUb is unable to induce 
a conformational change in the inactive catalytic pocket, which makes OTULIN unreactive 
towards monoUb-based suicide inhibitors such as Ub-AMC (Keusekotten et al., 2013; Rivkin, 
2013). The minimal substrate cleaved by OTULIN is Met1-linked diUb. Its binding to OTULIN 
causes release of the auto-inhibited state and elicits enzymatic activity. 
 
Figure 2-7: OTULIN specifically disassembles Met1-Ub.  
A) Schematic representation of OTULIN. OTULIN consists of a flexible N-terminus and a catalytic OTU domain, which is 
sufficient for both Met1-linkage specificity and cleavage activity. The PUB-interacting motif (PIM) in the N-terminus mediates the 
interaction with HOIP. 
B) Met1-linked proximal Ub is specifically bound by the S1´ binding site in OTULIN. Upon binding, Glu16 of the proximal Ub is 
inserted into the catalytic pocket, where it co-ordinates the catalytic triad for the cleavage reaction (substrate-assisted catalysis). 
Asterisk: catalytic center. 
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OTULIN´s unique specificity for Met1-linked Ub chains can be attributed to two molecular 
circumstances (Keusekotten et al., 2013): On the one hand, OTULIN has a very selective 
Met1-Ub binding site. Besides the common interaction between the S1 site and the distal Ub, 
the S1´ site of OTULIN orients the proximal Ub in such a way that the peptide bond points 
towards the catalytic center (Figure 2-7B). Even structurally similar Lys63-Ub would not fit 
properly into the S1´ binding site, which explains the 100-fold lower affinity of OTULIN 
towards Lys63-Ub. Moreover, OTULIN is not able to hydrolyze Lys63-Ub since the 
isopeptide bond is shielded from the catalytic center by a dedicated binding pocket. On the 
other hand, Met1-specificity of OTULIN can be attributed to a cleavage mechanism referred 
to as substrate-assisted catalysis (Keusekotten et al., 2013). The specific attachment of 
Met1-Ub leads to the insertion of the proximal Ub residue Glu16 into the catalytic pocket, 
where it rearranges the catalytic residues and hence enables the own cleavage (Figure 
2-7B). 
Gumby mice carrying a homozygous mutation (GumW96R or GumD336E) die during embryonic 
development between E12.5 and E14 due to defects in angiogenesis. The W96R mutation is 
located in the S1´ site of Otulin/gumby and drastically reduces affinity of Otulin towards 
Met1-Ub. Thus, the enzymatic activity is functionally impaired, leading to increased Met1-Ub 
steady-state levels in gumby mice (Rivkin, 2013). Also samples from patients carrying a 
homozygous mutation in OTULIN that compromises OTULIN stability and activity showed 
strong accumulation of linear Ub chains (Damgaard et al., 2016; Zhou et al., 2016), 
emphasizing that OTULIN is crucial for the homeostatic control of cellular Met1-Ub levels. 
Interestingly, depletion of CYLD which also cleaves linear Ub chains does not have an 
impact on basal Met1-Ub levels (Draber et al., 2015).  
Moreover, OTULIN counteracts LUBAC-mediated linear ubiquitination of immune receptor-
associated proteins and auto-ubiquitination of LUBAC (Fiil et al., 2013; Hrdinka et al., 2016; 
Keusekotten et al., 2013). OTULIN was shown to directly interact with the E3 ligase HOIP 
(Elliott et al., 2014; Schaeffer et al., 2014). A highly conserved peptide sequence of five 
amino acids (Asp54-Met55-Tyr56-Arg57-Ala58) in the OTULIN N-terminus mediates the 
interaction with the HOIP PUB domain, with Met55 and Tyr56 being the key residues (Figure 
2-7A) (Elliott et al., 2014). Other PUB domains, as they are found in PNGase or UBXD1, are 
not bound by this PIM of OTULIN. Phosphorylation of Tyr56 prevents the OTULIN-HOIP 
association and thus might represent a regulatory mechanism for the interaction in cells 
(Elliott et al., 2014; Schaeffer et al., 2014). 
 
OTULIN depletion in immune cells has cell type-specific consequences: In T and B cells, 
LUBAC is degraded leading to massive impairment of Met1-Ub signaling. In contrast, 
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Met1-Ub accumulates in myeloid cells resulting in constitutive NF-?B activation and 
overproduction of inflammatory cytokines (Damgaard et al., 2016), resembling the 
autoimmune disease termed ORAS (OTULIN-related autoinflammatory syndrome) from 
patients with hypomorphic mutations in the OTULIN gene (Damgaard et al., 2016; Zhou et 
al., 2016). Consistent with a critical requirement for OTULIN catalytic activity, adult OTULIN 
C129A mutant mice exhibit auto-inflammation, which relies on aberrant induction of cell 
death (Heger et al., 2018). 
Since the aberrant angiogenesis in gumby mice results from defective Wnt signaling, 
OTULIN has also been associated with canonical Wnt signaling during embryonic 
development (Rivkin, 2013), besides its regulatory function in signaling pathways of the 
immune system. In line with this, Wnt reporter assays revealed that the generation of 
Met1-Ub by LUBAC suppresses Wnt signaling, and OTULIN counteracts this suppression 
(Rivkin, 2013; Takiuchi et al., 2014). Moreover, an interaction between the OTULIN 
N-terminus and the protein DVL2, which is involved in Wnt signaling, was identified (Rivkin, 
2013). Importantly, so far all functions of OTULIN have been attributed to its role in Ub 
homeostasis by catalyzing deconjugation of Met1-linked Ub chains and LUBAC binding. 
2.3 Activity-based probes 
Activity-based probes (ABPs) are powerful tools to study enzyme activities and functions. 
They are composed of a reactive group, also referred to as a warhead, which is fused to a 
detection marker (Cravatt et al., 2008). In most cases the reactive group is an electrophile. In 
a nucleophilic attack by an active enzyme, the electrophilic warhead becomes covalently 
linked to the active site (Figure 2-8). In consequence of covalently modifying the active site, 
enzymes get irreversibly inhibited (Cravatt et al., 2008). The detection marker, for example a 
fluorophore or an affinity tag, is needed to detect the enzyme-coupled probe in subsequent 
experimental steps. ABPs often target large groups of enzymes that display similar catalytic 
features, like serine hydrolases, cysteine proteases or kinases.  
 
Figure 2-8: Schematic representation of an ABP. 
By a nucleophilic enzymatic attack, the electrophilic warhead becomes covalently coupled to the active site of the enzyme. 
Recognition elements increase target specificity of the probes. Detection markers such as affinity tags or fluorophors enable the 
detection of enzyme-ABP complexes in subsequent assays. 
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This enables acquisition of the functional state of the proteome in physiological and 
pathophysiological settings, a process that is called activity-based protein profiling (Cravatt et 
al., 2008). In order to reduce promiscuity and enhance target specificity, ABPs often 
additionally carry a recognition element that is based on the respective enzyme substrate 
(Figure 2-8) (Ovaa, 2007). 
2.3.1 ABPs for deubiquitinating enzymes 
The first ABPs for detecting DUB activities consisted of a Ub molecule as recognition 
element, which is C-terminally fused to an electrophilic group such as vinyl methyl ester 
(VME) or propargylamide (PA) (Figure 2-9A) (Borodovsky et al., 2002; de Jong et al., 2012). 
These commonly called suicide probes are attacked by the nucleophilic active site Cys that 
exists in most DUBs, generating a covalent bond between the probe and the enzyme. 
MonoUb-based ABPs like Ub-PA or Ub-VME promiscuously label DUBs from different DUB 
families (Borodovsky et al., 2002; Ekkebus et al., 2013). On the basis of this characteristic, 
such probes have been successfully used to analyze DUB activities in cell extracts (activity 
profiling) and to determine efficiency and specificity of DUB inhibitors (Altun et al., 2011). 
Moreover, the use of ABPs led to the identification of new DUBs (Borodovsky et al., 2002). 
For many DUBs it is still not known, in which cellular processes they are implicated. In this 
case, ABPs will help to identify new functions of deubiquitinating enzymes. 
To profile Ub chain linkage specificity of DUBs, ABPs have been generated that are based 
on linkage-specific diUbs. In these probes, the electrophilic warhead is mostly positioned 
between the two Ub moieties, where the DUB attack takes place (Figure 2-9B) (Li et al., 
2014; McGouran et al., 2013; Mulder et al., 2014). The challenge in designing a diUb-based 
ABP is that the introduced warhead has to mimic the linkage of the Ub molecules as 
accurately as possible. Only in this way, the ABP structurally resembles native diUb. Mulder 
et al. took advantage of the non-enzymatic native chemical ligation technique to generate 
diUb ABPs that are based on all seven Lys-linked diUbs (Mulder et al., 2014) and structurally 
closely resemble the native isopeptide-linked diUbs. However, this strategy was not 
applicable to the generation of Met1-linked diUb-based probes since the peptide bond 
 
Figure 2-9: Schematic respresentation of monoUb-based and linkage-specific diUb-based ABPs for DUBs. 
A) In monoUb-based suicide probes, the recognition element Ub is C-terminally fused to an electrophilic warhead. 
B) DiUb-based ABPs are used to profile linkage specificity of DUBs. The electrophilic warhead is positioned next to the scissile 
bond (yellow) between distal and proximal Ub. 
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between two linearly connected Ub molecules contrasts strongly with an isopeptide bond 
regarding structure and chemical nature (see Figure 2-5). The insertion of an appropriate 
electrophile mimicking the Gly-Met environment of a linear diUb linkage has caused 
difficulties to date. McGouran et al. generated a probe based on Met1-diUb (McGouran et al., 
2013), which labeled many USPs that usually cleave linear Ub chains only with low efficiency 
(Faesen et al., 2011; Komander et al., 2009b). More importantly, the Met1-specific DUB 
OTULIN was not labeled with this probe (McGouran et al., 2013). In this context, one should 
mention again that OTULIN does not react with common monoUb-based suicide inhibitors, 
since the substrate-assisted Ub chain hydrolysis relies on a native Met1-linked diUb as 
substrate (Keusekotten et al., 2013; Mevissen et al., 2013). The low specificity of the probe 
was attributed to the greater flexibility of the introduced electrophile and the loss of the Met1 
side chain (McGouran et al., 2013).  
In another attempt to generate an ABP based on linear diUb, Met1 in the proximal Ub moiety 
was replaced by the electrophilic non-canonical amino acid dehydroalanine (Dha) (Haj-
Yahya et al., 2014). Dha is a small warhead that is easily generated by conversion of Cys 
through oxidative elimination (Bernardes et al., 2008). However, instead of becoming 
covalently attached to the active site of OTULIN, the probe was cleaved by OTULIN and by 
USP2 as well (Haj-Yahya et al., 2014). To date, no DUB ABP has been generated that 
closely resembles native Met1-linked diUb and labels Met1-specific active OTULIN. In 
addition, all DUB ABPs generated so far target a broad range of DUBs and do not exhibit 
specificity towards one particular enzyme. 
2.4 Endosomal sorting by the retromer complex 
The endosomal network is an essential traffic system for proteins. As a result of endocytosis, 
the cellular plasma membrane is constantly engulfed and forms intracellular membrane-
coated early endosomes. Along with the plasma membrane, transmembrane proteins such 
as nutrient transporters, ion channels or surface receptors are also internalized. These 
proteins, referred to as cargos, are sorted and can take different routes through the cell: 
Either they are directly transported back to the plasma membrane for reuse (‘recycling’) (Hsu 
et al., 2012) or they migrate to the trans-Golgi network (TGN) by retrograde transport (Figure 
2-10) (Johannes and Wunder, 2011). Remaining in the endosome, cargos undergo the 
process of endosomal maturation and are finally degraded in the lysosome. Proper 
functioning of endosomal sorting is crucial for the maintenance of cellular homeostasis. It 
must be ensured that essential membrane proteins are excluded from lysosomal degradation 
(Burd and Cullen, 2014). 
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In eukaryotes, an important mediator of this sorting process is the retromer complex, which is 
assembled on endosomes. The mammalian retromer is a heterotrimeric protein complex 
composed of the vacuolar protein sorting-associated proteins (VPS)26, VPS29 and VPS35 
(Gallon and Cullen, 2015). Composed of 796 amino acids, VPS35 is the largest retromer 
subunit that interacts via its C-terminus with VPS29 and via its N-terminus with VPS26 
(Norwood et al., 2011). Three paralogous genes for VPS26 exist in mammals: VPS26A, 
VPS26B and Down´s syndrome critical region 3 (DSCR3) (Kerr et al., 2005; Koumandou et 
al., 2011). VPS26A and VPS26B display 69% amino acid sequence identity and 82% 
similarity and adopt very similar arrestin-fold structures (Kerr et al., 2005). They form two 
distinct retromer complexes with VPS35 and VPS29 as both utilize the same binding site in 
VPS35 and cannot bind simultaneously (Collins et al., 2008; Gallon and Cullen, 2015). To 
date, it is unclear whether DSCR3 contributes to retromer function. 
The retromer regulates export of cargos from the endosomes to the TGN or to the plasma 
membrane (Gallon and Cullen, 2015). It forms functionally distinct complexes with different 
family members of the sorting nexins (SNXs). The specific complex composition determines 
which cargo is transported and where it is transported to (Figure 2-10).  
In mammals, 33 SNX proteins (Cullen, 2008) have been identified to date, six of which 
(SNX1, SNX2, SNX3, SNX5, SNX6 and SNX27) interact with the retromer complex (Gallon 
and Cullen, 2015; Lucas and Hierro, 2017). All SNX proteins have a characteristic Phox 
 
Figure 2-10: Retromer-mediated endosomal sorting of cargos. 
Endocytosis leads to the internalization of plasma membrane proteins (cargos) into early endosomes. Distinct SNX-retromer 
complexes then mediate cargo export from the endosomes to the plasma membrane or to the TGN to prevent lysosomal 
degradation. 
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homology (PX) domain that preferentially binds phosphatidylinositol 3-phosphate (PI(3)P) 
membrane lipids. Therefore, most SNXs are recruited to PI(3)P-rich early endosomes 
(Teasdale and Collins, 2012).  
As the retromer itself is not able to directly bind membranes, association with SNX proteins 
facilitates its recruitment to endosomes (Gallon and Cullen, 2015). For instance, SNX3 can 
recruit the retromer by interacting with VPS26. This SNX3-retromer complex formation 
enables recognition and binding of the divalent cation transporter DMT1-II at the 
SNX3-VPS26 interface and its transport to the TGN (Figure 2-10) (Lucas et al., 2016). SNX1, 
SNX2, SNX5 and SNX6 carry a Bin/Amphiphysin/Rvs (BAR) domain in addition to the PX 
domain (van Weering et al., 2010). BAR domains form hetero- or homo-dimers that adopt 
concave structures enabling sensing and binding of curved membranes (Gallon and Cullen, 
2015). It has been proposed that higher-order helical arrays of SNX-BAR proteins might also 
trigger and stabilize membrane tubules to generate carrier structures for cargos (Frost et al., 
2008; Gallon and Cullen, 2015; Lucas and Hierro, 2017; van Weering et al., 2012). The 
SNX-BAR-retromer complex also mediates the retrograde transport of cargos to the TGN 
(Gallon and Cullen, 2015).  
The SNX27-retromer, however, transports cargos such as the ?2-adrenergic receptor 
(?2-AR) or the glucose transporter GLUT1 from the early endosomes to the plasma 
membrane (Figure 2-10) (Lauffer et al., 2010; Steinberg et al., 2013). Recognition of cargos 
is achieved by sorting signals. In the case of transmembrane proteins sequence motifs are 
present in the cytoplasmic tail and are bound by adaptor proteins. Both the retromer and 
retromer-associated SNXs can function as adaptors (Gallon and Cullen, 2015).  
Proper sorting of cargos not only relies on appropriate functioning of SNX-retromer 
complexes, but also on the dynamic formation of actin polymers on the endosomal 
membrane. Actin patches control endosomal biogenesis and maturation, regulate endosomal 
morphology and motility and stabilize endosomal subdomains, providing a scaffold for cargo 
sorting at the endosomes (Simonetti and Cullen, 2018). Inhibition of actin polymerization by 
drugs leads to defects in cargo segregation and in endosomal maturation (Ohashi et al., 
2011). The Wiskott-Aldrich syndrome protein and SCAR homologue (WASH) complex is 
composed of the five proteins WASH1, strumpellin, SWIP, FAM21 and coiled-coil domain 
containing protein 53 (CCDC53) and promotes the nucleation of filamentous actin by the 
actin-related protein 2/3 (Arp2/3) complex at the endosomes (Derivery et al., 2009; Seaman 
et al., 2013). The interaction of FAM21 with the retromer complex and with SNX27, 
respectively, links the actin nucleation-promoting activity of the WASH complex to the 
targeted sorting process of cargos (Jia et al., 2012; Lee et al., 2016). 
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2.4.1 SNX27-dependent endosome-to-plasma trafficking 
Like all other SNX proteins, SNX27 also has a PX domain, which recruits SNX27 to early 
endosomes (Figure 2-11A) (Cai et al., 2011; Lauffer et al., 2010; Rincon et al., 2007). 
Additionally, SNX27 has a less well-characterized C-terminal FERM (4.1, ezrin, radixin, 
moesin)-like domain, which interacts with the SNX-BAR protein SNX1 and with the WASH 
complex, and comprises another lipid-binding site that preferentially binds bi- and 
tri-phosphorylated phosphatidylinositol lipids (Ghai et al., 2015; Lee et al., 2016; Steinberg et 
al., 2013). Among the SNX proteins, SNX27 is the only member that also bears a unique 
post-synaptic density 95/discs large/zonula occludens (PDZ) domain (Figure 2-11A) (Gallon 
et al., 2014). PDZ domains commonly mediate protein-protein interactions by binding to 
C-terminal peptide sequences, the so-called PDZ-binding motifs (PDZbms) in the binding 
partner (Doyle et al., 1996). In line with this, the SNX27 PDZ domain binds C-terminal 
PDZbms with the class I consensus sequence X-[Thr/Ser]-X-?, where X is any and ? a 
bulky amino acid (Gallon and Cullen, 2015; Hung and Sheng, 2002; Lunn et al., 2007). Such 
PDZbms are found in transmembrane proteins such as GLUT1 (Steinberg et al., 2013) or 
?2-AR (Lauffer et al., 2010) that are recycled by the SNX27-retromer complex. These sorting 
signals are recognized and bound by SNX27 and transported from the endosomes to the 
plasma membrane in association with the retromer complex (Cullen and Korswagen, 2011; 
Gallon and Cullen, 2015; Temkin et al., 2011). 
 
Figure 2-11: The PDZ domain of SNX27 interacts with VPS26A and PDZbm-containing cargos. 
A) Schematic representation of SNX27. The PDZ domain that interacts with both VPS26A and PDZbm-containing cargos is 
highlighted in yellow.  
B) Crystal structure of the rat SNX27 PDZ domain (yellow) bound to mouse VPS26A (green) depicted as ribbon (PDB ID: 4P2A) 
(Gallon et al., 2014). The putative PDZbm binding pocket and the ?3-?4 loop that interacts with VPS26A are highlighted. 
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Besides transmembrane proteins, cytoplasmic proteins with PDZbms like diacylglycerol 
kinase ? (DGK?) (Rincon et al., 2007) or ?-PIX (Valdes et al., 2011) can also bind to the 
SNX27 PDZ domain.  
 
Structural analysis of the SNX27 PDZ domain revealed that it corresponds to the core 
structure of other PDZ domains with the exception that it contains an additional ?-hairpin 
loop (?3-?4 loop) that protrudes from this core structure (Balana et al., 2011; Gallon et al., 
2014). This ?3-?4 loop directly binds to both paralogs of the retromer component VPS26 and 
allows simultaneous binding of cargos in the spatially divided PDZbm binding pocket (Figure 
2-11B) (Gallon et al., 2014). Taken together, the SNX27 PDZ domain mediates the binding of 
cargos as well as the retromer association, enabling rapid endosome-to-plasma membrane 
transport. Proteomic analyses revealed that the surface expression of more than 100 cargos 
depends on both SNX27 and retromer (Steinberg et al., 2013). Through the additional 
interaction of the FERM domain with the WASH complex and SNX1, SNX27 brings 
components of the endosomal trafficking machinery closely together and thus regulates fast 
cargo recycling to the plasma membrane (Lee et al., 2016; Steinberg et al., 2013).  
The particular importance of SNX27 and retromer in neurons is recognizable by numerous 
neuropathologies like Parkinson´s disease, Alzheimer´s disease, Down syndrome and 
infantile epilepsy caused by mutations or altered expression patterns (Li et al., 2016). SNX27 
knockout (KO) mice die either in utero or within three weeks after birth. Born mice are small, 
fail to thrive and display neuronal deficits in the brain (Cai et al., 2011; Wang et al., 2013). 
Moreover, SNX27 deficiency in mice leads to synaptic dysfunction, memory and learning 
deficits and to a reduction in surface levels of NMDA (N-methyl-D-aspartate) and AMPA 
(?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors (Loo et al., 2014; Wang et 
al., 2013). Finally, it was shown that endosomal SNX27 is recruited to the immunological 
synapse in activated T cells and tumor-engaged natural killer cells but its role at the 
immunological synapse has not been well defined (Ghai et al., 2015; MacNeil and Pohajdak, 
2007; Rincon et al., 2011). So far, it is unclear, whether all SNX27 functions are connected to 
cargo sorting. 
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3. Aims of the study 
OTULIN is the only known DUB that exclusively cleaves Met1-linked Ub chains. Due to its 
hydrolase activity, it is of central importance for the homeostatic control of Met1-Ub levels. 
Besides its role as homeostatic factor, OTULIN has been associated with signaling 
pathways, which are regulated by linear Ub chains, such as NF-?B or cell death signaling.  
While the molecular basis for the specific cleavage of Met1-Ub by OTULIN has been 
clarified, it remains unclear, how much of the endogenous OTULIN is active, and whether 
catalytic activity of OTULIN is affected by various stimuli. Additionally, only the interaction 
with HOIP and LUBAC has been described in detail to date, and it is not known if OTULIN 
binds to other proteins and controls other cellular pathways. 
 
Therefore, the main aim of this study was to better characterize the DUB OTULIN with regard 
to its cellular activity and its cellular functions. To this end, a diUb-based active site-directed 
probe was chemically synthesized, which covalently labels OTULIN (OTULIN ABP). Initially, 
reactivity of OTULIN towards the new probe was validated using recombinant OTULIN in 
direct DUB assays and structural analyses as well as with endogenous OTULIN in cellular 
extracts. To enrich OTULIN and other ABP-binding proteins from cell extracts, the ABP was 
equipped with an affinity tag. By OTULIN ABP pull-downs from cell extracts and their 
subsequent mass spectrometric analysis, the selectivity of the OTULIN-directed ABP was 
analyzed. The very few cross-reactions were abolished by a small change in the probe 
design, yielding a specific OTULIN ABP.  
 
In the second part, the newly developed and well-characterized tool was used to search for 
OTULIN interactors. By mass spectrometric analysis of OTULIN ABP pull-downs, we 
identified SNX27 as a new interaction partner of OTULIN. Cellular interaction was verified by 
co-immunoprecipitations, confocal microscopy and analytical gel filtration analysis. Moreover, 
structural, biophysical and cellular analyses were performed in order to specify the 
mechanism of this interaction. The final aim of this study was to investigate the function of 
the OTULIN-SNX27 interaction and thus to describe a potential novel role of OTULIN in the 
cell.
RESULTS 
   
  27 
 
4. Results 
4.1 A linear diubiquitin-based ABP for efficient and selective detection of 
OTULIN 
To develop an experimental tool to function as OTULIN ABP, the following criteria needed to 
be met: (i) the ABP should be based on Met1-linked diUb since this corresponds to the 
minimal native OTULIN substrate (Keusekotten et al., 2013) and, (ii) the amino acid 
dehydroalanine (Dha) should be positioned near the scissile bond between the two Ub 
molecules as a small electrophilic warhead. The probe was designed and chemically 
synthesized by our collaboration partner Farid El Oualid (UbiQ, The Netherlands). He 
generated an N-terminally biotin-labeled Met1-diUb, in which the Gly76 of the distal Ub was 
substituted with Dha (bio-UbG76Dha-Ub, Figure 4-1). Introducing the small electrophile at this 
site prevents alterations (in terms of structure and flexibility) in the peptide bond environment 
between the two linearly linked Ub molecules. In order to facilitate efficient access to the 
biotin tag, an aminohexanoic (Ahx) linker was inserted between the tag and the N-terminus 
of Ub, generating some extra space (de Jong et al., 2012). 
The detailed protocol for the total chemical synthesis of bio-UbG76Dha-Ub is published in 
(Weber et al., 2017). Here, the synthesis is described only briefly: First, the two basic 
modules, bio-Ahx-labeled Ub1-75 and Cys-Ub, were produced by means of Fmoc 
(fluorenylmethoxycarbonyl)-based solid-phase peptide synthesis. Following fusion of the 
distal and proximal Ub moieties by native chemical ligation, the Cys residue was finally 
converted into Dha by oxidative elimination (Bernardes et al., 2008). 
4.1.1 Recombinant OTULIN is labeled by bio-UbG76Dha-Ub (OTULIN ABP) 
To test the reactivity of OTULIN toward the newly developed probe, the recombinantly 
produced catalytic OTU domain of OTULIN (OTULINcat, aa 80-352) was incubated with 
bio-UbG76Dha-Ub. The probe formed a covalent adduct with OTULINcat, which can be observed 
Figure 4-1: Bio-UbG76Dha-Ub closely resembles native Met1-diUb. 
Schematic of Met1-diUb in comparison with the active site-directed probe, bio-UbG76Dha-Ub (OTULIN ABP). The peptide bond 
linking the two Ub molecules is depicted in yellow, while the electrophilic Dha residue is displayed in red. 
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from a molecular weight (MW) shift in OTULIN by SDS-PAGE and Coomassie staining 
(Figure 4-2A, asterisk). The increase in MW corresponds to the MW of a diUb (~17 kDa). 
The catalytically inactive OTULIN mutant (C129A) did not react with the probe. Since 
catalytic activity is required for covalent probe attachment, bio-UbG76Dha-Ub represents the 
first described OTULIN ABP. A point mutation in the S1´ binding site of OTULINcat (W96A), 
previously shown to drastically diminish Met1-diUb affinity (Keusekotten et al., 2013), also 
prevented covalent adduct formation (Figure 4-2A). 
To monitor kinetics of the OTULIN-ABP complex formation, OTULINcat was incubated with 
OTULIN ABP at 30°C and equimolar concentrations. Adduct formation was detected after 
10 seconds, but within 30 minutes the educts were not completely converted (Figure 4-2B). 
Approximately 5-fold molar excess of ABP was required for almost complete labeling of 
OTULINcat within 15 minutes (Figure 4-2C). 
As expected for an ABP that covalently and irreversibly labels the active site of an enzyme, 
the probe inhibited Met1-tetraUb cleavage by OTULINcat in a dose-dependent manner 
(Figure 4-3A). 
 
Figure 4-2: Recombinant OTULINcat is labeled by the OTULIN ABP. 
A) Recombinant OTULINcat (1 µg) was incubated with 4 µg bio-UbG76Dha-Ub (2 hrs, 37°C). OTULIN-ABP complex formation was 
assessed by SDS-PAGE and Coomassie staining. Asterisk: OTULIN-ABP complex. 
B) 250 ng OTULINcat was incubated at 30°C in a 1:1 molar ratio with OTULIN ABP. OTULIN-ABP complex formation was 
monitored by Silver Staining after SDS-PAGE.  
C) 250 ng OTULINcat was incubated with increasing OTULIN ABP concentrations for 15 min at 30°C. OTULIN-ABP complex 
formation was monitored by Silver Staining after SDS-PAGE. 
 
Figure 4-3: OTULIN is inhibited by covalent attachment of the ABP. 
A) A TetraUb cleavage assay was performed after pre-treatment of OTULIN with increasing ABP concentrations. TetraUb chain 
cleavage was analyzed by Western Blot (WB) using anti-Ub antibody. 
B) A TetraUb cleavage assay was performed after pre-treatment of OTULIN with increasing PR-619 concentrations. TetraUb 
chain cleavage was assessed by WB using anti-Ub antibody. 
C) Following pre-treatment with increasing PR-619 concentrations, OTULINcat (500 ng) was incubated with 2 µg OTULIN ABP 
(5 min, 30°C). OTULIN-ABP complex formation was monitored by Silver staining. 
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Under these in vitro conditions, the ABP blocked OTULIN activity and tetraUb cleavage in a 
concentration range from 12 to 37 nM. To confirm that our probe only labels active OTULIN, 
we made use of the small-molecule inhibitor PR-619, which inhibits a broad range of DUBs 
(Altun et al., 2011). PR-619 dose-dependently inhibited Met1-tetraUb cleavage by OTULIN 
(Figure 4-3B) and prevented OTULIN-ABP complex formation (Figure 4-3C). PR-619 
concentrations between 370 nM and 1.1 µM rendered OTULIN inactive towards both tetraUb 
chains and OTULIN ABP. Altogether these data demonstrate that the OTULIN ABP 
efficiently labels the active site of recombinant OTULINcat. 
4.1.2 Structural analysis of the OTULIN-ABP complex 
To better characterize the OTULIN-ABP interaction, the complex was crystallized and 
analyzed by X-ray crystallography by our collaboration partner Paul Elliott (MRC, Cambridge; 
University of Oxford). The detailed analysis is published in (Weber et al., 2017). The 
OTULIN-ABP complex structure (PDB ID: 5OE7) was determined at 3 Å resolution (Figure 
4-4A) and is nearly indistinguishable from the published OTULIN C129A-Met1-diUb complex 
structure (PDB: 3ZNZ) (Keusekotten et al., 2013). The distal and proximal Ub moieties are 
arranged identically on the OTULINcat surface (Figure 4-4B). Further, the OTULIN active site 
adopts a similar conformation (Figure 4-4C). The structural analysis confirmed that the active 
site-directed probe reacts with OTULIN as expected. The electron density in the well-ordered 
active site enabled complete building of the thioether bond formed by the reaction between 
the Dha and catalytic Cys129 of OTULIN (Figure 4-4C, left). The inserted proximal Glu16 of 
the probe reveals that the ABP enables OTULIN to react with the ABP through substrate-
assisted catalysis. 
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4.1.3 Selectivity analysis of the OTULIN ABP towards recombinant DUBs 
To acquire a first impression of the OTULIN ABP selectivity, the probe was incubated with 
recombinant DUBs from different families (Figure 4-5A). Although the OTU domains of 
OTULIN and OTUB1 structurally closely resemble each other (Keusekotten et al., 2013), 
Lys48-specific OTUB1 did not react with the probe, to a similar extent as A20, another OTU 
DUB, and UCHL1 and UCHL3 from the UCH DUB family. The Ub-specific proteases USP2, 
USP7 and USP8 also did not form a covalent adduct with the ABP, although many USPs 
cleave a broad range of Ub chains (Komander et al., 2009a; Ritorto et al., 2014). In contrast, 
a small proportion of USP5 (IsoT) was covalently labeled by the OTULIN ABP, evident from 
a MW shift in SDS-PAGE (Figure 4-5A, asterisks). 
In parallel, the DUBs were either incubated with the suicide inhibitor Ub-PA or with Lys48-
linked diUb to ensure that all DUBs are active and that an inability to react with the ABP 
cannot be attributed to a lack of DUB activity. 
 
Figure 4-4: Structural analysis of the OTULIN-ABP complex.  
A) Structure of the OTULIN-ABP complex is depicted as ribbon. OTULINcat (aa 80–352) is shown in blue with the distal and 
proximal Ub moieties of the OTULIN ABP colored in dark and light green, respectively. Circle: catalytic triad of OTULIN.
(PDB ID: 5OE7) (Weber et al., 2017) 
B) Superimposition of the OTULIN-ABP complex structure (dark blue) and the OTULIN C129A-Met1-diUb complex structure
(OTULIN C129A – grey; PDB ID: 3ZNZ) (Keusekotten et al., 2013). 
C) Close-up views of the OTULIN active site bound to OTULIN ABP (left) or bound to Met1-diUb (C129A, middle) and overlay of 
both structures highlighting the identical arrangement of the catalytic triad. Relevant residues are shown in stick format.  
A-C) Illustrations provided by P. Elliott (MRC, Cambridge; University of Oxford) (Weber et al., 2017). 
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Beside OTULIN that fails to react with Ub-PA, because it requires an entire diUb substrate 
(Keusekotten et al., 2013; Mevissen et al., 2013), all tested DUBs formed Ub adducts with 
the suicide inhibitor and consequently were active (Figure 4-5B). Lys48-diUb was hydrolyzed 
by OTUB1, A20 and USP8, proving their catalytic activity (Figure 4-5C). 
 
Since OTULIN and USP5 can hydrolyze Met1-Ub, two additional Met1-Ub cleaving USP 
DUBs, USP21 and CYLD (Komander et al., 2009b; Sato et al., 2015; Ye et al., 2011), were 
assessed for their reactivity toward the OTULIN ABP (Figure 4-6A). Neither USP21cat nor 
CYLD reacted with the probe, even though they were proven to be active by means of Ub-PA 
(Figure 4-6B). Especially for CYLD, which preferentially cleaves Met1- and Lys63-Ub, this 
finding was unexpected. For both OTULIN and CYLD, it has been shown that they fail to 
hydrolyze Ub chains with G76S mutations (Keusekotten et al., 2013; Komander et al., 2008). 
Still, OTULIN reacts with the ABP, approving the G76Dha substitution, whereas CYLD does 
not do so. Referring to our ABP design, we wanted to determine whether the G76A mutation 
in the distal Ub (His-UbG76A-Ub) would be tolerated. 
 
Figure 4-5: OTULIN ABP selectively labels recombinant OTULIN and USP5. 
A) Recombinant DUBs (0.5 - 1 µM) were incubated with 3 µM OTULIN ABP (1 h, 30°C). Covalent adduct formation was 
assessed by Silver staining. Asterisks: DUB-ABP adducts. 
B) Recombinant DUBs (0.5 µM) were incubated with 5 µM Ub-PA (1 h, 30°C). Covalent adduct formation was determined by 
Silver staining. Asterisks: DUB-Ub adducts. 
C) OTUB1, A20cat and USP8 (0.5 µM) were incubated with 500 ng Lys48?linked diUb (1 h, 30°C). DiUb cleavage was examined
by Silver staining. 
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OTULINcat, USP21cat and CYLD hydrolyzed wild-type (WT) Met1-diUb, but were unable to 
cleave the G76A mutant (Figure 4-6C). To determine whether the mutation impairs binding of 
His-UbG76A-Ub to OTULIN, pull-down (PD) experiments of StrepII-tagged OTULIN 
(OTULINcat-Strep) with either Met1-diUb or UbG76A-Ub were performed (Figure 4-6D). WT 
Met1-diUb was strongly bound and pulled down by the catalytically inactive OTULINcat 
C129A mutant. The binding affinity of OTULIN WT or C129A for UbG76A-Ub, by contrast, was 
strongly reduced. This suggests that the binding affinity of OTULIN towards Met1-diUb 
strongly depends on the distal Gly76 and that the replacement of Gly76 by Dha in the ABP 
diminishes affinity. Nevertheless, the weak interaction is apparently sufficient to facilitate the 
reaction of OTULIN with the electrophilic Dha in our probe, which does not apply to CYLD. 
In addition to the desired ABP reactivity towards OTULIN, the first ABP selectivity analysis 
revealed that the probe slightly cross-reacts with recombinant USP5, which disassembles 
unanchored polyUb chains in cells (Amerik et al., 1997; Reyes-Turcu et al., 2006). 
 
Figure 4-6: The Met1-Ub cleaving DUBs USP21 and CYLD do not react with OTULIN ABP. 
A) Recombinant DUBs (0.5 - 1 µM) were incubated with 3 µM OTULIN ABP (1 h, 30°C). Covalent adduct formation was 
assessed by Silver staining. Asterisk: DUB-ABP adduct.  
B) Recombinant DUBs (0.5 µM) were incubated with 5 µM Ub-PA (1 h, 30°C). Covalent adduct formation was determined by 
Silver staining. Asterisks: DUB-Ub adducts.  
C) Recombinant OTULINcat, USP21cat or CYLD (1 µg) were incubated with either Met1-linked diUb WT or UbG76A-Ub (1 h, 37°C). 
DiUb cleavage was analyzed by WB. 
D) Strep-PD of OTULINcat-Strep in the presence of Met1-linked His-diUb WT or His-UbG76A-Ub. Interaction between the proteins 
was analyzed by WB. 
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4.1.4 OTULIN ABP reacts with OTULIN in cell extracts 
To determine whether the OTULIN ABP reacts with full-length OTULIN in cell extracts, 
HEK293 lysates from Flag-tagged OTULIN overexpressing cells were incubated with the 
ABP. The extracts were separated via SDS-PAGE and transferred to membranes by 
Western Blotting. Complex formation was analyzed by probing the membranes with anti-Flag 
antibody. 
Indeed, overexpressed OTULIN WT was entirely labeled by the probe and formed a covalent 
complex with the ABP (Figure 4-7A). The catalytically inactive OTULIN mutant, however, did 
not react with the probe as seen with recombinant OTULIN C129A (see Figure 4-2A). 
Probing the Western Blot (WB) membranes with anti-OTULIN antibody revealed that 
endogenous OTULIN was also labeled by OTULIN ABP (Figure 4-7A). Interestingly, all 
OTULIN present in HEK293 cells seems to be active or is activated through the ABP 
interaction as no uncoupled endogenous OTULIN could be detected following OTULIN ABP 
incubation. Reactivity of other overexpressed DUBs towards the OTULIN ABP was assessed 
in a similar manner (Figure 4-7B), even though the limited number of plasmids restricted the 
extent of the analysis. None of the tested full-length DUBs formed a covalent complex with 
the ABP. 
To test whether the observed cross-reactivity of the OTULIN ABP towards recombinant 
USP5 also persists towards cellular USP5, lysates of untransfected HEK293 cells were 
incubated with ABP. In accordance with the previous results, a small proportion of 
endogenous USP5 formed a covalent complex with the ABP (Figure 4-8A). However, it is 
important to mention that the majority of cellular USP5, contrary to OTULIN, did not become 
covalently attached to the ABP. Probing the WB membranes with other available 
 
Figure 4-7: OTULIN ABP labels active OTULIN in cell extracts. 
A) Extracts from HEK293 cells overexpressing Flag-OTULIN WT or C129A were incubated with 1 µg OTULIN ABP 
(~2.5x105 cells/reaction, 30 min, 30°C). Labeling of exo- and endogenous OTULIN was analyzed by WB. 
B) Experiment was performed as in A) with extracts from HEK293 cells overexpressing Flag-tagged DUBs  
(incubation time: 1 h). 
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DUB-specific antibodies confirmed that endogenous UCHL3, OTUB1 and CYLD did not react 
with the electrophilic Dha in the OTULIN ABP. 
To monitor the kinetics of the coupling reaction between cellular OTULIN and the ABP, 
extracts from 2x107 Jurkat T cells were incubated at room temperature (RT) with increasing 
amounts of ABP for 15 min (Figure 4-8B). As observed for HEK293 cells, the entire cellular 
OTULIN amount reacted with the active site-directed probe in T cells, and thus seems to be 
active. 
The reaction proceeded dose-dependently and 1 µg ABP was sufficient to achieve almost 
complete binding of OTULIN to the ABP. The USP5-ABP adduct was already detectable 
after incubation with 0.5 µg ABP, the amount of USP5-ABP complex did not accumulate with 
increasing ABP concentrations though. Upon incubation of the lysates with 1 µg ABP, 
OTULIN-ABP complex formation was already observed after 10 to 30 seconds, whereas the 
USP5-ABP complex formed with delay after 15 min (Figure 4-8C). However, to achieve 
almost complete coupling a 15-minute incubation time was required at RT. 
Thus, incubation of cellular extracts with ABP showed that active cellular OTULIN can also 
be detected with the probe and confirmed the cross-reactivity of the probe towards USP5. 
 
Figure 4-8: Endogenous OTULIN and USP5 react with OTULIN ABP in cell extracts. 
A) Incubation of HEK293 cell extracts was performed as in Figure 4-7A. Cross-reactivity of OTULIN ABP was assessed by WB
using the indicated anti-DUB antibodies. 
B and C) Extracts of Jurkat T cells (2x107 cells/sample) were incubated at RT with increasing OTULIN ABP amounts for 15 min 
(B) or with 1 µg OTULIN ABP for different times (C). 
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4.1.5 Incubation of cell extracts with ABP induces polyUb chain formation 
To further examine the selectivity of our OTULIN ABP, HEK293 cell extracts were treated 
with OTULIN ABP as in previous experiments and analyzed for ABP adducts by probing the 
WB membranes with an antibody that specifically binds Met1-linked Ub. Since our ABP is 
based on Met1-diUb, the anti-Met1-Ub antibody should recognize both the free ABP and 
ABP-labeled proteins. Indeed, uncoupled ABP and the OTULIN-ABP complex were 
detectable with this antibody (Figure 4-9A). 
30-minute incubation at 30°C led to the appearance of a ladder-like pattern with smear in the 
high-MW range that closely resembles Met1-linked polyUb chains (Figure 4-9A). Reducing 
the incubation time (ice control, 2 min, 30°C) and a subsequent incubation on ice, gave rise 
to considerably less Met1-Ub smearing, suggesting that the generation of this Met1-Ub 
pattern is enzymatically driven. 
 
Figure 4-9: ABP treatment of cell extracts causes polyUb chain formation. 
A) HEK293 cell extracts (~2.5x105 cells/reaction) were incubated with 1 µg OTULIN ABP for 30 min at 30°C. As control, the 
enzymatic reaction was put on ice following an initial 2-minute incubation at 30°C. Formation of ABP adducts was analyzed by 
WB. 
B) For ATP depletion, extracts from 6x105 HEK293 cells were incubated with apyrase prior to the incubation with 1 µg OTULIN 
ABP for 30 min. Ubiquitin chain formation and ABP adducts were determined by WB. 
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Removal of ATP from the extracts by recombinant apyrase before ABP incubation prevented 
the in vitro formation of polyUb chains that could be detected not only with anti-Met1-Ub, but 
also with a general anti-Ub antibody (Figure 4-9B). Two distinct bands at ~60 kDa and 
~130 kDa were detected with the anti-Met1-Ub antibody after ATP depletion (Figure 4-9B). 
The MW of these proteins corresponds to the MW and the electrophoretic migration pattern 
of the OTULIN-ABP and USP5-ABP adducts that were detected by OTULIN- and USP5-
specific antibodies. Importantly, besides these two protein bands only very weak background 
signals were detected following ATP depletion with the anti-Met1-Ub antibody. This suggests 
that OTULIN and USP5 are selectively labeled by the OTULIN ABP.  
Furthermore, the data indicate that incubation of the lysates with OTULIN ABP and inhibition 
of the two Met1-Ub cleaving DUBs, OTULIN and USP5, results in the assembly of polyUb 
chains via the ATP-dependent enzymatic ubiquitination cascade. 
4.1.6 Global selectivity analysis of the OTULIN ABP by LC-MS/MS 
To accurately define the OTULIN ABP specificity, the ABP was subjected to a global mass 
spectrometric analysis. Following incubation of cell extracts with the ABP, the N-terminal 
biotin tag enabled us to enrich the ABP and ABP binders in a biotin-PD using streptavidin 
beads. Under non-stringent conditions, the OTULIN-ABP complex could be precipitated in 
the ABP-PD, as well as the known OTULIN interactor HOIP (Figure 4-10A). In order to 
identify covalently bound ABP interactors, PD stringency was optimized. Up to 1% SDS in 
the washing buffer did not have a negative impact on PD efficiency of the OTULIN-ABP 
complex, whereas detection of non-covalently bound HOIP was already greatly reduced after 
washing with 0.1% SDS-containing buffer (Figure 4-10A). Accordingly, for the mass 
spectrometry (MS) analysis of covalent ABP adducts, all PD samples were washed with 1% 
SDS-containing buffer to deplete most non-covalent interactors. In the LC-MS/MS (liquid 
chromatography-tandem MS) analysis we compared a sample that had been incubated with 
the OTULIN ABP (sample 2) with a control sample, to which no ABP had been added 
(sample 1). Additionally, in sample 3, ATP was depleted by apyrase to abolish interactions 
that result from the polyUb chains that are generated upon ABP incubation (see 4.1.5). As 
additional control, the general DUB inhibitor PR-619 was added to sample 4, to prevent 
DUB-ABP complex formation. For statistical significance, four biological replicates were 
prepared. OTULIN-ABP complex formation and pull-down were detected by WB 
independently from apyrase treatment, whereas PR-619 prevented OTULIN labeling and its 
pull-down (Figure 4-10B). After performing PD experiments, PD eluates were sent to Adan 
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Pinto-Fernandez and Sarah Bonham (Benedikt M. Kessler group, University of Oxford) for 
the MS analysis including protein digest, LC-MS/MS and data analysis. 
The comparison of the samples with and without OTULIN ABP (1 vs. 2) revealed that only 
three DUBs, namely OTULIN, USP5 and UCHL3, were significantly enriched in the ABP-PD 
(Figure 4-10C). The enrichment of OTULIN and USP5 confirmed the labeling by the ABP in 
previous experiments. However, the enrichment of UCHL3 was unexpected, because using 
recombinant, transfected or endogenous UCHL3 no UCHL3-ABP complex formation was 
detected (see Figure 4-5, Figure 4-7B and Figure 4-8A). DUB inhibitor PR-619 treatment led 
to the significant depletion of OTULIN from the PD samples, validating that the catalytic 
Figure 4-10: LC-MS/MS analysis confirms high selectivity of OTULIN ABP. 
A) Biotin-PD of OTULIN ABP under highly stringent conditions to enrich covalent ABP interactors. Jurkat T cell extracts 
(18x106 cells/sample) were incubated with 4 µg OTULIN ABP (15 min, RT). Following PD, beads were washed twice with buffer 
containing different SDS concentrations. PD of the OTULIN-ABP complex and the non-covalent HOIP association were
assessed by WB. 
B) Control of OTULIN?ABP PD in samples before LC?MS/MS analysis. Jurkat T cell extracts (5x107 cells/sample) were treated 
with apyrase and PR-619 as indicated prior to the incubation with ABP. Following PD, beads were washed with 1% SDS-
containing buffer. 5% of the PD eluates were analyzed by WB, the rest was sent to LC-MS/MS analysis. 
C) Volcano plot illustrating enrichment of identified DUBs (blue) after ABP-PD (sample 1 vs. 2). Curves depict significant 
enrichment or depletion, respectively. Illustration provided by A. Fernandez (Benedikt M. Kessler group, University of Oxford). 
D) Volcano plot illustrating loss of DUB binding (blue) to ABP upon DUB inhibition by PR-619 (sample 3 vs. sample 4). Curves 
depict significant enrichment or depletion, respectively. Illustration provided by A. Fernandez (Benedikt M. Kessler group, 
University of Oxford). 
E) Jurkat T cell extracts were treated like LC-MS/MS samples. Labeling of proteins in extracts was analyzed by WB. 
F) ABP-PDs were performed under the same conditions as for LC-MS/MS analysis (extracts from 2x107 Jurkat T cells) and 
analyzed by WB to verify the MS results. 
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activity of OTULIN is required for covalent binding (3 vs. 4, Figure 4-10D). In contrast, neither 
USP5 nor UCHL3 were depleted from the ABP-PD by PR-619, suggesting that these DUBs 
bind to the ABP even under highly stringent conditions (1% SDS) in a non-covalent manner 
(3 vs. 4, Figure 4-10D). 
To exclude that PR-619 does not affect USP5 activity, Jurkat T cell extracts were treated in 
the same manner as the LC-MS/MS samples and directly analyzed for USP5-ABP complex 
formation by WB. Loss of the USP5-ABP adduct following inhibitor treatment proved that 
PR-619 inhibits USP5, as well as OTULIN (Figure 4-10E). The experiment also confirmed 
again that UCHL3 did not become covalently attached to the ABP. This suggests that the 
binding affinities between USP5 or UCHL3 and the OTULIN ABP are very high and that the 
interactions seem to be mostly non-covalent. The validation of the MS results by WB analysis 
confirmed that USP5 and UCHL3 bind the OTULIN ABP and are pulled down, regardless of 
whether the extracts were treated with apyrase or PR-619 (Figure 4-10F). It is important to 
note that both DUBs were detected at MWs that correspond to the MWs of the unbound 
proteins and not of the ABP adducts. This proves that the DUBs USP5 and UCHL3 are 
strong Ub binders and mostly non-covalently interact with the OTULIN ABP. Altogether, the 
LC-MS/MS analysis revealed that the OTULIN ABP is very selective for OTULIN and that its 
cross-reactivity towards USP5 is negligible. 
4.1.7 LC-MS/MS analysis reveals coupling of E1 enzymes to ABP 
Next, global reactivity of the OTULIN ABP was examined by comparing the entire 
interactome enriched by ABP-PD in sample 1 versus sample 2 (Figure 4-11A). Besides the 
three DUBs (blue), only four other proteins (red) were identified, namely UBC, NEDD8, UBA1 
and UBA6. The Ub precursor protein UBC corresponds to the probe itself, which consists of 
two Ub moieties. Interestingly, binding of the mammalian E1 enzymes UBA1 and UBA6 to 
the ABP was prevented by ATP depletion (Figure 4-11B). This ATP-dependent ABP binding 
of E1 enzymes could be confirmed by WB (Figure 4-11C) and closely resembles the first 
Ub-activating step of the ubiquitination cascade, in which a Ub C-terminus reacts under ATP 
consumption with the catalytic Cys in the E1 enzyme and a high-energy thioester bond is 
formed. The covalent ABP-E1 enzyme complex could not be visualized under reducing 
conditions by SDS-PAGE (Figure 4-11D), supporting that binding is most likely achieved 
through a thioester bond. In accordance with the fact that incubation of cell extracts with ABP 
leads to the ATP-dependent formation of polyUb chains (4.1.5), the diUb-based ABP seems 
to be activated by E1 enzymes, in common with monoUb. Moreover, MS results indicate that 
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the ATP-dependent assembly of polyUb chains by the probe may not be based on inhibition 
of OTULIN or other DUBs but on the insertion of the probe itself into Ub chains. 
4.1.8 E1-dependent auto-conjugation of the OTULIN ABP 
After the MS analysis, the assumption that the ATP-dependent Ub chain assembly by the 
probe is not based on inhibiton of OTULIN and USP5, but instead, on ABP activation and 
conjugation by E1 enzymes, should be verified. For that purpose, the ability of the non-
inhibitory and cleavage-resistant diUb mutant His-UbG76A-Ub (see Figure 4-6C) to also induce 
chain formation in extracts was investigated. 
Indeed, the G76A mutant still induced Ub chain formation in a dose-dependent manner, 
which could be detected with anti-Met1-Ub antibody (Figure 4-12A). To prove that 
uncleavable diUbs like His-UbG76A-Ub and bio-UbG76Dha-Ub are embedded into Ub chains, cell 
extracts were incubated with ABP in order to induce polyUb chain formation and afterwards 
cleaned again from the ABP and ABP-adducts using streptavidin beads (Figure 4-12B). After 
the biotin-PD, the free ABP and the formed Ub chains were completely depleted from the 
supernatant, suggesting that ABP is covalently incorporated into polyUb chains. 
To determine the linkage type of the Ub chains formed by ABP incubation and incorporation, 
the technique of Ubiquitin Chain Restriction Analysis (UbiCREST) was applied (Hospenthal 
et al., 2015). In this assay, the polyUb chains of interest are incubated with commercially 
available linkage-specific DUBs and then checked for degradation. In this case, HEK293 
 
Figure 4-11: The E1 enzymes UBA1 and UBA6 bind to the ABP in an ATP-dependent manner. 
A) Volcano plot illustrating the enrichment of identified proteins after ABP-PD under highly stringent conditions (DUBs – blue, 
others – red; sample 1 vs. 2). Curves depict significant enrichment or depletion, respectively. Illustration provided by A. 
Fernandez (Benedikt M. Kessler group, University of Oxford). 
B) Volcano plot illustrating loss of E1 enzyme binding to OTULIN ABP upon ATP depletion (sample 2 vs. 3). Curves depict 
significant enrichment or depletion, respectively. Illustration provided by A. Fernandez (Benedikt M. Kessler group, University of 
Oxford). 
C) See Figure 4-10F. 
D) See Figure 4-10E. 
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extracts were first incubated with OTULIN ABP (30 min, 30°C) and subsequently mixed with 
the recombinant DUBs for another 30 min.  
WB analysis using anti-Met1-Ub and anti-Ub antibodies revealed that recombinant OTULIN 
was coupled and inhibited by OTULIN ABP (see asterisk), but even in excess, it failed to 
cleave the chains generated by ABP incubation (Figure 4-12C). Likewise, Lys11-specific 
Cezanne, Lys48-specific OTUB1 and Lys63-specific AMSH were not able to cleave the 
chains. Only the promiscuous DUB USP2, which cleaves all types of ubiquitin linkages, was 
able to completely remove the high-MW ubiquitin smear.  
These data indicate that the chains are complex polyABP assemblies of bio-UbG76Dha-Ub, 
which are poorly accessible for linkage-specific DUBs. Furthermore, the data suggest that 
various lysine residues in the OTULIN ABP or in His-UbG76A-Ub can serve as attachment 
sites for the ubiquitination with activated diUbs. Head-to-tail linkages can be excluded, since 
the N-terminal tags block the access to the ?-amino group of Met1 in the distal Ub moiety. 
Figure 4-12: OTULIN ABP is incorporated into polyABP assemblies by E1 enzymes.  
A) HEK293 cell extracts (6×105 cells/sample) were incubated with increasing amounts of His-UbG76A-Ub or with 1 ?g OTULIN 
ABP (45 min, 30°C). Formation of Ub chains and OTULIN-ABP or USP5-ABP complexes was analyzed by WB. 
B) Jurkat T cell extracts (6x105 cells/sample) were incubated with 1 µg OTULIN ABP (45 min, 30°C) and subjected to biotin-PD. 
Extracts were assessed for the presence of Ub chains before and after the PD by WB using anti-Met1-Ub antibody. Depletion of 
OTULIN-ABP complex is shown as control.  
C) Linkage analysis of Ub chains formed in extracts of HEK293 cells following OTULIN ABP incubation (30 min, 30°C) by 
UbiCREST digestion. Treatment with linkage-specific DUBs was performed for another 30 min. Ub chains were analyzed by 
WB. Asterisk: OTULIN-ABP adduct.  
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4.1.9 OTULIN ABP ?G76: the first specific OTULIN ABP 
USP5 preferentially cleaves unanchored Ub chains from the proximal end. Recognition and 
binding of the C-terminal di-Gly motif by a dedicated binding pocket in USP5 is essential for 
the hydrolysis reaction (Reyes-Turcu et al., 2006). In addition, the C-terminal Gly76 in the Ub 
molecule enables its recognition and activation by E1 enzymes in the ubiquitination process 
(Ciechanover et al., 1982). We decided to generate another OTULIN ABP, which lacks the 
Gly76 in the proximal Ub moiety (OTULIN ABP ?G76), in order to eliminate the cross-
reactivities of the ABP with USP5 and E1 enzymes. 
This time, the precursor protein His-UbG76C-Ub(1-75) was recombinantly produced in E. coli 
and then sent to our collaboration partner Farid el Oualid (UbiQ), who converted the Cys76 in 
the distal Ub into electrophilic Dha by means of oxidative elimination (Figure 4-13A).  
Incubation of cell extracts with the new OTULIN ABP ?G76 revealed that the probe still 
reacts with active OTULIN, however no longer with USP5 (Figure 4-13B). Deletion of the 
C-terminal Gly76 also abolished cross-reactivity with E1 enzymes (Figure 4-13C) and thus 
likewise prevented polyABP chain formation in cell extracts (Figure 4-13B). In a His-PD of 
the probe, not only the OTULIN-ABP ?G76 complex, but also USP5 and UCHL3, could be 
enriched (Figure 4-13C). This confirms the conclusion from the MS analysis that the DUBs 
Figure 4-13: OTULIN ABP ?G76 does not cross-react with USP5 and E1 enzymes. 
A) Synthesis scheme of OTULIN ABP ?G76. 
B) HEK293 cell extracts (6x105 cells) were incubated with 1 µg OTULIN ABP or 1 µg OTULIN ABP ?G76 (45 min, 30°C). 
Labeling of OTULIN and USP5 as well as Ub chain formation was analyzed by WB. 
C) Jurkat T cell extracts (2x107 cells) were treated with 4 µg OTULIN ABP ∆G76 prior to His-PD. Interactions between the new 
probe and the indicated proteins were analyzed by WB. 
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USP5 and UCHL3, due to their high binding affinity towards diUb, strongly and non-
covalently interact with the OTULIN ABP. Altogether, these results prove that the OTULIN 
ABP ?G76 is the first specific OTULIN ABP. 
4.1.10 Substrate-bound OTULIN interacts with LUBAC 
It has previously been demonstrated that OTULIN interacts with LUBAC via HOIP (Elliott et 
al., 2014; Schaeffer et al., 2014). We wanted to verify this interaction by means of the newly 
developed and highly selective OTULIN ABP. For this purpose, various human cell lines 
were lysed and subjected to ABP-PDs. In order to detect non-covalently bound OTULIN 
interactors, PD was performed under mild co-immunoprecipitation (co-IP) conditions without 
SDS. 
The OTULIN-ABP complex was precipitated from any extract (Figure 4-14). Further, the 
entire LUBAC composed of HOIP, HOIL-1 and SHARPIN was enriched from any cell line 
along with substrate-bound OTULIN. This indicates that the OTULIN ABP enables detection 
of OTULIN-associated protein complexes. Not only direct binding partners of OTULIN, like 
HOIP, but also indirect interactors like HOIL-1 and SHARPIN can be precipitated with the 
OTULIN-ABP complex. 
4.1.11 Neither OTULIN activity nor the OTULIN-LUBAC interaction are affected by 
TNF? stimulation 
The generation of Met1-linked Ub chains is involved in TNFR-dependent activation of NF-?B 
(Sasaki and Iwai, 2015). Therefore we wanted to determine whether OTULIN activity is 
altered upon TNF? stimulation. Stimulation of Jurkat T cells with TNF? for up to 90 min 
resulted in NF-?B activation, evident from I?B? phosphorylation and degradation (Figure 
4-15A). However, OTULIN-ABP complex formation in the extracts did not change, indicating 
that OTULIN activity remains constant following TNF? stimulation. 
 
Figure 4-14: LUBAC associates with substrate-bound OTULIN.  
ABP-PD under mild conditions from extracts of different human cell lines (2x107 cells/sample, 4 µg OTULIN ABP). Interaction of 
the OTULIN-ABP complex with LUBAC components was examined by WB. 
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Next, we wondered whether the OTULIN-LUBAC interaction changes in Jurkat T cells upon 
stimulation with TNF?. Due to constant acitivity of OTULIN after TNF? treatment (Figure 
4-15A), equal amounts of the OTULIN-ABP complex were pulled down in the ABP-PD 
(Figure 4-15B). Likewise, the amounts of co-precipitated OTULIN-associated LUBAC 
components HOIP, HOIL-1 and SHARPIN did not alter significantly, suggesting that the 
OTULIN-LUBAC interaction is neither attenuated nor strengthened by TNF? stimulation. 
4.1.12 The majority of cellular LUBAC is not associated with OTULIN 
To get an impression of how much of the cellular LUBAC is associated with OTULIN in 
unstimulated Jurkat T cells, protein amounts of OTULIN, HOIP, HOIL-1 and SHARPIN in the 
extracts prior to (input) and after the ABP-PD (supernatant) were compared (Figure 4-16A). 
Although the OTULIN-ABP complex could be almost completely precipitated from the lysate, 
a considerable proportion of LUBAC components remained in the supernatant.  
To determine this proportion more precisely, protein levels of HOIP, HOIL-1, SHARPIN and 
OTULIN were quantified in the input (total LUBAC amount) and in the supernatant (‘free’, 
OTULIN-ABP unbound LUBAC). To this end, the respective protein band intensities were 
measured using ImageJ software and normalized to ?-actin in six independent experiments. 
The ratio of quantified proteins between the supernatant and input was calculated to obtain 
relative amounts of free, OTULIN-ABP unbound proteins. Whereas the ABP-PD removed 
more than 80% of active OTULIN from the extracts, less than 25% of each LUBAC subunit 
was co-precipitated (Figure 4-16B).  
 
Figure 4-15: TNF? stimulation has no impact on OTULIN activity or the OTULIN-LUBAC interaction. 
A) Jurkat T cells were stimulated with TNF? (20 ng/ml). Lysates (2.5x105 cells/sample) were incubated with 1 µg OTULIN ABP 
and analyzed for changes in OTULIN activity by WB. 
B) ABP-PD (co-IP conditions) from Jurkat T cell extracts following stimulation with TNF? (20 ng/ml; 2x107 cells/sample; 4 µg 
OTULIN ABP). Interaction of the OTULIN-ABP complex with LUBAC components was evaluated by WB. 
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These data suggest that the majority of the LUBAC complex (>75%) is not associated with 
substrate-bound OTULIN. Accordingly, the majority of cellular OTULIN is most likely also not 
in complex with LUBAC, what raised the question, which other proteins interact with OTULIN. 
Since the OTULIN ABP is an excellent tool to deplete OTULIN almost entirely from cell 
extracts and thus to monitor OTULIN-associated protein complexes, we addressed the 
question of further OTULIN interactors with the ABP. 
4.2 Identification of SNX27 as a novel OTULIN interactor 
4.2.1 Identification of OTULIN interactors by LC-MS/MS 
Following the generation and characterization of the highly selective OTULIN ABP (section 
4.1), we used it to identify potential novel OTULIN interactors by LC-MS/MS. For this 
purpose, Jurkat T cell extracts were initially treated with apyrase to prevent the ATP-
dependent formation of polyABP assemblies (see sections 4.1.5 and 4.1.8). One sample was 
incubated with ABP to identify interactors of ABP-bound OTULIN (sample 2), whereas no 
probe was added to the control sample (sample 1). PR-619 was added to another control 
sample to inhibit OTULIN activity and thus prevent the OTULIN-ABP complex formation 
(sample 3). After the PD, beads were washed under mild co-IP conditions to avoid loss of 
non-covalently bound OTULIN interactors. For statistical significance, the ABP-PDs were 
performed in quadruplicate and the PD eluates were sent again to Adan Fernandez and 
Sarah Bonham (Benedikt M. Kessler group, University of Oxford) for trypsin digestion, 
LC-MS/MS and data analysis.  
The comparison between the samples with and without probe shows the significant 
enrichment of the OTULIN ABP interactome (Figure 4-17A) comprising of covalent and 
 
Figure 4-16: The majority of cellular LUBAC is not OTULIN-associated.  
A) Protein amounts of OTULIN, HOIP, HOIL-1 and SHARPIN in Jurkat T cell extracts were assessed by WB, prior to (input), 
and following ABP-PD (supernatant). 
B) Levels of LUBAC subunits and OTULIN in Jurkat T cell extracts were assessed by WB, prior to (input), and following ABP-PD 
(supernatant), and quantified using ImageJ software. The quantified relative amounts of ‘free’, OTULIN-ABP unbound proteins 
are depicted. Data represent the mean ± SD of six independent experiments. 
RESULTS 
   
  45 
 
non-covalent ABP binders. In addition to the proteins that had been identified in the previous 
PDs under highly stringent conditions (see 4.1.7 and Figure 4-11A), seven more proteins 
were identified by LC-MS/MS analysis. Some of them have been directly linked with the Ub 
system (BRAP, HOIP, USP3 and VCP), whereas others have not been primarily associated 
with Ub regulation (HDAC6, SNX27 and WRNIP1). PR-619 treatment resulted not only in the 
significant removal of OTULIN from the ABP, but also in the significant loss of HOIP and 
SNX27 binding (Figure 4-17B). The expected OTULIN-dependent ABP binding of HOIP, as 
known OTULIN interactor, indicated that SNX27 could also be a potential OTULIN binding 
partner. 
To verify the MS results, ABP-PDs were repeated under the same conditions as for 
LC-MS/MS and analyzed by WB. The validation experiment confirmed the enrichment of 
HOIP and SNX27 along with the OTULIN-ABP complex (Figure 4-17C). Moreover, ABP 
binding and enrichment was lost upon OTULIN inhibition by PR-619. Protein enrichment and 
depletion by PR-619, respectively, could be detected independently from ATP depletion by 
apyrase, suggesting that polyABP assembly formation does not affect the observed 
 
Figure 4-17: Identification of SNX27 as potential OTULIN interactor by LC-MS/MS. 
A) Volcano plot illustrating the enrichment of identified proteins after ABP-PD under co-IP conditions (-ABP vs +ABP). Curves 
depict significant enrichment or depletion, respectively. Illustration provided by A. Fernandez (Benedikt M. Kessler group, 
University of Oxford). 
B) Volcano plot illustrating loss of HOIP and SNX27 binding to OTULIN ABP upon OTULIN depletion by PR-619 (ABP vs. 
ABP+PR-619). Curves depict significant enrichment or depletion, respectively. Illustration provided by A. Fernandez (Benedikt 
M. Kessler group, University of Oxford). 
C) ABP-PDs were performed under the same conditions as for LC-MS/MS analysis (extracts from 2x107 Jurkat T cells) or
without apyrase treatment and analyzed by WB to verify the MS results. 
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interactions. Altogether, the OTULIN-ABP complex-dependent enrichment of SNX27 gave a 
first hint that it might be a potential OTULIN interactor. 
4.2.2 SNX27 interacts with OTULIN independently from HOIP 
To verify the putative interaction between OTULIN and SNX27, OTULIN-deficient Jurkat T 
cells were generated using the CRISPR/Cas9 technology. To this end, a single guide RNA 
(sgRNA) targeted at exon 2 of the OTULIN gene was designed and transfected into cells 
along with Cas9 to induce a double-strand break (DSB) in the genomic DNA (Figure 4-18A). 
In mammalian cells, DSBs are mainly repaired by the non-homologous end joining (NHEJ) 
pathway, generating nucleotide insertions or deletions at the respective sites. These indels 
can lead to insertions or deletions of amino acids or to frameshift mutations creating a 
premature stop codon within the open reading frame of the gene of interest. After expansion 
of single-cell clones, all clones were initially checked for the OTULIN protein expression by 
WB analysis (Figure 4-18B). In some clones, OTULIN expression was as high as in the 
parental cells or slightly reduced (clone #12, Figure 4-18B). In extracts of the clones #3, #6 
and #11, no OTULIN could be detected (Figure 4-18B). Genomic DNA of these identified KO 
clones was amplified by PCR around the targeted site, in order to track changes on the DNA 
level. That way, all KOs were verified (data not shown). 
 
Figure 4-18: Generation of OTULIN-, HOIP- and SNX27-deficient Jurkat T cells by CRISPR/Cas9. 
A), C) and E) Schematic representations of the OTULIN (A), RNF31 (C) and SNX27 (E) genes. Targeted sequences by 
sgRNAs, in exon 2 and exon 1, respectively, are depicted in bold type. 
B), D) and F) Exemplary WBs of the KO screenings. Cell clones were analyzed for OTULIN (B), HOIP (D) or SNX27 (F) 
expression by WB and compared to the expression in parental Jurkat T cells. 
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To facilitate further studies, HOIP- and SNX27-deficient Jurkat T cell lines were also 
generated. For HOIP KO cells the sgRNA was targeted at exon 1 of the HOIP/RNF31 gene 
(Figure 4-18C) in accordance with the previously published HOIP KO in Jurkat T cells (Yang 
et al., 2016). For the SNX27 KO, a sgRNA was designed that is targeted at exon 1 of the 
SNX27 gene (Figure 4-18E). Several clones were obtained that are deficient in either HOIP 
or SNX27 expression (Figure 4-18D and F). Again, all KOs were verified on genomic level 
(data not shown). 
 
To verify the putative interaction between OTULIN and SNX27, extracts of parental and 
OTULIN-deficient Jurkat T cells were incubated with OTULIN ABP and subsequently 
subjected to ABP-PDs. While HOIP and SNX27 were pulled down together with the 
OTULIN-ABP complex from WT cell extracts, both could not be enriched from 
OTULIN-deficient lysates without the formation and pull-down of the OTULIN-ABP adduct 
(Figure 4-19A). This proves that SNX27 binding to the ABP is OTULIN-dependent. 
To exclude that OTULIN association of SNX27 proceeds indirectly via HOIP, ABP-PDs from 
HOIP-deficient and parental cell extracts were perfomed. HOIP was not present in the 
OTULIN-ABP complex in HOIP KO extracts (Figure 4-19B). Nevertheless, SNX27 binding to 
OTULIN-ABP could still be detected, suggesting that this interaction is independent of HOIP. 
Thus, experiments with the generated KO cell lines indicated that SNX27 is an OTULIN 
interactor, which binds OTULIN independently from HOIP. 
4.2.3 ABP-independent MS approach confirms OTULIN-SNX27 interaction 
Infection of cells with lentiviruses enables integration of DNA constructs in the genome and 
their stable expression. This technique was used to reconstitute OTULIN-deficient Jurkat T 
cells with N-terminally StrepII-StrepII-Flag-tagged (SSF-)OTULIN or with the SSF-tag (mock). 
 
Figure 4-19: ABP binding of SNX27 is OTULIN-dependent. 
A) ABP-PD was performed from extracts of 2x107 parental and OTULIN KO Jurkat T cells. Enrichment of HOIP and SNX27 in 
PDs was analyzed by WB. 
B) ABP-PD was performed from extracts of 2x107 parental and HOIP KO Jurkat T cells. SNX27 enrichment in PDs was 
assessed by WB. 
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Transduction efficiency was assessed by co-expression of the cell surface marker ?CD2 
(see also section 7.2.6) through flow cytometry. More than 95% of the cells were infected 
(Figure 4-20A). Moreover, the protein amount of stably expressed OTULIN was checked by 
WB and compared to the expression of endogenous OTULIN in the parental cell line (Figure 
4-20B). Reconstituted cells expressed OTULIN, even though at slightly reduced levels 
compared to Jurkat T cells. 
Subsequently, Strep-PDs from extracts of the mock- and SSF-OTULIN-reconstituted cells 
were performed in triplicate and sent to Adan Fernandez and Sarah Bonham for LC-MS/MS 
analysis (Benedikt M. Kessler group, University of Oxford). We compared the enriched 
interactome in samples of mock and OTULIN-reconstituted cells and observed that SNX27 
was again highly enriched in the presence of OTULIN (Figure 4-20C). The identified 
interaction of SSF-OTULIN and SNX27 was also verified by WB analysis (Figure 4-20D). 
HOIP was not identified, which might be due to the fact that the N-terminal SSF-tag of 
OTULIN impairs HOIP binding at the OTULIN N-terminus. 
 
Figure 4-20: OTULIN interacts with SNX27 in reconstituted KO cells. 
A) Transduction efficiency was determined by co-expression of the cell surface marker ?CD2 by flow cytometry. Negative 
control: untransduced OTULIN-deficient Jurkat T cells. 
B) SSF-OTULIN expression of lentivirally reconstituted cells was checked by WB and compared to endogenous OTULIN
expression in Jurkat WT cells. 
C) Volcano plot demonstrating the significant enrichment of identified proteins after Strep-PD from extracts of SSF-OTULIN or 
mock expressing reconstituted OTULIN-deficient Jurkat T cells. Curves depict significant enrichment or depletion, respectively.
Illustration provided by A. Fernandez (Benedikt M. Kessler group, University of Oxford). 
D) Verification of the OTULIN-SNX27 interaction by WB analysis of the Strep-PDs. 
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This second and OTULIN ABP-independent approach for the identification of OTULIN 
interactors revealed that the OTULIN-SNX27 interaction in Jurkat T cells is also detected by 
direct OTULIN precipitation. 
4.2.4 Human and murine OTULIN-SNX27 interaction is not cell type-specific 
To ascertain whether the OTULIN-SNX27 interaction is T cell-specific, immunoprecipitations 
(IPs) of OTULIN or SNX27 were performed from extracts of different cell lines and tested for 
co-IP of the respective binding partner (Figure 4-21). OTULIN could be isolated efficiently 
from human and murine cell extracts using anti-OTULIN antibody (Figure 4-21A and B). As 
expected, SNX27 co-precipitated with OTULIN from Jurkat extracts (Figure 4-21A). In the 
isotype control, both OTULIN and SNX27 were not pulled down, proving specificity of the IP. 
 
Figure 4-21: OTULIN interacts with SNX27 in different human and murine cell lines. 
A) OTULIN-IP from extracts of 5x107 Jurkat and HEK293T cells. As isotype control, rabbit IgG antibody was used. OTULIN 
enrichment and co-IP of SNX27 were analyzed by WB. 
B) OTULIN-IP was performed as in A) from extracts of OTULIN KO MEFs / ctrl MEFs (2.5x107 cells) or isloated murine primary 
CD4 T cells (5x107 cells). 
C) ABP-PD from murine primary CD4 T cell extracts (2x107 cells/sample; 2 µg OTULIN ABP). Interaction of the murine OTULIN-
ABP complex with SNX27 was assessed by WB. 
D) SNX27-IP from extracts of 5x107 Jurkat and HEK293T cells. As isotype control, mouse IgG antibody was used. SNX27 
enrichment and co-IP of OTULIN were analyzed by WB. 
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SNX27 also co-precipitated with OTULIN from extracts of HEK293T cells (Figure 4-21A), 
mouse embryonic fibroblasts (MEFs) and murine primary CD4 T cells (Figure 4-21B). 
Additionally, SNX27 was pulled out of the primary CD4 T cell lysates together with active 
OTULIN through an OTULIN ABP-PD (Figure 4-21C). Vice versa, SNX27 could also be 
efficiently enriched from Jurkat and HEK293T cell extracts by IP using anti-SNX27 antibody 
and OTULIN co-precipitated with SNX27 (Figure 4-21D). These results reveal that the 
OTULIN-SNX27 interaction exists in several human and murine cell lines as well as in 
primary cells. 
4.2.5 OTULIN interacts with the SNX27 PDZ domain via a canonical PDZbm 
SNX27 is involved in the fast transport of internalized cargos, like cell surface receptors and 
transmembrane transporters, back to the plasma membrane (Gallon and Cullen, 2015). The 
recycled cargos and other cytosolic proteins have been shown to bind the PDZ domain of 
SNX27 via a C-terminal class I PDZ-binding motif (PDZbm) with the consensus sequence 
X-[Thr/Ser]-X-? (X - any aa, ? - aa with a bulky hydrophobic residue) (Gallon and Cullen, 
2015; Lunn et al., 2007). An alignment of OTULIN amino acid sequences of different 
tetrapods indicated that a putative class I PDZbm also exists in the OTULIN C-terminus 
(Figure 4-22A). In human OTULIN this motif is formed by the last four amino acids, Glu-Thr-
Ser-Leu (ETSL, aa 349-352). 
To map the interaction sites of OTULIN and SNX27, different 3xFlag-tagged (Flag-)OTULIN 
mutants were generated by site-directed mutagenesis: One construct encoded C-terminally 
truncated OTULIN (aa 1-348, OTULIN ?ETSL), lacking the putative PDZbm. Other 
constructs encoded catalytically inactive OTULIN (C129A), the Ub-binding mutant (W96A), 
the HOIP-binding mutant (Y56F), or the OTU domain of OTULIN only (OTULINcat, aa 80-352) 
(Figure 4-22A). All constructs were transiently overexpressed along with GFP-SNX27 in 
HEK293 cells and immunoprecipitated after lysis using anti-Flag antibody (Figure 4-22B). 
WB analysis demonstrated that all proteins were expressed at equivalent levels. As expected 
GFP-SNX27 was co-immunoprecipitated with OTULIN WT. The Y56F mutation in the 
OTULIN N-terminus, which abrogates HOIP binding to OTULIN (Elliott et al., 2014), did not 
impair the association of SNX27. The fact that both the OTU domain (OTULINcat) and 
catalytically inactive OTULIN (C129A) strongly interacted with SNX27, indicated that neither 
the N-terminus (aa 1-79) of OTULIN nor its catalytic activity are required for binding. It 
appears that only slightly less SNX27 bound the Ub-binding mutant W96A. However, it is 
well established that mutations at the site of Trp96 perturb the OTU domain structure (Rivkin, 
2013), which might also affect SNX27 binding.  
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A complete loss of the SNX27 interaction was only achieved by deletion of the putative 
PDZbm in OTULIN ?ETSL (Figure 4-22B). This proves that OTULIN indeed contains a 
C-terminal PDZbm that is indispensable for the interaction with SNX27. 
SNX27 is the only sorting nexin that has a PDZ domain. Via this PDZ domain (Figure 4-22C), 
SNX27 binds, on the one hand, cargos and, on the other hand, the retromer complex 
composed of VPS26, VPS35 and VPS29. It has previously been demonstrated that a 
mutation of His114 to Ala prevents binding to cargos and that a partial deletion of the ?3-?4 
loop (?67-77) destroys the retromer interaction (Gallon et al., 2014; Lauffer et al., 2010). To 
 
Figure 4-22: Canonical PDZ-PDZbm interaction mediates the SNX27-OTULIN association. 
A) Schematic of OTULIN with a sequence alignment of OTULIN homologs of different tetrapods, revealing the existence of a 
conserved putative class I PDZbm. Protein sequences were retrieved from the Ensembl database, release 94 (Zerbino et al., 
2018). 
B) HEK293 cells were co-transfected with different Flag-OTULIN constructs and GFP-SNX27 as indicated. After lysis, co-IPs 
were performed using anti-Flag antibody and tested for the OTULIN-SNX27 interaction by WB. 
C) Schematic representation of SNX27. 
D) Experiment was performed as in B) after co-overexpression of different GFP-SNX27 constructs and Flag-OTULIN in HEK293 
cells. 
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confirm the PDZ-PDZbm interaction between SNX27 and OTULIN, GFP-SNX27 WT and 
these mutants were overexpressed together with Flag-OTULIN WT in HEK293 cells and 
subjected to Flag co-IPs (Figure 4-22D). While again a strong interaction between the WT 
proteins could be detected, this interaction was abolished by the H114A mutation in SNX27. 
Deletion of the ?3-?4 hairpin loop (?67-77) also attenuated SNX27 binding to OTULIN, which 
indicates that additional surfaces besides the PDZ-PDZbm interface may be involved in 
SNX27-OTULIN binding. 
These data reveal that the binding of SNX27 to OTULIN is mediated by a canonical 
PDZ-PDZbm interaction, as is the case with classical cargos, and potentially by an additional 
interface. 
 
To obtain more insights into the association of SNX27 and OTULIN, our collaboration partner 
Paul Elliott (MRC, Cambridge; University of Oxford) determined the structure of the 
catalytically inactive OTU domain of OTULIN (OTULINcat C129A) in complex with the PDZ 
domain of SNX27 (SNX27PDZ, aa 40-135) by X-ray crystallography at 2 Å resolution (Figure 
4-23A and B). Electron density corresponding to the PDZbm could be unambiguously 
assigned for the entire C-terminus of OTULIN. Indeed, this C-terminus provides the main 
interaction surface for the PDZ domain of SNX27 (Figure 4-23A). The major part of 
OTULINcat including the catalytic site is not located in close proximity to SNX27PDZ, explaining 
why the binding to SNX27 could be identified by means of the active site-directed diUb 
probe.  
A close-up view of the PDZ-PDZbm interface (Figure 4-23B) revealed that the OTULIN 
PDZbm is bound in a canonical orientation identically to the previously described SNX27-
binding peptides of cargos like diacylglycerol kinase ? (DGK?) (Clairfeuille et al., 2016). 
SNX27 His114, which was shown to be essential for cargo binding (Lauffer et al., 2010), 
forms hydrogen bonds to the peptide backbone of the OTULIN PDZbm and also to OTULIN 
Thr350, explaining the strict necessity of this interaction for complex assembly (Figure 
4-23B). 
Additionally, Paul Elliott (MRC, Cambridge; University of Oxford) performed isothermal 
calorimetry (ITC) experiments and measured a KD of 1.1 ± 0.035 µM for the OTULIN PDZbm 
peptide (Ac-VRVCEETSL) and SNX27PDZ (Figure 4-23C). So far, the PDZbm peptides of 
DGK? and PHLPP1 (PH Domain and Leucine Rich Repeat Protein Phosphatase 1) display 
the highest affinities for SNX27PDZ with a KD of approximately 2 µM (Clairfeuille et al., 2016). 
This reveals that the affinity of the OTULIN PDZbm peptide for SNX27PDZ is approximately 
twice as high as the affinity of any other previously analyzed cargo peptide. With a KD of 
0.031 ± 0.014 µM, the determined binding affinity of the entire OTULINcat for SNX27PDZ was 
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more than 30 times higher than the affinity of the isolated C-terminal peptide (Figure 4-23C) 
and the highest ever reported affinity for a SNX27 PDZ domain interaction (Clairfeuille et al., 
2016). This indicated once again that there might be a potential second interface between 
OTULIN and SNX27. No binding could be detected in ITC studies between SNX27PDZ and 
OTULINcat ?ETSL, confirming the finding from the co-IP studies that the PDZbm controls the 
association of OTULIN with SNX27 (see Figure 4-22B). 
4.2.6 Second interface mediates the high-affinity interaction between OTULIN and 
SNX27 
Besides the canonical PDZ-PDZbm interaction, Paul Elliott (MRC, Cambridge; University of 
Oxford) identified a second OTULIN-SNX27 interface (Figure 4-24A), which involves parts of 
the SNX27 ?3-?4 loop (aa 67-79). Deletion of this loop, which is unique for the SNX27 PDZ 
domain, and which is required for VPS26A binding (Gallon et al., 2014), impaired OTULIN 
binding in previous experiments (see Figure 4-22D). The second interface comprises 
hydrogen bonds between the side chain carboxyl groups of OTULIN Glu85, Asp87 and 
Asp90, and Arg68 and Arg100 in SNX27 (Figure 4-24A). Additional important hydrogen 
bonds were established between OTULIN Glu209 and the amide backbone of SNX27 Gly64. 
Single mutations of OTULIN Asp87 or Glu85 to Arg decreased the binding affinity of OTULIN 
 
Figure 4-23: Structural analysis of the OTULIN-SNX27 complex. 
A) Structure of the OTULIN-SNX27 complex. SNXPDZ (aa 40-135) is rendered in surface representation (yellow) with OTULINcat
(aa 80–352, blue) depicted as ribbon. Circle: catalytic center, rectangle: PDZ-PDZbm interaction site.  
B) Close-up view of the PDZ-PDZbm interface. C-terminal OTULIN peptide (aa 345-352) is rendered in stick representation 
(blue) on SNX27PDZ (yellow).  
C) Binding affinities of OTULINcat or the C-terminal PDZbm peptide and SNX27PDZ determined by ITC. 
Illustrations and ITC data are provided by P. Elliott (MRC, Cambridge; University of Oxford). 
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for SNX27 in ITC studies approximately 10- to 30-fold (Figure 4-24B). Single mutations of 
SNX27 Gly64 or Arg100 to Glu likewise reduced binding affinities tenfold. A combination of 
both mutations in either SNX27PDZ or OTULINcat resulted in KD values of 1.09 ± 0.007 µM or 
2.07 ± 0.12 µM, respectively (Figure 4-24B). These values closely resemble the binding 
affinity of the isolated OTULIN PDZbm peptide for SNX27PDZ (KD of 1.1 ± 0.035 µM; see 
Figure 4-23C). This suggests that the second OTULIN-SNX27 interface mainly contributes to 
the high-affinity interaction of the two proteins. 
Co-IP experiments confirmed that the overexpressed OTULIN E85R/D87R mutant bound 
considerably more weakly to GFP-SNX27 WT in comparison to WT OTULIN (Figure 4-24C). 
However, since the PDZ-PDZbm complex could still be formed, only deletion of the PDZbm 
in OTULIN resulted in the complete loss of the interaction. In GFP-Traps, less HA-OTULIN 
was co-precipitated by overexpressed GFP-SNX27 G64E/R100E than by WT SNX27 (Figure 
4-24D). Again, complete abrogation of the OTULIN-SNX27 interaction was only achieved by 
 
Figure 4-24: Second non-canonical interface.  
A) Close-up view of the second OTULIN-SNX27 interface (OTULIN – blue, SNX27 – orange). Relevant residues are shown in 
stick format, dashed lines indicate hydrogen bonds. Illustration provided by P. Elliott (MRC, Cambridge; University of Oxford).  
B) Summary of binding affinities of SNX27PDZ and OTULINcat mutants determined by ITC (P.Elliott, MRC, Cambridge; University 
of Oxford). Mutations were designed based on the structure of the second interface. 
C) and D) Extracts of HEK293 cells expressing different HA-OTULIN or GFP-SNX27 constructs (as indicated) were subjected to 
immunoprecipitations. Differences in OTULIN-SNX27 association were determined by WB. 
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mutation of SNX27 at the canonical cargo-binding site (H114A). Altogether, these results 
reveal that the canonical PDZbm-PDZ interaction is essential for binding of OTULIN to 
SNX27 and that a second non-canonical interface considerably contributes to strengthening 
the interaction. 
4.3 OTULIN counteracts SNX27-dependent cargo recycling 
4.3.1 OTULIN competes with the VPS26 subunit of the retromer for binding to SNX27 
ABP-PDs of active OTULIN as well as Strep-PDs of OTULIN from cell extracts of OTULIN-
reconstituted cells led to the identification of SNX27 as OTULIN interaction partner (see 
sections 4.2.1 and 4.2.3). However, association of OTULIN with components of the retromer 
complex (VPS26, VPS35) or the WASH complex (WASH1) were not detected in any 
experiment although these proteins are known SNX27 interactors (Gallon and Cullen, 2015). 
The studies of the second non-canonical OTULIN-SNX27 interface moreover demonstrated 
that OTULIN interacts with SNX27 very closely to the ?3-?4 loop, and forms hydrogen 
bonds, for example, with Gly64 before the loop and Arg68 within the loop (see section 4.2.6). 
However, SNX27 Arg68 is also implicated in binding of VPS26A (Gallon et al., 2014), 
suggesting that the interaction surfaces of OTULIN and VPS26A with SNX27 partially 
overlap and that a simultaneous binding of all three proteins is unlikely (Figure 4-25A).  
To check whether a ternary OTULIN-SNX27-VPS26A complex could form in cells, different 
HA-OTULIN constructs were expressed together with Flag-VPS26A and GFP-SNX27 in 
HEK293 cells. GFP-SNX27 interacted with Flag-VPS26A just as with HA-OTULIN after the 
respective double transfection (Figure 4-25B). Upon simultaneous expression of all three 
constructs, however, SNX27 lost the binding to VPS26A and only interacted with OTULIN. 
This effect was independent of OTULIN´s deubiquitinating activity (C129A) but dependent on 
the canonical interaction between SNX27 and OTULIN. By deleting the OTULIN PDZbm 
(OTULIN ?ETSL), the OTULIN-SNX27 interaction was abrogated and the effect on VPS26-
SNX27 binding was reversed. In line with this, association of the endogenous retromer 
components VPS26 and VPS35 with overexpressed SNX27 was diminished upon co-
overexpression OTULIN WT and C129A, whereas OTULIN ?ETSL did not impair the 
interaction (Figure 4-25C). 
These results indicate that binding of OTULIN and VPS26 to SNX27 are mutually exclusive, 
and that OTULIN competes with VPS26 for complex formation with SNX27. This implicates 
that OTULIN cannot be a cargo of the SNX27-retromer complex, although it binds to SNX27 
in a similar manner to known cargos. 
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4.3.2 OTULIN removes SNX27 from early endosomes 
To determine the cellular localization of OTULIN-SNX27 complexes, RFP-OTULIN and 
GFP-SNX27 were overexpressed in U2OS cells and subjected to confocal fluorescence 
microscopy. As it has been previously reported (Cai et al., 2011; Rincon et al., 2007), 
GFP-SNX27 co-localized with the protein EEA1 and is thus mainly associated with early 
endosomes (Figure 4-26A). Upon co-overexpression of RFP-OTULIN, however, GFP-SNX27 
lost its distinct association with early endosomes and became evenly distributed throughout 
the cytoplasm where it co-localized with OTULIN (Figure 4-26B). 
Figure 4-25: Binding of OTULIN and VPS26 to SNX27 is mutually exclusive.  
A) Topology diagram of SNX27PDZ. The OTULIN PDZbm and other class I PDZbms bind to the canonical cargo-binding site in 
SNX27. VPS26A and OTULIN (second interface) binding sites at the ?3-?4 loop partially overlap. Illustration provided by P. 
Elliott (MRC, Cambridge; University of Oxford). 
B) HEK293 cells were co-transfected with GFP-SNX27, Flag-VPS26A and HA-OTULIN constructs as indicated. After cell lysis, 
GFP-SNX27 was immunoprecipitated by GFP-Traps and tested for interactions with VPS26A and OTULIN by WB. 
C) Experiment was performed as in B) without overexpressing VPS26A. Binding of endogenous VPS26 and VPS35 to 
GFP-SNX27 was monitored by WB. 
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Catalytically inactive OTULIN affected the cellular distribution of SNX27 in a similar manner. 
Again, deletion of the PDZbm in OTULIN ?ETSL prevented detachment of SNX27 from the 
early endosomes and the even distribution of SNX27 throughout the cytoplasm. Thus, 
OTULIN is able to remove SNX27 from the early endosomal sorting compartment. 
4.3.3 Formation of a ternary HOIP-OTULIN-SNX27 complex 
As OTULIN interacts with HOIP via its N-terminal PIM (Elliott et al., 2014; Schaeffer et al., 
2014) and with SNX27 through its C-terminal PDZbm, we wanted to know whether a ternary 
complex may form. To answer this question, GFP-SNX27, HA-HOIP and different 
Flag-OTULIN constructs were co-expressed in HEK293 cells. GFP-SNX27 was 
immunoprecipitated from extracts by GFP-Traps and its association to HOIP and OTULIN, 
respectively, was assessed by WB. Upon co-expression of all three proteins, a ternary HOIP-
OTULIN-SNX27 complex could be detected (Figure 4-27). Expression of the SNX27-binding 
mutant (?ETSL) or the HOIP-binding mutant (Y56F) of OTULIN prevented the formation of a 
complex, confirming that OTULIN bridges the indirect interaction between SNX27 and HOIP. 
A very weak interaction between HA-HOIP and GFP-SNX27 was already detectable without 
overexpression of OTULIN, most likely mediated by endogenous OTULIN.  
Thus, the two binding sites of SNX27 and HOIP in the OTULIN molecule might enable 
ternary complex formation in cells as a result of their physical distance. 
 
Figure 4-26: OTULIN removes SNX27 from early endosomes. 
A) GFP-SNX27 was expressed in U2OS cells. Cells were immunostained for EEA1 (red) and co-localization of SNX27 with 
EEA1 was analyzed by confocal fluorescence microscopy. 
B) RFP-OTULIN WT, ?ETSL or C129A was expressed together with GFP-SNX27 in U2OS cells and localization was analyzed 
by confocal fluorescence microscopy.  
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4.3.4 The endogenous OTULIN-SNX27 complex is predominantly not LUBAC-
associated 
Knowing that a ternary HOIP-OTULIN-SNX27 complex can basically exist in cells (section 
4.3.3), we wanted to determine whether an endogenous ternary complex consisting of HOIP, 
OTULIN and SNX27 could be formed. To this end, extracts of Jurkat T cells were separated 
by analytical size exclusion chromatography (Figure 4-28A). As it has been previously 
observed (Elliott et al., 2014), only a very small proportion of OTULIN co-migrated with HOIP, 
which eluted in fractions 4-7 at an apparent MW of approximately 400-670 kDa (Figure 
4-28A). SNX27 also did not co-migrate with HOIP for the most part, suggesting that, if at all, 
an endogenous ternary complex exists at low levels. Interestingly, SNX27 also barely co-
eluted with the two retromer components VPS26 and VPS35, which eluted in fractions 8-11, 
corresponding to an apparent MW of approximately ~130-400 kDa. Importantly, the majority 
of cellular SNX27 eluted together with OTULIN in fractions 12-14 at an apparent MW of ~44-
130 kDa. Thus, peak elution profiles of OTULIN (~42 kDa) and SNX27 (~61 kDa) closely 
resemble a complex with a molecular mass of ~100 kDa. This would be the expected size for 
an OTULIN-SNX27 complex consisting of two monomers as seen in the crystal structure. 
 
Figure 4-27: OTULIN can simultaneously interact with SNX27 and HOIP. 
HEK293 cells were co-transfected with GFP-SNX27, HA-HOIP and different Flag-OTULIN constructs as indicated. After lysis, 
GFP-SNX27 was immunoprecipitated by GFP-Traps and analyzed for its association with OTULIN and HOIP by WB. 
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To confirm these results, gel filtration analysis of extracts from OTULIN- or SNX27-deficient 
Jurkat T cells was performed (Figure 4-28B and C). Elution peaks of OTULIN and SNX27 
 
Figure 4-28: Gel filtration analysis of parental and KO Jurkat T cell extracts. 
Extracts from parental (A), OTULIN-deficient (B) or SNX27-deficient (C) Jurkat T cells were fractionated by analytical size 
exclusion chromatography. Elution profiles of the indicated proteins were determined by WB. 
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shifted to a lower MW by 1 or 2 fractions. OTULIN eluted in the absence of SNX27, in 
fractions 14 and 15 at an apparent MW of about 44 kDa (Figure 4-28C). SNX27 migrated 
without OTULIN in fractions 13-15 (Figure 4-28B). These shifts approximately correspond to 
the expected elution profile of OTULIN and SNX27 monomers. Although OTULIN competes 
with the retromer for SNX27 binding (Figure 4-25), SNX27 was not increasingly detected in 
the retromer-containing fractions following OTULIN depletion (Figure 4-28B). Further, neither 
the elution profile of HOIP nor the elution profile of the retromer components shifted in 
extracts of KO Jurkat T cells. 
Thus, analytical size exclusion chromatography experiments indicated that endogenous 
OTULIN and SNX27 form a stable complex that is mainly not associated with the LUBAC or 
the retromer complex. 
4.3.5 SNX27 does not have an impact on the regulation of Met1-Ub 
To investigate whether SNX27 affects the homeostatic control of the Met1-Ub machinery by 
OTULIN, extracts of different KO clones were analyzed for HOIP levels and basal Met1-Ub 
levels (Figure 4-29). To this end, OTULIN- and SNX27-deficient HEK293 cells were 
additionally generated analogous to the Jurkat KO cell lines (section 4.2.2, Figure 4-18).  
As it has been previously described (Damgaard et al., 2016), depletion of OTULIN led to 
downregulation of HOIP in Jurkats, as well as in HEK293 cells (Figure 4-29A and B). By 
contrast, HOIP levels were not reduced in SNX27-deficient cells. SNX27-deficient HEK293 
clones even displayed slightly increased HOIP expression, but this effect could not be 
observed in SNX27 KO Jurkat T cells. 
 
Figure 4-29: SNX27 deficiency does not result in accumulation of Met1-Ub. 
Extracts of parental, OTULIN-deficient and SNX27-deficient Jurkat T cells (A) or HEK293 cells (B), respectively, were analyzed 
for Met1-Ub and HOIP expression by WB. 
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In OTULIN-deficient Jurkat T cells, SNX27 expression was reduced, but again this effect 
could not be detected in OTULIN KO HEK293 clones. These data suggest that the 
expression of SNX27 is tightly regulated and, depending on the cell type, closely related to 
the OTULIN expression.  
In line with the homeostatic control of cellular Met1-Ub levels by OTULIN, OTULIN-deficient 
clones from both cell lines displayed an accumulation of linear Ub (Figure 4-29). SNX27 KO 
clones, however, did not show changes in Met1-Ub levels, indicating that the OTULIN-
SNX27 interaction does not play a role in the regulation of Met1-Ub cellular availability. 
4.3.6 NF-?B, MAPK and Wnt signaling are not severly affected in OTULIN- and 
SNX27-deficient Jurkat T cells 
Since OTULIN has been implicated in the negative regulation of NF-?B signaling by cleaving 
Met1-Ub (Damgaard et al., 2016; Keusekotten et al., 2013), we wanted to assess how the 
absence of OTULIN in OTULIN-deficient Jurkat T cells affects NF-?B activation after 
stimulation with the pro-inflammatory cytokine TNF? (Figure 4-30A), as well as following 
CD3/28 co-stimulation (Figure 4-30C). 
Stimulation of the parental cell line with TNF? for up to 30 min resulted in NF-?B activation, 
evident from I?B? phosphorylation and degradation. NF-?B activation was not significantly 
altered in all OTULIN KO clones (Figure 4-30A). Moreover, neither the reduction of SNX27 
(clone 8) nor the complete absence of SNX27 (clones 14, 19, 20) had an impact on NF-?B 
activation in Jurkat T cells in response to TNF? (Figure 4-30B). 
CD3/CD28 co-stimulation of the parental cell line for up to 30 min induced likewise 
phosphorylation and degradation of I?B? (Figure 4-30C and D). Besides, the MAPK signaling 
pathway was also activated, evident from ERK phosphorylation. Again, no significant 
changes in I?B? phosphorylation and degradation or ERK phosphorylation could be 
observed in OTULIN-deficient Jurkat T cell clones (Figure 4-30C). It has been previously 
described that SNX27 may be a negative regulator of ERK phosphorylation following 
TCR/CD28 stimulation in Jurkat T cells (Rincon et al., 2011). However, no significant 
alterations in ERK phosphorylation became apparent in our SNX27 KO clones in response to 
CD3/CD28 co-stimulation (Figure 4-30D). I?B? phosphorylation and degradation were also 
not significantly altered in SNX27-deficient cells. 
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OTULIN and SNX27 have been associated with the regulation of canonical Wnt signaling 
(Rivkin, 2013; Sun et al., 2016; Takiuchi et al., 2014). To study whether loss of OTULIN or 
SNX27 in Jurkat T cells has an impact on ?-catenin stabilization, cells were stimulated with 
recombinant Wnt3a protein (Figure 4-31). In the parental cell line, stabilization of ?-catenin 
increased steadily within the four-hour stimulation. This stabilization, however, was not 
reduced, delayed, enhanced, or accelerated in OTULIN- (Figure 4-31A) or SNX27-deficient 
cells (Figure 4-31B). 
Altogether, lack of OTULIN or SNX27 in Jurkat T cells did not have a significant impact on 
NF-?B signaling following stimulation with TNF? and following CD3/CD28 co-stimulation, 
respectively. OTULIN and SNX27 KO clones also did not significantly affect ?-catenin 
stabilization following Wnt3a stimulation. 
 
Figure 4-30: Neither NF-?B nor MAPK signaling are affected in OTULIN- and SNX27-deficient in Jurkat T cells. 
A & B) OTULIN-deficient (A) or SNX27-deficient (B) Jurkat T cells were stimulated with recombinant TNF? (20 ng/ml) for the 
indicated times. Extracts were analyzed for NF-?B activation by WB using antibodies against p-I?B? and I?B?. 
C & D) OTULIN-deficient (C) or SNX27-deficient (D) Jurkat T cells were stimulated with anti-CD3 and anti-CD28 antibodies for 
the indicated times. Extracts were analyzed for T cell activation by WB using the indicated antibodies. 
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4.3.7 OTULIN counteracts binding of cargos to SNX27 
Since OTULIN binds the SNX27 PDZ domain at the same site as PDZbm-containing cargos 
(see section 4.2.5), we wanted to analyze whether OTULIN interferes with cargo loading of 
SNX27. To this end, first the attachment of known cargos (Steinberg et al., 2013) to 
overexpressed GFP-SNX27 was determined in HEK293 cells by GFP-Traps. The previously 
identified cargos, ATP7A, MRP4, DGK?, GLUT1 and STEAP3, co-precipitated together with 
GFP-SNX27 (Figure 4-32A). Cargo binding was either prevented or severly diminished by 
mutating His114 in the canonical PDZbm binding pocket.  
Upon co-expression of HA-OTULIN, not only the SNX27-retromer interaction, but also 
association of SNX27 to PDZbm-containing cargos like ATP7A, MRP4, DGK?, GLUT1 and 
STEAP3, were reduced (Figure 4-32B). Prevention of the OTULIN-SNX27 interaction by 
deletion of the PDZbm in OTULIN abolished this effect. Interestingly, catalytically inactive 
OTULIN C129A still counteracted cargo binding to SNX27, however, it was less effective 
than OTULIN WT (Figure 4-32B). Since catalytically inactive OTULIN is a strong Ub binder 
(Keusekotten et al., 2013), we wanted to exclude that this Ub binding impairs the ability of 
OTULIN to counter cargo binding to SNX27. Indeed, the C129A/L259E mutant, which is 
catalytically dead and fails to bind Met1-Ub (Keusekotten et al., 2013), could restrict cargo 
binding to SNX27 to the same extent as WT OTULIN (Figure 4-32B). 
 
Figure 4-31: ?-catenin stabilization is not affected by OTULIN or SNX27 deficiency. 
OTULIN-deficient (A), SNX27-deficient (B) or the parental Jurkat T cells were stimulated with recombinant Wnt3a (20 ng/ml) for 
up to 4 hrs. Activation of the canonical Wnt signaling pathway was monitored by ?-catenin stabilization on WBs. 
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4.3.8 OTULIN limits cell surface recycling of GLUT1 
Since endosome-to-plasma membrane transport of the glucose transporter GLUT1 is 
SNX27-retromer-dependent (Steinberg et al., 2013), and since OTULIN competes with 
GLUT1 for SNX27 binding (Figure 4-32B), we finally wanted to assess whether OTULIN 
affects GLUT1 recycling. 
To this end, we overexpressed OTULIN or OTULIN ?ETSL in U2OS cells together with the 
co-expressed surface marker ?CD2 and determined GLUT1 levels on the cell surface of 
transfected (?CD2 positive) cells by flow cytometry (Figure 4-33). First, cells were gated 
based on low and high expression of ?CD2 (Figure 4-33A). In low expressing cells, no 
changes in GLUT1 surface expression were observed (Figure 4-33B). In high expressing 
cells, however, OTULIN reduced the surface expression of GLUT1 to approximately 65% 
(Figure 4-33C). This indicates that OTULIN restricts SNX27-mediated endosome-to-plasma 
membrane trafficking of GLUT1 by binding to SNX27 and displacing GLUT1. Again, deletion 
of the PDZbm in OTULIN reversed the downregulation of the GLUT1 surface expression 
(Figure 4-33C) and resulted in GLUT1 amounts comparable with the amounts on mock-
 
Figure 4-32: OTULIN competes with cargos for SNX27 binding. 
A) Different GFP-SNX27 constructs were overexpressed in HEK293 cells and immunoprecipitated by GFP-Traps following cell 
lysis. Association of SNX27 with cargos was assessed by WB analysis. 
B) Experiment was performed as in A) after overexpression of GFP-SNX27 and different HA-OTULIN constructs. 
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transfected cells. This proves that the OTULIN-SNX27 interaction is critical for counteracting 
SNX27-mediated GLUT1 recycling. 
 
 
Figure 4-33: OTULIN limits GLUT1 recycling. 
A) Mock, OTULIN and OTULIN ?ETSL expressing U2OS cells were determined by flow cytometry by co-expression of the 
surface marker ?CD2. Gates were set on low and high ?CD2 expressing cells. 
B and C) GLUT1 surface expression of low (B) and high (C) ?CD2 expressing cells (upper panels). The quantified relative 
GLUT1 surface expression (normalized to mock) is depicted in the lower bar graphs. Data represent the mean ± SD of three
independent experiments. ***p<0.001; n.s. - not significant; unpaired t-test. 
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5. Discussion 
5.1 Generation and characterization of active site-directed probes for OTULIN 
5.1.1 OTULIN ABPs covalently label active OTULIN 
To date, no DUB ABP has been generated that closely resembles native Met1-linked diUb 
and labels Met1-specific active OTULIN. In this study, the first substrate-based active 
site-directed probes were generated that covalently label the Met1-specific DUB OTULIN. As 
a supplement to previously developed probes that are based on all seven Lys-linked diUbs 
(Mulder et al., 2014), the Met1-diUb based probes, bio-UbG76Dha-Ub (OTULIN ABP) and 
His10-UbG76Dha-Ub ?G76 (OTULIN ABP ?G76), complete the toolkit of linkage-specific DUB 
ABPs. 
 
In a previous attempt to develop a Met1-diUb based probe, the introduction of a large, 
flexible electrophile resulted in loss of specificity and thus OTULIN was not labeled 
(McGouran et al., 2013). Therefore we decided to use the small non-canonical amino acid 
Dha as reactive group in order to better mimic the structure and chemical features of the 
peptide bond in linear diUb. With reference to the crystal structure of catalytically inactive 
OTULIN in complex with Met1-diUb (Figure 5-1A), we assumed that the position of Gly76 in 
the distal Ub might be accessible for a nucleophilic attack by the catalytic Cys (Keusekotten 
et al., 2013). Accordingly, we substituted this Gly76 with Dha in the OTULIN ABPs. 
 
Figure 5-1: Bio-UbG76Dha-Ub is attacked by the nucleophilic Cys129 of OTULIN. 
A) Structure of OTULINcat C129A (grey) in complex with Met1-diUb (green) (PDB ID: 3ZNZ) (Keusekotten et al., 2013). A close-
up view of the catalytic pocket of OTULIN is depicted. Relevant residues are shown in stick format. Gly76dist points towards the 
catalytic site, which does not apply to Met1prox. 
B) Surface representation of OTULINcat (white) in complex with OTULIN ABP (green cartoon) (PDB ID: 5OE7) (Weber et al., 
2017). A close-up view of the catalytic site of OTULIN is depicted. OTULIN residues that form the substrate channel are shown 
in stick representation. 
Illustrations provided by P. Elliott (MRC, Cambridge; University of Oxford) (Weber et al., 2017). 
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Moreover, the crystal structure reveals that the proximal Met1 side chain does not point 
toward the catalytic Cys (Figure 5-1A). This explains why the replacement of Met1 by Dha in 
a recently generated probe did not result in covalent coupling to OTULIN but instead in its 
cleavage by OTULIN (Haj-Yahya et al., 2014). 
 
By determining the structure of OTULIN in complex with the OTULIN ABP, we confirmed that 
the electrophilic Dha76 in the distal Ub moiety reacts with the catalytic Cys129 in active 
OTULIN (Figure 4-4). The close structural resemblance of the OTULIN-ABP and 
OTULIN-Met1-diUb complexes emphasizes the unique Met1-specificity of OTULIN that is 
based on both Met1-Ub specific binding sites and the substrate-assisted cleavage reaction 
(Keusekotten et al., 2013). 
Mutation of the distal Gly76 in linear diUb to alanine strikingly reduced binding affinity to 
OTULIN and thus prevented cleavage by OTULIN (Figure 4-6C and D). In line with this, it 
was shown earlier that OTULIN fails to hydrolyze Ser76-Met1 linkages (Keusekotten et al., 
2013). A close-up view of the active site of OTULIN bound to the OTULIN ABP indicates that 
there is very little space and that the accommodation of an alanine at the Gly76 position 
might be difficult (Figure 5-1A and B). As the Dha, despite its apparently lower binding 
affinity, still reacts with the active Cys, we conclude that the coupling reaction between 
OTULIN and the ABP is mainly driven by the electrophile and less by the affinity. 
5.1.2 OTULIN ABPs label OTULIN with high selectivity 
The most remarkable feature of the OTULIN ABP is its high selectivity for OTULIN, which 
was determined in direct in vitro DUB assays as well as in global MS analysis (sections 
4.1.3 - 4.1.6). Interestingly, the Met1-Ub cleaving DUBs USP2, USP21 and CYLD did not 
react with the OTULIN ABP (Figure 4-6A). For the promiscuous DUBs USP2 and USP21, 
which cleave all types of Ub chains, this might be the result of their low reactivity towards 
Met1-Ub (Bremm et al., 2010; Faesen et al., 2011; Komander et al., 2009b; Virdee et al., 
2010; Ye et al., 2011). CYLD efficiently disassembles Met1- and Lys63-linked Ub chains 
(Sato et al., 2015), but was still not labeled by the OTULIN ABP. A structural comparison of 
the OTULIN-ABP complex and the non-covalent zebrafish CYLD (C596S)-Met1-diUb 
complex (Sato et al., 2015) may provide an explanation (Figure 5-1B and Figure 5-2): In the 
active site of CYLD, Lys756, Ser800 and Asp794 form a very narrow channel that surrounds 
the distal Ub tail and the Gly76-Met1 linkage (Sato et al., 2015). It is likely that the OTULIN 
ABP does not fit into this channel due to the slightly bigger Dha residue at the distal Gly76 
position and can therefore not be attacked by the catalytic Cys.  
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Amino acid residues interacting with the Ub C-terminus are well conserved in other USPs 
such as USP2, USP7, USP14 and USP21 (Hu et al., 2002; Hu et al., 2005; Renatus et al., 
2006; Ye et al., 2011). In line with this, USP21 and CYLD failed to hydrolyze UbG76A-Ub 
(Figure 4-6C), suggesting that the distal Gly76 is crucial for binding to and cleavage by 
USPs. 
 
The only, albeit weak, DUB cross-reactivity of the OTULIN ABP was toward recombinant and 
endogenous USP5 (Figure 4-5A and Figure 4-8A). In cells, USP5 recognizes and binds the 
C-terminal di-Gly motif in free unanchored Ub chains via its ZnF UBP domain and 
disassembles them from the proximal end (Reyes-Turcu et al., 2006; Reyes-Turcu et al., 
2008). Apparently, USP5 is in the same way allosterically activated by the C-terminal di-Gly 
motif in the OTULIN ABP and thus attacks the active site-directed probe. This cross-reactivity 
could be eliminated by generating the OTULIN ABP ?G76, which lacks the Gly76 in the 
proximal Ub (Figure 4-13B). 
Covalent USP5-ABP adducts, which are only formed by a small amount of cellular USP5, 
were exclusively detected by direct staining but not in biotin-ABP pull-downs. One possible 
explanation for this could be that the biotin-tag of USP5-bound ABP is not accessible for 
streptavidin beads due to structural constraints of the catalytic pocket. 
USP5 was also identified together with UCHL3 and OTULIN in the selectivity analysis of the 
OTULIN ABP by LC-MS/MS (Figure 4-10C). After treatment with the broad-ranging DUB 
inhibitor PR-619, only ABP binding of OTULIN was lost, although USP5 and UCHL3 are 
likewise affected by the inhibitor (Altun et al., 2011). This indicates that USP5 and UCHL3 
predominantly non-covalently interact with the ABP, which might be due to their high cellular 
abundance (Clague et al., 2015). Indeed, USP5 is one of the most abundant DUBs in HeLa 
and Swiss3T3 cells (Clague et al., 2015). In addition, it has been demonstrated that UCHL3 
 
Figure 5-2: Close-up view of the CYLD catalytic pocket in complex with Met1-diUb. 
Surface representation of zebrafish CYLD (zCYLD) (aa 578-951, C596S, white) in complex with Met1-diUb (green cartoon) 
(PDB ID: 3WXE) (Sato et al., 2015). A close-up view of the catalytic site of CYLD is depicted. CYLD residues that form a tight 
substrate channel around the Gly76-Met1 peptide bond are shown in stick format. 
Illustration provided by P. Elliott (MRC, Cambridge; University of Oxford) (Weber et al., 2017). 
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non-covalently associates with Ub dimers in vitro and in cells without cleaving them (Setsuie 
et al., 2009). 
So far, all DUB ABPs that are based on Lys-linked diUb target a broad range of DUBs in cell 
extracts and do not exhibit specificity towards one particular enzyme (Li et al., 2014; Mulder 
et al., 2014). This mainly results from the large number of USP DUBs that rather 
unspecifically hydrolyze different types of Ub chains (Faesen et al., 2011; Komander et al., 
2009a; Ritorto et al., 2014). In contrast, the OTULIN ABP ?G76 is the first specific active 
site-directed probe that reacts with one single DUB. Highly selective labeling of OTULIN by 
means of the two new OTULIN ABPs emphasizes its unique ability to specifically recognize 
and efficiently cleave Met1-Ub (Keusekotten et al., 2013). 
5.1.3 ABP coupling to E1 enzymes triggers formation of polyABP assemblies 
Interestingly, incubation of cell extracts with OTULIN ABP led to the ATP-dependent 
formation of linear polyUb assemblies, which could be detected with anti-Met1-Ub antibody 
(Figure 4-9). Moreover, ATP-dependent binding of the E1 enzymes UBA1 and UBA6 to the 
ABP was determined in the proteome-wide selectivity analysis (Figure 4-11). This finding 
suggests that the accumulation of linear polyUb adducts is not caused by the ABP-induced 
inhibition of OTULIN and the unrestricted synthesis of Met1-Ub, as observed in knock-in 
mice that express catalytically inactive OTULIN (Heger et al., 2018). The data rather indicate 
that the OTULIN ABP is assembled into polyABP adducts by enzymes of the ubiquitination 
cascade. In line with this, the uncleavable and non-inhibitory diUb mutant His-UbG76A-Ub was 
also incorporated into high molecular polyUb assemblies, detectable with anti-Met1-Ub 
antibody (Figure 4-12A). As the diUb N-termini are occupied by affinity tags, internal lysine 
residues must serve as docking sites for other diUb molecules. And since only USP2, which 
can cleave all Ub linkages, was able to completely degrade the polyABP assemblies (Figure 
4-12C), different lysines seem to function as attachment sites for the formation of branched 
Ub chains. 
Currently, it is unclear whether the finding of the in vitro synthesis of such branched artificial 
chains is physiologically relevant. However, unanchored ubiquitin dimers and chains exist in 
cells and thus might be used for polyubiquitin conjugation (Chen and Pickart, 1990; Martinez-
Fonts and Matouschek, 2016; Strachan et al., 2012). For the generation of diUb-based DUB 
ABPs it should be noted that deletion of Gly76 in the proximal Ub prevents cross-reactivity 
with E1 enzymes (Figure 4-13C). 
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5.1.4 Potential applications for the OTULIN ABP 
Recently, the OTU DUB Cezanne was crystallized in complex with a Lys11-linked 
diUb-based ABP (Mevissen et al., 2016). By means of this substrate-bound structure, both 
the reason for the Lys11-specificity of Cezanne and conformational changes of the S1´ 
binding site during the catalytic cycle were revealed, demonstrating the benefit of utilizing 
selective ABPs in functional analyses of DUBs (Mevissen et al., 2016).  
In this study, further potential applications for the highly selective OTULIN ABP were 
validated. The OTULIN ABP can be used in order to analyze OTULIN activity in cell extracts. 
Upon treatment of cell extracts with OTULIN ABP, all OTULIN reacted with the probe (Figure 
4-7A and Figure 4-8A). This indicates that in these cells, all OTULIN is active or rather 
becomes activated by binding of Met1-Ub to the Met1-Ub specific binding sites, which 
enables substrate-assisted catalysis (Keusekotten et al., 2013). TNF? stimulation did not 
lead to a decrease in OTULIN activity (Figure 4-15A). As it yet might well be that OTULIN 
activity is down-regulated in response to other stimuli or in other cell lines, the OTULIN ABP 
will be helpful for such investigations. 
By means of the biotin-labeled OTULIN ABP, substrate-bound OTULIN was almost entirely 
depleted from extracts. Thus, its association with protein complexes can also be analyzed 
(Figure 4-15B and Figure 4-16). Equivalent levels (<25%) of all LUBAC components 
interacted with substrate-bound OTULIN in ABP-PDs. Accordingly, the majority (>75%) of 
LUBAC is not stably associated with substrate-bound OTULIN. Certainly, affinity of LUBAC 
for OTULIN might vary depending on whether OTULIN is present in a substrate-bound 
or -unbound state. However, gel filtration experiments also revealed that the majority of 
cellular OTULIN does not form a complex with the catalytic LUBAC subunit HOIP (Figure 
4-28A). This finding is in accord with a recent study, in which it was shown that the majority 
of LUBAC does not interact with OTULIN (Elliott et al., 2014). It was suggested that 
phosphorylation of the PIM in OTULIN prevents the OTULIN-LUBAC interaction and thus 
might represent a potential regulatory mechanism of the interaction (Elliott et al., 2014; 
Schaeffer et al., 2014). TNF? does not seem to have an effect on such regulation, since the 
amount of LUBAC associated with substrate-bound OTULIN in ABP-PDs did not change by 
TNF? stimulation (Figure 4-15B). This observation and the fact that LUBAC-SPATA2-CYLD 
but not LUBAC-OTULIN complexes are recruited to the TNFR complex in order to counteract 
LUBAC activity after receptor engagement suggest that two distinct LUBAC-DUB complexes 
exist that are regulated independently of each other (Elliott et al., 2016; Kupka et al., 2016a; 
Schlicher et al., 2016; Wagner et al., 2016).  
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5.2 OTULIN regulates the SNX27-retromer function 
5.2.1 High-affinity interaction between OTULIN and SNX27 
In this study, SNX27 was identified as OTULIN interactor by means of the newly developed 
OTULIN ABP and LC-MS/MS analysis (Figure 4-17). The OTULIN-SNX27 interaction is not 
cell type-specific, detectable in both human and murine cells (Figure 4-21) and not 
dependent on either the catalytic activity of OTULIN (Figure 4-22B) or HOIP binding to 
OTULIN (Figure 4-19B).  
In common with typical SNX27 cargos (Gallon and Cullen, 2015; Steinberg et al., 2013), 
OTULIN directly binds to the canonical cargo-binding site in the SNX27 PDZ domain via a 
C-terminal class I PDZbm, which is indispensable for the interaction and highly conserved 
among tetrapods (Figure 4-22 and Figure 4-23). Interestingly, the affinity of the OTULIN 
PDZbm peptide (KD ~1.1 µM) is at least twofold higher compared to all measured affinities of 
SNX27PDZ-binding PDZbm peptides (Figure 5-3). So far, the peptides of DGK? and PLHPP1 
have displayed the highest affinity for SNX27 with KD values of approximately 2 µM, 
whereas, for example, the peptide of LRRC3B (KD ~73 µM) has an approximately 66-fold 
lower affinity than the OTULIN peptide (Figure 5-3) (Clairfeuille et al., 2016). 
In structural analyses it was shown that amino acid residues upstream of the P-5 position in 
the DGK? PDZbm peptide do not contribute to binding of the SNX27 PDZ domain (Clairfeuille 
et al., 2016). In contrast, our structural analysis of the OTULINcat-SNX27PDZ complex 
revealed that also Val346 (P-6) and Arg354 (P-7) in the OTULIN C-terminus form hydrogen 
bonds with residues in SNX27 (Figure 4-23B). This might explain why the SNX27 affinity of 
the OTULIN PDZbm peptide is higher than the affinity of the DGK? PDZbm peptide. 
To date, all structural and biophysical data of SNX27-cargo interactions have been based on 
studies with PDZbm peptides of cargos (Clairfeuille et al., 2016; Gallon et al., 2014). The 
 
Figure 5-3: Summary of ITC data for the association of SNX27PDZ with PDZbm peptides.  
(Clairfeuille et al., 2016; Gallon et al., 2014; Shinde and Maddika, 2017) 
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crystal structure of the OTULINcat-SNX27PDZ complex reveals for the first time, how an entire 
PDZbm-containing protein domain binds to SNX27 (Figure 4-23A). Interestingly, the affinity 
of OTULINcat for SNX27PDZ is with a KD value of ~31 nM about 35 times higher than the 
affinity of the C-terminal OTULIN peptide and the highest of all ever measured affinities of 
SNXPDZ interactors (Clairfeuille et al., 2016). The high affinity can be explained by a second 
interface between OTULIN and SNX27, which was determined by means of the crystal 
structure (Figure 4-23 and Figure 4-24). This second interaction surface is spatially 
separated from the canonical PDZ-PDZbm interface and involves parts of the ?3-?4 loop in 
SNX27 and conserved amino acids in the OTU domain of OTULIN that are not contributing 
to its hydrolase activity (Keusekotten et al., 2013). Accordingly, the OTULIN substrate 
Met1-diUb could be modeled onto the OTULINcat-SNX27PDZ structure without having any 
impact on the interfaces between OTULIN and SNX27 (Figure 5-4). This is in line with the 
fact that SNX27 was identified as interactor of OTULIN in complex with the substrate-like 
ABP. Mutations in the second interface, both on the SNX27 and on the OTULIN side, 
reduced the affinity to that of the PDZbm peptide (Figure 4-24B). This indicates that the 
second interface considerably strengthens the OTULIN-SNX27 interaction, which is primarily 
mediated by the attachment of the PDZbm to the PDZ domain. 
Analogous to this, it was shown that a second interface between PlexinB2 and the PDZ 
domain of RhoGEF also increases binding affinity at least by tenfold to a KD of 2 µM (Pascoe 
et al., 2015). These findings imply that the existence of a second interaction surface might be 
a general concept to regulate binding affinities and possibly, selectivities of PDZ interactors. 
 
Figure 5-4: Met1-diUb and SNX27 can simultaneously bind to OTULIN.  
OTULINcat (aa 80–352) is rendered in surface representation with SNXPDZ (aa 40-135) depicted as ribbon (yellow). Met1-linked 
diUb (green) is modeled onto the complex by superimposition of the OTULINcat-Met1-diUb structure (PDB: 3ZNZ) (Keusekotten 
et al., 2013). Illustration provided by P. Elliott (MRC, Cambridge; University of Oxford). 
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5.2.2 OTULIN binds the SNX27 PDZ domain with high selectivity 
Consistent with the in vitro ITC data, mutations in the canonical or non-canonical interfaces 
resulted in loss or attenuation of the OTULIN-SNX27 interaction in cells (Figure 4-22 and 
Figure 4-24). The cellular OTULIN-SNX27 complex was detected in OTULIN ABP-PDs, 
co-immunoprecipitations and confocal fluorescence microscopy. OTULIN was also recently 
identified in a mass spectrometric analysis of the GFP-SNX27 interactome, but the 
interaction was not validated or further investigated (Tello-Lafoz et al., 2017). 
In the human proteome, more than 150 proteins exist that contain at least one PDZ domain 
(Ivarsson, 2012). In a previous report, it has been suggested that OTULIN interacts with 
several PDZ domain-containing proteins via its PDZbm (Rivkin, 2013). In our LC-MS/MS 
analysis, however, we identified SNX27 as the only PDZ domain-containing protein in the 
OTULIN interactome across two independent experiments. Since the ?3-?4 loop is a unique 
feature of the SNX27 PDZ domain (Gallon et al., 2014) and since it is involved in the non-
canonical OTULIN-SNX27 interaction, this might explain the observed selectivity of OTULIN 
for SNX27. It is probable that other PDZ domains would fail to bind OTULIN due to the lack 
of the ?3-?4 loop and other structural differences.  
At present, more than 400 structures of PDZ domains, either alone or in complex with 
binding partners, have been determined (Laskowski et al., 2018). Future structural and 
biophysical studies with OTULIN and other PDZ domains are necessary to better understand 
the high selectivity of OTULIN for SNX27. 
5.2.3 SNX27 does not affect OTULIN and LUBAC functions 
So far, all cellular functions of OTULIN have been attributed to its catalytic activity as a 
deubiquitinating enzyme for Met1-Ub. OTULIN-deficient HEK293 and Jurkat T cells 
generated in this study showed increased Met1-Ub levels and reduced HOIP amounts in 
comparison with parental cells (Figure 4-29). Other research groups have also observed that 
depletion of OTULIN, but not CYLD, leads to a massive accumulation of linear Ub chains 
under unstimulated conditions and that OTULIN deficiency in T and B cells results in loss of 
LUBAC components (Damgaard et al., 2016; Draber et al., 2015). These observations 
emphasize the important role of OTULIN in the homeostatic control of Met1-Ub and the 
LUBAC stabilization (Damgaard et al., 2016; Draber et al., 2015). 
In spite of the fact that Met1-Ub and SNX27 can simultaneously bind to OTULIN (Figure 5-4), 
SNX27PDZ had no impact on the proteolytic cleavage of Met1-linked tetraUb chains by 
OTULINcat in vitro (Paul Elliott, unpublished data). Moreover, we neither detected increased 
Met1-Ub levels nor reduced HOIP amounts in SNX27 KO HEK293 or Jurkat T cells, 
DISCUSSION 
   
  74 
 
suggesting that SNX27 is not required for the homeostatic regulation of Met1-Ub or for 
LUBAC stabilization by OTULIN. 
 
OTULIN interacts with HOIP via its N-terminal PIM, which is distant from the C-terminal 
PDZbm (Elliott et al., 2014; Schaeffer et al., 2014). Co-immunoprecipitations following 
overexpression of HOIP, OTULIN and SNX27 demonstrated that a ternary complex can 
form, in which OTULIN mediates the interaction between HOIP and SNX27 (Figure 4-27). 
The study of endogenous complexes by gel filtration analysis, however, revealed that the 
cellular OTULIN-SNX27 complex is not associated with LUBAC (Figure 4-28). Besides, the 
majority of OTULIN does also not form a complex with the LUBAC component HOIP, which 
is in line with a recently published gel filtration analysis (Elliott et al., 2014). It might be that 
the interaction is impaired by phosphorylation of the PIM in OTULIN, as suggested by Elliott 
et al. (Elliott et al., 2014), or that the OTULIN-HOIP interaction is very unstable and hardly 
detectable by size exclusion chromatography. However, it is important to emphasize that the 
association with SNX27 does not seem to prevent OTULIN binding to HOIP since the elution 
peak of OTULIN does not shift to HOIP-containing fractions in SNX27-deficient cell extracts 
as well. So far, the role of a ternary complex, which may form under physiological conditions 
is unclear and could be investigated in the future. While it cannot be excluded that LUBAC 
affects the recycling function of the SNX27-retromer complex, the OTULIN-SNX27 
interaction can certainly not contribute to this, as OTULIN counters formation of the 
SNX27-retromer complex (see section 5.2.4).  
 
The absence of OTULIN in Jurkat T cells had no significant impact on NF-?B activation 
following TNF? stimulation and CD3/CD28 co-stimulation, respectively, implying that OTULIN 
is not an essential regulator of Met1-Ub in NF-?B and MAPK signaling (Figure 4-30). 
Likewise, data from other research groups indicate that CYLD is instead the central DUB that 
restricts Met1-Ub and also Lys63-Ub in signaling complexes after stimulation (Draber et al., 
2015; Harhaj and Dixit, 2012; Hrdinka et al., 2016; Kupka et al., 2016b). CYLD is also 
recruited by LUBAC to the receptor-associated signaling complexes upon TNFR1 or NOD2 
engagement, whereas minimal or no OTULIN is detected in activated signaling complexes 
(Draber et al., 2015; Elliott et al., 2016; Kupka et al., 2016a; Schlicher et al., 2016; Wagner et 
al., 2016). It should be noted that effects of OTULIN deficiency can vary in different cell 
types. While loss of OTULIN in T and B cells results in LUBAC destabilization, as mentioned 
above, in myeloid cells knockout of OTULIN triggers spontaneous Met1-Ub formation and 
NF-?B activation (Damgaard et al., 2016). Thus, the OTULIN-LUBAC interaction might be 
differentially regulated depending on the cell type.  
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OTULIN has also been associated with canonical Wnt signaling during embryogenesis 
(Rivkin, 2013). Moreover, OTULIN counteracts LUBAC-mediated suppression of Wnt 
signaling in reporter assays (Rivkin, 2013; Takiuchi et al., 2014). We could not determine any 
significant changes in the stabilization of ?-catenin upon treatment of OTULIN KO Jurkat T 
cells with recombinant Wnt3a, indicating that OTULIN is at least not required for ?-catenin 
stabilization after Wnt3a stimulation (Figure 4-31).  
It has been previously proposed that SNX27 may be a negative regulator of ERK 
phosphorylation following TCR/CD28 stimulation in Jurkat T cells (Rincon et al., 2011). 
SNX27 has further been associated with the regulation of canonical Wnt signaling as it 
interacts with Frizzled receptor Fzd7 (Sun et al., 2016). The absence of SNX27 in Jurkat T 
cells did, however, just as the absence of OTULIN, not significantly affect TNF, TCR/CD28 
and Wnt signaling (Figure 4-30 and Figure 4-31). Altogether, these data reveal that the 
interaction between OTULIN and SNX27 has no effect on NF-?B, MAPK and Wnt signaling in 
Jurkat T cells. 
5.2.4 OTULIN is not a cargo of the SNX27-retromer 
The formation of the endosomal SNX27-retromer complex is important for the fast 
endosome-to-plasma membrane recycling of SNX27-associated cargos (Gallon and Cullen, 
2015). The retromer component VPS26 binds to the ?3-?4 loop in the SNX27 PDZ domain 
(Gallon et al., 2014), which also interacts with OTULIN (Figure 4-24).  
Superimposition of the SNX27PDZ-OTULINcat and SNX27PDZ-VPS26A complexes revealed 
that binding sites of OTULIN and VPS26A partially overlap (Figure 4-24 and Figure 4-25A). 
The resulting clash excludes the possibility that OTULIN and VPS26 simultaneously bind to 
SNX27. Due to its high affinity for SNX27, OTULIN rather competes with retromer for binding 
to SNX27 (Figure 4-25). Confocal fluorescence microscopy moreover revealed that OTULIN, 
which is not located on early endosomes, counteracts endosomal association of SNX27 
(Figure 4-26).  
To analyze the distribution of SNX27 and OTULIN in cellular complexes, analytical size 
exclusion chromatography with extracts from parental, OTULIN KO and SNX27 KO Jurkat T 
cells was performed (Figure 4-28). It became apparent that the majority of endogenous 
OTULIN and SNX27 exists in a stable complex with 1:1 stoichiometry, which is consistent 
with the results from the crystal structure analysis of the OTULIN-SNX27 complex. Despite 
its essential role in retromer-mediated cargo transport to the plasma membrane (Steinberg et 
al., 2013), the majority of SNX27 was surprisingly not detected together with the retromer 
complex but with OTULIN. Even though preparation of the cell extracts might favor cytosolic, 
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not membrane-associated protein complexes, our data suggest that only a small proportion 
of endogenous SNX27 interacts with the retromer. This explains why the SNX27–retromer 
interaction has so far only been shown in immunoprecipitations after overexpression of at 
least one component (Gallon et al., 2014; Steinberg et al., 2013) and why the endogenous 
interaction has never been detected. It is important to emphasize that the OTULIN-SNX27 
complex was not detected together with the retromer complex in our gel filtration analysis.  
Altogether, structural analysis, immunoprecipitations, fluorescence microscopy and 
comparative analytical size exclusion chromatography provided evidence that OTULIN 
cannot be a cargo of the SNX27-retromer complex since OTULIN prevents formation of the 
SNX27-retromer complex.  
5.2.5 OTULIN counteracts cargo recycling by the SNX27-retromer 
Much is known about the structure of the recombinant SNX27-VPS26-VPS35-VPS29 
complex (Gallon and Cullen, 2015; Kovtun et al., 2018). However, it is entirely ambiguous, 
how and when the cellular SNX27-retromer complex assembles on the endosomes, how 
cargos are selectively recruited, and how the transport complex is disassembled again at the 
plasma membrane. The fact that the endogenous interaction has never been detected in 
immunoprecipitations indicates that the interaction might occur at low frequency or that the 
regulation of the interaction might be very dynamic. Our data suggest that OTULIN regulates 
and tightly controls the assembly of the SNX27-retromer by binding and thus retaining a 
majority of endogenous SNX27. Furthermore, OTULIN might also be responsible for the 
disassembly of cargo-bound SNX27-retromer complexes once they have reached the 
plasma membrane.  
 
OTULIN not only competes with the retromer complex for binding to SNX27, but also hinders 
classical cargos from interacting with SNX27 by binding to the canonical cargo-binding site 
(Figure 4-32). Consequently, OTULIN impairs the recycling of cargos by the SNX27-retromer 
complex, as it has been shown for the glucose transporter GLUT1 (Figure 4-33 and Figure 
5-5). While catalytic activity of OTULIN is crucial for controlling the cellular Met1-Ub 
concentration, regulation of the SNX27-retromer proceeds independently from the hydrolase 
activity (Figure 5-5).  
Currently, the spatiotemporal regulation of the SNX27-retromer by OTULIN is unclear and 
requires further investigation. Recently, it was shown that phosphorylation of C-terminal 
peptides with PDZbm have the ability to increase or decrease peptide affinities for PDZ 
domains (Sundell et al., 2018). Analogous to this, phosphorylation of some cargo peptides 
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augments their binding to SNX27 (Clairfeuille et al., 2016). Thus, phosphorylation in the 
OTULIN PDZbm, for example at the positions P-2 (Thr350) and P-1 (Ser351), might also 
influence the OTULIN-SNX27 interaction, represent a potential regulatory mechanism for the 
interaction, and alter the balance of OTULIN and cargo binding to SNX27. In addition, it was 
reported that in ITC experiments the affinity of SNX27 for the PDZbm-containing peptides of 
Kir3.3 and GLUT1 is enhanced upon VPS26A binding, suggesting that the SNX27-retromer 
interaction may facilitate cargo binding (Gallon et al., 2014). 
Remarkably, loss of OTULIN is insufficient to detect a higher amount of SNX27 in the 
retromer-containing fractions in gel filtration experiments (Figure 4-28B). Thus, further events 
are necessary to form the SNX27-retromer or the complex is not stable enough for analysis 
by means of size exclusion chromatography. 
Analogous to the role of OTULIN, it was recently suggested that the phosphatase PTEN 
impairs assembly of the SNX27-retromer complex and thus counteracts SNX27-retromer 
mediated GLUT1 recycling (Shinde and Maddika, 2017). With a KD of 37 µM the affinity of 
the PDZbm-containing PTEN peptide is approximately 33 times lower than the affinity of the 
OTULIN peptide and also very low for an interaction partner that competes with the retromer 
and cargos for binding to SNX27. The study does not contain structural data of the PTEN-
SNX27 complex, but still it reveals that besides OTULIN, additional proteins might exist that 
regulate or control the function of the SNX27-retromer. 
 
Figure 5-5: Model for the dual role of OTULIN. 
Via the degradation of Met1-linked Ub chains synthesized by LUBAC, OTULIN regulates the Met1-Ub concentration in the cell 
and thus acts as homeostatic control factor. By contrast, catalytic activity of OTULIN is not required for the interaction with 
SNX27. The interaction is mediated by the canonical PDZbm-PDZ interface and a second non-canonical interface. OTULIN 
binding to SNX27 suppresses formation of the cargo-SNX27-retromer complex and thus counteracts endosomal sorting and fast 
recycling of plasma membrane proteins, such as GLUT1. 
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The impairment of the deubiquitinase activity of OTULIN is associated with severe 
phenotypes. In humans, hypomorphic germline mutations in the OTULIN gene reduced the 
stability of OTULIN (L272P) and its affinity for Met1-Ub, causing a severe disease called 
OTULIN-related auto-inflammatory syndrome (ORAS) or otulipenia (Damgaard et al., 2016; 
Zhou et al., 2016). In mice, both the loss of Otulin and a mutation in the Met1-Ub specific 
binding site (W96R) are embryonically lethal (Damgaard et al., 2016; Rivkin, 2013). Inducible 
Otulin deletion and the expression of catalytically inactive Otulin (C129A) in adult mice result 
in spontaneous, fatal auto-inflammation and lethal weight loss within five days (Damgaard et 
al., 2016; Heger et al., 2018). SNX27-deficient mice suffer from growth retardation and die 
within three weeks after birth (Cai et al., 2011). To unravel the physiological consequences of 
the OTULIN-SNX27 interaction, in vivo studies will be necessary. However, the serious 
consequences of an OTULIN or SNX27 deficiency make it impossible to investigate the 
physiological role of the OTULIN-SNX27 interaction in currently available mouse models.  
5.3 Conclusion and perspectives 
In this study, we generated the first diUb-based ABPs for the Met1-specific DUB OTULIN. 
Direct DUB assays and structural analysis of the OTULIN-ABP complex revealed that active 
OTULIN reacts with the probe via its catalytic Cys and is thus covalently and irreversibly 
bound. By global LC-MS/MS analysis of ABP-bound proteins, a high selectivity of the 
OTULIN ABP could be determined. Minimal cross-reactivities with USP5 and E1 enzymes 
could be prevented by deleting Gly76 in the proximal Ub moiety of the ABP. Thus, OTULIN 
ABP ?G76 is the first completely specifc ABP for OTULIN. The OTULIN ABP does not only 
enable us to analyze OTULIN activity in cell extracts of unstimulated or stimulated cells, but 
also to efficiently enrich active OTULIN along with its associated interactors from lysates.  
The OTULIN ABP might be used in the future to determine cell type-specific differences in 
OTULIN activity and to analyze influences of different stimuli on OTULIN activity. By the 
efficient pull-down of OTULIN by means of the ABP, the association with LUBAC may also 
be investigated more precisely. Thus, conclusions could be drawn about the cell type-specific 
regulation of the Met1-Ub machinery. These insights would be important for explaining 
distinct phenotypic effects of OTULIN depletion in lymphocytes and myeloid cells (Damgaard 
et al., 2016). Additionally, the OTULIN ABP might be helpful for localizing active OTULIN in 
intact cells via fluorescence microscopy.  
 
By ABP-PDs in combination with LC-MS/MS, we could identify SNX27 as new OTULIN 
interactor. The OTULIN-SNX27 interaction could be verified by means of ABP-PDs, confocal 
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microscopy, analytical size exclusion chromatography and co-IPs in various human and 
murine cell lines. It could be demonstrated by structural, biophysical and cellular analyses 
that the interaction is independent of the catalytic activity of OTULIN, and relies on direct 
binding of a highly conserved C-terminal PDZbm in OTULIN to the canonical cargo-binding 
site in the PDZ domain of SNX27. The identification of a second interface could additionally 
explain the high affinity of the two proteins.  
Binding studies and functional analyses revealed that the OTULIN-SNX27 association 
prevents the retromer subunit VPS26A and cargos from binding to SNX27 and that OTULIN 
removes SNX27 from the early endosomes. Consequently, OTULIN is not a cargo of SNX27, 
but counteracts fast cargo recycling mediated by the SNX27-retromer. Thus it regulates 
surface expression of plasma membrane proteins, as it was shown for GLUT1. 
Taken together, we identified in this study a novel biological function of OTULIN that is 
important for the maintenance of the cellular homeostasis. While OTULIN controls the 
cellular Met1-Ub concentration through its deubiquitinase activity, it regulates 
SNX27/retromer-mediated endosomal sorting of plasma membrane proteins independently 
from its catalytic activity, by binding to SNX27.  
In a next step, the question should be addressed, how the OTULIN-SNX27 interaction is 
regulated. To this end, it will be necessary to check interfaces between OTULIN and SNX27 
for post-translational modifications by mass spectrometric analysis. Structural, biophysical 
and cellular studies will be useful to find out whether potential modifications strengthen or 
weaken the interaction. Since phosphorylation of C-terminal cargo peptides as well as 
binding of VPS26 to SNX27 can have a bearing on the affinity of cargos for SNX27, it will be 
important to study the OTULIN-SNX27 interaction in the context of the SNX27-retromer 
assembly. 
The fatal consequences of a loss of OTULIN´s catalytic function make it impossible to study 
the physiological role of the OTULIN-SNX27 interaction in currently available mouse models. 
Therefore, the generation of an appropriate mouse model would be of particular importance. 
Considering the structural information on the OTULIN-SNX27 interaction from this work, the 
generation of a knock-in mouse line expressing a truncated version of OTULIN that lacks the 
C-terminal PDZbm would be useful. Alternatively, point mutations in the second interface 
might help to elucidate the physiological relevance of the high affinity and selectivity of 
OTULIN for SNX27. The apparently very stable OTULIN-SNX27 complex suggests that the 
interaction might also play additional, completely new roles besides the regulation of cargo 
recycling.  
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6. Materials 
6.1 Instruments and equipment 
Instrument / equipment Source 
Agarose gel chambers  NeoLab, Heidelberg 
Autoclave – VX-95 Systec, Linden 
Bacterial culture flasks/tubes Schott, Zwiesel; BD, Heidelberg 
Cell culture flasks/plates  BD, Heidelberg; Nunc, Wiesbaden 
Cell scraper  Sarstedt, Newton, USA 
Cell viability analyzer - ViCell-XR  Beckman Coulter, Krefeld 
Centrifuge  Beckman Avanti J-26 XP  Beckman Coulter, Krefeld 
Centrifuges - 5810R, 5417R, 5471C, 5804  Eppendorf, Hamburg 
CO2 incubators Binder, Tuttlingen 
Cryo tubes Greiner Bio-One, Frickenhausen 
Developer - Optimax Protec, Oberstenfeld 
Electroporation cuvettes - Gene Pulser Bio-Rad, München 
Electroporator - Gene Pulser Xcell System Bio-Rad, München 
Eppendorf tubes Eppendorf, Hamburg 
FACS Attune Acoustic Focusing Cytometer Thermo Fisher Scientific, Waltham, USA 
FACS tubes  BD, Heidelberg 
Falcon tubes BD, Heidelberg 
Filter pipette tips - TipOne StarLab, Hamburg 
Freezers and Fridges  Liebherr, Ochsenhausen 
Gel Documentation System - Intas Gel iX Imager Intas, Göttingen 
Gel filtration column – Superdex200 10/300  GE Healthcare, München 
Heat blocks Techne, Burlington, USA 
Ice machine – Scotsman AF20 Scotsman Ice Systems, Vernon Hills, USA 
Incubator shaker – I 26 New Brunswick Scientific, Hamburg 
Incubators  Sartorius, Göttingen; Heraeus, Hanau 
LC columns – StrepTrap HP, HisTrap HP, HiTrap 
Desalting GE Healthcare, München 
LC system - ÄKTA Purifier System GE Healthcare, München 
Magnetic stirrer NeoLab, Heidelberg 
Micro scales, scale Kern & Sohn, Balingen 
Microscopes Leica, Wetzlar 
Microwave SHARP, Hamburg 
Petri dishes  Greiner Bio-One, Frickenhausen 
pH meter - inoLab pH7110 WTW, Weilheim 
Pipette tips Eppendorf, Hamburg 
Pipettes - Reference Eppendorf, Hamburg 
Pipetting aid - accu-jet pro Brand, Wertheim 
Power supplies - EV202, EV243 Consort, Turnhout, Belgium 
Precision scale – New Classic MS Mettler Toledo, Gießen 
Rotator – Intelli-Mixer NeoLab, Heidelberg 
SDS-PAGE gel chambers Roth, Karlsruhe 
Serological pipettes - Cellstar Greiner Bio-One, Frickenhausen 
Shaker - Polymax 1040 Heidolph Instruments, Schwabach 
Spectral photometer - Biophotometer Eppendorf, Hamburg 
Syringes   Braun, Melsungen 
Thermocycler – Mastercycler gradient Eppendorf, Hamburg 
Thermomixer comfort Eppendorf, Hamburg 
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Instrument / equipment Source 
Tissue culture hoods Safeflow 1.2 Nunc, Wiesbaden 
Ultracentrifuge – Optima MAX Beckman Coulter, Krefeld 
Ultra-pure water system - Milli-Q Plus Merck Millipore, Darmstadt 
Ultrasonic Device - UP200S Hielscher Ultrasonics GmbH, Teltow 
UV cuvettes micro Brand, Wertheim 
UV-Vis Spectrophotometer - NanoDrop 2000 Thermo Fisher Scientific, Waltham, USA 
Vortexer Heidolph Instruments, Schwabach 
Western blotting detection – Amersham 
Hyperfilm TM ECL GE Healthcare, München 
Western blotting transfer – PVDF-membrane, 
0.45 µm Merck Millipore, Darmstadt 
Western blotting transfer - Semi-dry blotter Peqlab, Erlangen 
Western blotting transfer – Whatman paper Roth, Karlsruhe 
6.2 Chemicals 
6.2.1 General chemicals 
Chemical Source 
Acrylamide/Bisacrylamide  Roth, Karlsruhe 
Agarose  Biozym, Hessisch Oldendorf 
Ammonium persulfate (APS)  Bio-Rad, München 
Ampicillin  Roth, Karlsruhe 
Anhydrotetracycline hydrochloride (AHT) IBA, Göttingen 
Boric acid  Roth, Karlsruhe 
Bovine serum albumin (BSA)  Sigma-Aldrich, Taufkirchen 
Calcium chloride (CaCl2)  Roth, Karlsruhe 
Chloramphenicol Roth, Karlsruhe 
Chloroquine-diphosphate Sigma-Aldrich, Taufkirchen 
Coomassie-based PageBlue Protein Staining 
Solution Thermo Fisher Scientific, Waltham, USA 
cOmplete – Protease Inhibitor Cocktail Roche, Mannheim 
cOmplete Tablets, Mini, EDTA-free Roche, Mannheim 
Dimethyl sulfoxide (DMSO)  Roth, Karlsruhe 
Dithiothreitol (DTT)  Sigma-Aldrich, Taufkirchen 
DNA 1kb plus ladder  Thermo Fisher Scientific, Waltham, USA 
dNTP-Mix  Thermo Fisher Scientific, Waltham, USA 
Donkey serum Jackson ImmunoResearch, Cambridgeshire, UK 
DPBS (w/o MgCl2 and CaCl2) Thermo Fisher Scientific, Waltham, USA 
Ethanol (EtOH, p. a.)  Merck, Darmstadt 
Ethidium bromide (EtBr) Roth, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA)  Roth, Karlsruhe 
Gel Loading Dye, Purple (6x) NEB, Frankfurt 
GFP-Trap Chromotek, Martinsried 
GLUT1.RBD.GFP Pelobiotech, Planegg 
Glycerol Roth, Karlsruhe 
Glycine Roth, Karlsruhe 
HEPES Roth, Karlsruhe 
Hoechst33342  Thermo Fisher Scientific, Waltham, USA 
Human recombinant TNF? Biomol, Hamburg 
Imidazole Roth, Karlsruhe 
Isopropyl alcohol (p.a.) Merck, Darmstadt 
Isopropyl ?-D-1-thiogalactopyranoside (IPTG) Thermo Fisher Scientific, Waltham, USA 
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Chemical Source 
Kanamycin Roth, Karlsruhe 
LB-Agar (Luria/Miller)  Roth, Karlsruhe 
LB-Medium (Luria/Miller) Roth, Karlsruhe 
Methanol (MeOH, p.a.) Merck, Darmstadt 
Milk powder Roth, Karlsruhe 
Monopotassium phosphate (KH2PO4) Roth, Karlsruhe 
Nonidet P40 substitute (NP-40)  Sigma-Aldrich, Taufkirchen 
PageRuler Prestained Protein Ladder  Thermo Fisher Scientific, Waltham, USA 
Pierce High Capacity Streptavidin Agarose Thermo Fisher Scientific, Waltham, USA 
Polybrene Sigma-Aldrich, Taufkirchen 
Poly-L-lysine solution (P4832) Sigma-Aldrich, Taufkirchen 
Potassium chloride (KCl) Roth, Karlsruhe 
PR-619 Merck, Darmstadt 
Protein-G-Sepharose (PGS) 4B Thermo Fisher Scientific, Waltham, USA 
Protino Ni-NTA Agarose Macherey-Nagel, Düren 
Roti-Histofix 4% Roth, Karlsruhe 
Roti-Load 1 -  4x SDS sample buffer Roth, Karlsruhe 
S.O.C. Medium Thermo Fisher Scientific, Waltham, USA 
Sodium chloride (NaCl) Roth, Karlsruhe 
Sodium dodecyl sulfate (SDS) Roth, Karlsruhe 
Sodium fluoride Sigma-Aldrich, Taufkirchen 
Sodium hydrogen phosphate (Na2HPO4) Roth, Karlsruhe 
Sodium vanadate Roth, Karlsruhe 
Strep Elution Buffer (10x) IBA, Göttingen 
Strep Regeneration Buffer (10x) IBA, Göttingen 
Strep-Tactin Sepharose  IBA, Göttingen 
TAE buffer (50x) Omnilab, Bremen 
Tetramethylethylenediamine (TEMED) Roth, Karlsruhe 
Tris(hydroxymethyl)-aminomethan (Tris) Roth, Karlsruhe 
TritonX-100 Roth, Karlsruhe 
Trypan blue Thermo Fisher Scientific, Waltham, USA 
Tween-20 Roth, Karlsruhe 
Western blotting detection (ECL substrate) 
20x LumiGlo and 20x Peroxide Cell Signaling Technology, Frankfurt 
X-tremeGENE HP Transfection Reagent  Roche, Mannheim 
?-Glycerophosphate Sigma-Aldrich, Taufkirchen 
6.2.2 Cell culture media and supplements 
Medium / supplement Source 
DMEM (Dulbecco’s modified eagle medium)  Thermo Fisher Scientific, Waltham, USA 
Fetal calf serum (FCS) Thermo Fisher Scientific, Waltham, USA 
Penicillin-Streptomycin (10,000 U/ml) Thermo Fisher Scientific, Waltham, USA 
RPMI (Roswell Park Memorial Institute) 1640 Thermo Fisher Scientific, Waltham, USA 
Trypsin (0.05%)/EDTA Thermo Fisher Scientific, Waltham, USA 
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6.3 Buffers and solutions 
Buffer / solution Composition 
2x HBS (HEPES buffered saline) 50 mM HEPES (pH 7), 280 mM NaCl, 1.5 mM Na2HPO4 
4x Stacking gel buffer 0.5 M Tris (pH 6.8) 
5x Separation gel buffer 1.88 M Tris (pH 8.8) 
Annealing buffer 10 mM Tris (pH 8), 50 mM NaCl, 1 mM EDTA 
Blocking solution  
(Confocal microscopy) 
0.1% Tween-20, 10% (v/v) FCS, 0.1% (w/v) BSA, 
3% (v/v) donkey serum in PBS 
Blocking solution (WB) 5% (w/v) milk powder in PBS-T 
Blotting buffer 25 mM Tris (pH 8.3), 192 mM Glycine, 20% (v/v) MeOH 
Cargo buffer 50 mM Tris (pH 7.4), 0.5% (v/v) NP-40, cOmplete – Protease Inhibitor Cocktail 
Co-IP buffer 
150 mM NaCl, 25 mM HEPES (pH 7.5), 0.2% (v/v) NP-40, 1 mM 
glycerol, 1 mM DTT, cOmplete protease inhibitors, 10 mM NaF, 
8 mM ?-glycerophosphate, 300 µM sodium vanadate 
Desalting buffer 20 mM Tris (pH 8), 100 mM NaCl 
DUB Reaction buffer 50 mM Tris (pH 7.5), 5 mM DTT, +/- 0.03% (w/v) BSA 
FACS buffer 3% (v/v) FCS in PBS 
High salt buffer 
20 mM HEPES (pH 7.9), 350 mM NaCl, 20% (v/v) glycerol, 
1 mM MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 1% (v/v) NP-40, 
1 mM DTT, cOmplete protease inhibitors, 10 mM NaF, 8 mM 
?-glycerophosphate, 300 µM sodium vanadate 
His Binding buffer 
100 mM Tris (pH 8), 150 mM NaCl, 30 mM imidazole 
Add just before use: EDTA-free cOmplete Mini protease 
inhibitors and 0.5 mg/ml lysozyme 
His Lysis buffer (PD) 
150 mM NaCl, 50 mM NaH2PO4 (pH 8), 0.2% NP-40, 
10% glycerol, 10 mM imidazole, 1 mM DTT, 10 mM sodium 
fluoride, 8 mM ?-glycerophosphate and 300 µM sodium 
vanadate 
His Elution buffer 100 mM Tris (pH 8), 150 mM NaCl, 300 mM imidazole 
His Washing buffer 100 mM Tris (pH 8), 150 mM NaCl, 30 mM imidazole 
LB agar 40 g/l 
LB medium 25 g/l 
PBS (phosphate buffered saline) 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.7 mM KH2PO4 
PBS-T 0.1% (v/v) Tween-20 in PBS 
Permeabilization buffer PBS, 0.1 M Glycine, 0.1% Triton X-100 
RIPA buffer 
250 mM NaCl, 1% (v/v) Triton-X, 0.5% (w/v) sodium 
deoxycholate, 0.1% (w/v) SDS, 10 mM Tris (pH 7.4), 1 mM DTT, 
cOmplete protease inhibitors, 10 mM NaF, 8 mM ?-
glycerophosphate, 300 µM sodium vanadate 
SDS Electrophoresis buffer 25 mM Tris (pH 8.8), 192 mM Glycine, 0.1% (w/v) SDS 
SEC buffer 20 mM Tris (pH 7.4), 150 mM NaCl, 2 mM DTT 
SEC lysis buffer 
25 mM HEPES (pH 7.5), 150 mM NaCl, 0.2% NP-40,  
1 mM DTT, cOmplete protease inhibitors, 10 mM NaF, 8 mM 
?-glycerophosphate, 300 µM sodium vanadate 
Separation gel 375 mM Tris (pH 8.8), 7.5-15% (v/v) Acrylamide,  0.1% (w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED 
Stacking gel 125 mM Tris (pH 6.8), 3% (v/v) Acrylamide, 0.1% (w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED  
Strep Lysis buffer 
100 mM Tris (pH 8), 150 mM NaCl, 1 mM EDTA. 
Add just before use: cOmplete Mini protease inhibitors and 
0.5 mg/ml lysozyme 
Strep Washing buffer 100 mM Tris (pH 8), 150 mM NaCl, 1 mM EDTA 
Strep-PD buffer A PBS, 0.1% (w/v) BSA, 5% (v/v) glycerol, 0.1% Triton-X, 
cOmplete protease inhibitors 
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Buffer / solution Composition 
Strep-PD buffer B PBS, 0.1% (w/v) BSA, 5% (v/v) glycerol, 0.5% Triton-X, 
cOmplete protease inhibitors 
Stripping buffer 0.2 M glycine, 0.1% (w/v) SDS, 1% (v/v) Tween-20, pH 2.2 
6.4 Kits 
Kit Source 
Deconjugating Enzyme Set R&D Systems, Minneapolis, USA 
GLUT1.RBD.GFP Pelobiotech, Planegg 
NucleoSpin Gel and PCR Clean-up Kit Macherey-Nagel, Düren 
NucleoSpin Plasmid Mini Kit Macherey-Nagel, Düren 
Pierce Silver Stain Kit Thermo Fisher Scientific, Waltham, USA 
Plasmid Maxi Kit Qiagen, Hilden 
QIAamp DNA Mini Kit Qiagen, Hilden 
Rapid DNA Ligation Kit  Roche, Mannheim 
Taq DNA Polymerase Kit Qiagen, Hilden 
UbiCREST Deubiquitinase Enzyme Set R&D Systems, Minneapolis, USA 
6.5 Enzymes 
Enzymes Source 
Deconjugating Enzyme Set R&D Systems, Minneapolis, USA 
E. coli recombinant Apyrase NEB, Frankfurt 
Herculase II Polymerase Agilent Technologies, Santa Clara, USA 
Lysozyme Roth, Karlsruhe 
Rapid DNA Ligation Kit  Roche, Mannheim 
Recombinant human GST-YOD1 Laboratory of D. Krappmann 
Recombinant human His6-CYLD Isoform 1 R&D Systems, Minneapolis, USA 
Recombinant human USP21cat Laboratory of T. Sixma 
Restriction enzymes and buffers NEB, Frankfurt 
T4 DNA Ligase NEB, Frankfurt 
Taq DNA Polymerase Kit Qiagen, Hilden 
UbiCREST Deubiquitinase Enzyme Set R&D Systems, Minneapolis, USA 
6.6 Oligonucleotides 
6.6.1 Oligonucleotides for the generation of KO cell lines 
Target  Sequence 
OTULIN – exon 2  5‘-CACCGATACATGAAAGAGGGGCATC-3‘ and 5‘-AAACGATGCCCCTCTTTCATGTATC-3 
SNX27 – exon 1 5´-CACCGGCTACGGCTTCAACGTGCG-3´ and 5´-AAACCGCACGTTGAAGCCGTAGCC-3´ 
HOIP – exon 1 5´-CACCGAGAGCTGGCTAGTAGCGGC-3´ and 5´-AAACGCCGCTACTAGCCAGCTCTC-3´ 
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6.6.2 Oligonucleotides for the verification of KO cell lines 
KO cell line Sequence 
OTULIN  
5´ primer: 
5´-GCCTTCAGAGCTACCTAGCAAATGAAG-3´ 
3´ primer: 
5´-GGAAATCAAGAACTGAGAGAGGACGG-3´ 
SNX27  
5´ primer: 
5´-ATTCATCCCTCAGCCCCTCA-3´ 
3´ primer: 
5´-GGCAGCCCACAAGGAGG-3´ 
HOIP 
5´ primer: 
5´-AGAGTGACCGTGGTCTGAGTGACCTGG-3´ 
3´ primer: 
5´-GTGGACAGGGTGTTGAGGTAGTTTCGG-3´ 
6.7 Plasmids 
Vector Information 
pASK-IBA3(+) IBA, Cat#2-1402-000;  For bacterial expression of recombinant proteins 
pASK-IBA3 OTULINcat-Strep WT C-terminal Strep-tag II, OTULINcat = aa 80-352, NheI/HindIII 
pASK-IBA3 OTULINcat-Strep C129A C-terminal Strep-tag II, aa 80-352, NheI/HindIII 
pASK-IBA3 OTULINcat-Strep W96A C-terminal Strep-tag II, aa 80-352, NheI/HindIII 
pASK-IBA3 His-Ub-Ub N-terminal His10-tag, XbaI/HindIII 
pASK-IBA3 His-UbG76A-Ub N-terminal His10-tag, XbaI/HindIII 
pASK-IBA3 His-UbG76C-Ub?G76 N-terminal His10-tag, XbaI/HindIII 
pEF Flag Modified pEF4 backbone (Scharschmidt et al., 2004); 3xFlag-tag 
pEF Flag-OTULIN WT N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-OTULIN C129A N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-OTULIN Y56F N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-OTULIN ?ETSL N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-OTULIN W96A N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-OTULINcat N-terminal 3xFlag-tag, aa 80-352, BamHI/NotI 
pEF Flag-VPS26A N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-OTUB1 Gift from K. Hadian; N-terminal 3xFlag-tag 
pEF Flag-CYLD Krappmann laboratory, K.Demski;  N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-A20 Krappmann laboratory (Duwel et al., 2009); N-terminal 3xFlag-tag, EcoRI/NotI 
pEF Flag-YOD1 Krappmann laboratory (Schimmack et al., 2017); N-terminal 3xFlag-tag, BamHI/NotI 
pEF Flag-UCHL3 Krappmann laboratory, L. Glockner;  N-terminal 3xFlag-tag, EcoRI/NotI 
pEF HA Modified pEF4 backbone; HA-tag 
pEF HA-OTULIN WT N-terminal HA-tag, BamHI/NotI 
pEF HA-OTULIN ?ETSL N-terminal HA-tag, BamHI/NotI 
pEF HA-OTULIN C129A N-terminal HA-tag, BamHI/NotI 
pEF HA-OTULIN E85R/D87R N-terminal HA-tag, BamHI/NotI 
pEF HA-OTULIN C129A/L259E N-terminal HA-tag, BamHI/NotI 
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Vector Information 
pSpCas9(BB)-2A-GFP (PX458) 
Gift from Feng Zhang (Addgene#48138);  
For the generation of KO cell lines. Cas9 from 
S. pyogenes with 2A-EGFP, and cloning 
backbone for sgRNA 
PX458 OTULIN KO For the generation of OTULIN KO cells. Cas9 from S. pyogenes with 2A-EGFP and sgRNA 
PX458 HOIP KO For the generation of HOIP KO cells. Cas9 from S. pyogenes with 2A-EGFP and sgRNA 
PX458 SNX27 KO For the generation of SNX27 KO cells. Cas9 from S. pyogenes with 2A-EGFP and sgRNA 
pHAGE-h?CD2-T2A-SSF Lentiviral vector; truncated human CD2-T2A-2xStrep-tag II-Flag (N-terminal) 
pHAGE-h?CD2-T2A-SSF-OTULIN WT N-terminal 2xStrep II-Flag-tag, XbaI/SalI 
pHAGE-h?CD2-T2A-SSF-OTULIN ?ETSL N-terminal 2xStrep II-Flag-tag, XbaI/SalI 
pHAGE-h?CD2-T2A-SSF-OTULIN C129A N-terminal 2xStrep II-Flag-tag, XbaI/SalI 
pMD2.G Gift from D. Trono, Addgene#12259;  VSV-G envelope expressing plasmid 
psPAX2 Gift from D. Trono, Addgene#12260;  Lentiviral packaging plasmid 
pEGFP-C1 Clontech, N/A; GFP-tag 
pEGFP-C1 GFP-SNX27 WT (Isoform 2) Gift from P. Cullen (Gallon et al., 2014);  N-terminal GFP-tag, HindIII/BamHI 
pEGFP-C1 GFP-SNX27 H114A (Isoform 2) Gift from P. Cullen;  N-terminal GFP-tag, HindIII/BamHI 
pEGFP-C1 GFP-SNX27 ?67-77 (Isoform 2) Gift from P. Cullen (Gallon et al., 2014);  N-terminal GFP-tag, HindIII/BamHI 
pEGFP-C1 GFP-SNX27 G64E/R100E N-terminal GFP-tag, HindIII/BamHI 
pcDNA3.1 (+) Thermo Fisher Scientific, Cat# V79020 
pcDNA3.1 RFP-OTULIN WT N-terminal RFP-tag, NotI/XbaI 
pcDNA3.1 RFP-OTULIN C129A N-terminal RFP-tag, NotI/XbaI 
pcDNA3.1 RFP-OTULIN ?ETSL N-terminal RFP-tag, NotI/XbaI 
pcDNA3.1 HA-HOIP Gift from K. Winklhofer (Muller-Rischart et al., 2013); N-terminal HA-tag 
6.8 Escherichia coli (E. coli) strains 
Strain [Source] Genotype Advantage 
One Shot TOP10 
Chemically Competent E. coli 
F- mcrA ?(mrr-hsdRMS-mcrBC) 
?80lacZ?M15 ?lacX74 recA1 
araD139 ?(ara-leu)7697 galU 
galK rpsL(StrR) endA1 nupG  
Stable replication of high-copy 
plasmids 
One Shot Stbl3  
Chemically Competent E. coli 
F– mcrB mrr hsdS20 (rB–, mB–) 
recA13 supE44 ara-14 galK2 
lacY1 proA2 rpsL20 (StrR ) xyl-5 
?– leu mtl-1 
Reduced frequency of 
homologous recombination ? 
cloning of the lentiviral vector 
BL21-CodonPlus(DE3)-RIPL 
Competent E. coli 
E. coli B F- opmT hsdS (rB- mB-) 
dcm+ Tetr gal ? (DE3) endA Hte 
[argU proL Camr] [argU ileY 
leuW Strep/Specr]  
Additional copies of tRNA genes 
? specialized in production of 
recombinant proteins 
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6.9 Eukaryotic cell lines 
Cell line Information 
Jurkat T cells human T cell line, derived from acute T cell leukemia patient 
HEK293 cells human embryonic kidney cell line containing Adenovirus 5 DNA 
HEK293T cells HEK293 cells containing SV40 large T-antigen 
U2OS  human osteosarcoma cell line 
OTULIN-/- Jurkat T cells human T cell line, generated by CRISPR/Cas9 
SNX27-/- Jurkat T cells human T cell line, generated by CRISPR/Cas9 
HOIP-/- Jurkat T cells human T cell line, generated by CRISPR/Cas9 
MEF Otulin-/- 
Mouse embryonic fibroblasts, OTULIN KO, 
polyclonal, immortalized, gift from D. Komander 
(MRC, Cambridge) 
MEF Otulin+/+ 
Mouse embryonic fibroblasts, control cell line, 
polyclonal, immortalized, gift from D. Komander 
(MRC, Cambridge) 
6.10 Recombinant proteins 
Recombinant protein Source Identifier 
Biotin-Ahx-UbG76Dha-Ub UbiQ, Amsterdam, NL Cat#UbiQ-121, (Weber et al., 2017) 
Biotin-Ahx-Ub-PA UbiQ, Amsterdam, NL Cat#UbiQ-076 
Deconjugating Enzyme Set R&D Systems, Minneapolis, USA Cat#K-E10B 
His10-UbG76Dha-Ub ?G76 A. Weber; UbiQ, Amsterdam, NL (Weber et al., 2017) 
Recombinant human diUb chains 
(K48-linked) R&D Systems, Minneapolis, USA Cat#UC-200-100 
Recombinant human GST-YOD1 Laboratory of D. Krappmann (Schimmack et al., 2017) 
Recombinant human His6-CYLD 
Isoform 1 R&D Systems, Minneapolis, USA Cat#E-556-050 
Recombinant human TNF alpha biomol, Hamburg Cat#50435.50 
Recombinant human USP21cat Gift from T. Sixma (Faesen et al., 2011) 
Recombinant human Wnt3a R&D Systems, Minneapolis, USA Cat#5036-WN-010 
Recombinant M1-linked tetraUb 
chains Enzo Life Sciences, Lörrach Cat#BML-UW0785-0100 
UbiCREST Deubiquitinase 
Enzyme Set R&D Systems, Minneapolis, USA Cat#K-400 
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6.11 Antibodies 
6.11.1 Primary antibodies 
Antibody Dilution Source Identifier 
Anti-normal mouse IgG Isotype control in IPs 
Santa Cruz 
Biotechnology, 
Heidelberg 
Cat#sc-2025; 
RRID: AB_737182 
Anti-normal rabbit IgG Isotype control in IPs Cell Signaling Technology, Frankfurt 
Cat#2729; 
RRID: AB_2617119 
Goat anti-biotin 1:3,000 Cell Signaling Technology, Frankfurt 
Cat#7075; 
RRID: AB_330923 
Goat polyclonal 
anti-Actin [I-19] HRP 1:2,000 
Santa Cruz 
Biotechnology, 
Heidelberg 
Cat#sc1616 HRP; 
RRID: N/A 
Human monoclonal 
anti-M1-polyUb 1:2,500 Gift from V. Dixit 
(Matsumoto et al., 
2012); RRID: N/A 
Mouse monoclonal 
anti-CYLD [E10] 1:1,000 
Santa Cruz 
Biotechnology, 
Heidelberg 
Cat#sc-74435; 
RRID: AB_1122022 
Mouse monoclonal 
anti-ubiquitin [P4D1] 1:1,000 
Santa Cruz 
Biotechnology, 
Heidelberg 
Cat#sc-8017; 
RRID: AB_2315523 
Mouse monoclonal 
anti-I?B? 1:1,000 
Cell Signaling 
Technology, Frankfurt 
Cat#4814; 
RRID: AB_390781 
Mouse monoclonal 
anti-phospho-I?B? 
(Ser32/36) [5A5] 
1:1,000 Cell Signaling Technology, Frankfurt 
Cat#9246; 
RRID: AB_2151442 
Mouse monoclonal 
anti-FLAG M2 1:10,000 
Sigma-Aldrich, 
Taufkirchen 
Cat#F3165; 
RRID: AB_259529 
Mouse monoclonal 
anti-HOIP 1:5,000 
R&D Systems, 
Minneapolis, USA 
Cat#MAB8039: 
RRID: AB_10676585 
Mouse monoclonal 
anti-SNX27 [1C6] 1:1,000 
Abcam, 
Cambridge, UK 
Cat#ab77799; 
RRID: AB_10673818 
Mouse monoclonal 
anti-ATP7A [D9] 1:1,000 
Santa Cruz 
Biotechnology, 
Heidelberg 
Cat#sc-376467; 
RRID: AB_11150485 
Mouse polyclonal 
anti-?-catenin 1:2,000 
BD Biosciences, 
Franklin Lakes, USA 
Cat#610153; 
RRID: AB_397554 
Rabbit monoclonal 
anti-M1-polyUb 1:1,000 
Merck Millipore, 
Darmstadt 
Cat#MABS19; 
RRID:AB_2576212 
Rabbit monoclonal anti-
EEA1 [C45B10] 1:500 
Cell Signaling 
Technology, Frankfurt 
Cat#3288; RRID: 
AB_2096811 
Rabbit monoclonal anti-
VPS35 [EPR11501(B)] 1:10,000 
Abcam, 
Cambridge, UK 
Cat#ab157220; 
RRID: AB_2636885 
Rabbit polyclonal 
anti-OTULIN 1:1,000 
Cell Signaling 
Technology, Frankfurt 
Cat#14127; 
RRID: AB_2576213 
Rabbit polyclonal 
anti-OTUB1 1:1,000 
Bethyl Laboratories, 
Montgomery, USA 
Cat#A302-917A; 
RRID: AB_10663033 
Rabbit polyclonal 
anti-USP5/IsoT 1:1,000 
Bethyl Laboratories, 
Montgomery, USA 
Cat#A301-542A; 
RRID: AB_1040028 
Rabbit polyclonal 
anti-SHARPIN 1:1,000 
Proteintech, 
Manchester, UK 
Cat#14626-1-AP; 
RRID: AB_2187734 
Rabbit polyclonal 
anti-GFP 1:1,000 
Cell Signaling 
Technology, Frankfurt 
Cat#2555; RRID: 
AB_390710 
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Antibody Dilution Source Identifier 
Rabbit polyclonal 
anti-SNX27 1:1,000 Gift from W. Hong (Cai et al., 2011) 
Rabbit polyclonal 
anti-VPS26 1:1,000 
Abcam, 
Cambridge, UK 
Cat#ab23892; 
RRID: AB_2215043 
Rabbit polyclonal 
anti-DGK? 1:1,000 
Abcam, 
Cambridge, UK 
Cat#ab105195; 
RRID: AB_10714139 
Rabbit polyclonal 
anti-GLUT1 1:100 
Abcam, 
Cambridge, UK 
Cat#ab15309; 
RRID: AB_301844 
Rabbit polyclonal 
anti-STEAP3 1:1,000 
Proteintech, 
Manchester, UK 
Cat#17186-1-AP; 
RRID: AB_2197841 
Rabbit polyclonal 
anti-KIDINS220 1:1,000 
Proteintech, 
Manchester, UK 
Cat#21856-1-AP; 
RRID: AB_10836934 
Rabbit polyclonal 
anti-Beta PIX 1:1,000 
Merck Millipore, 
Darmstadt 
Cat#07-1450-I; 
RRID: AB_1586904 
Rat monoclonal 
anti-HA [3F1] 1:10,000 
Core facility monoclonal 
antibodies HMGU RRID: N/A 
Rat monoclonal 
anti-HA [12CA5] 1:1,000 
Core facility monoclonal 
antibodies HMGU RRID: N/A 
Rat monoclonal 
anti-MRP4 [M4I-10] 1:2,500 Abcam, Cambridge, UK 
Cat#ab15602; 
RRID: AB_301991 
Sheep polyclonal 
anti-HOIL-1/RBCK1 1:1,000 
MRC PPU Reagents 
and Services, Dundee, 
UK 
Cat#S105D; 
RRID: N/A 
6.11.2 Secondary antibodies 
Antibody Dilution Source Identifier 
Donkey polyclonal anti-
human IgG 1:10,000 
Jackson 
ImmunoResearch, 
Cambridgeshire, UK 
Cat# 709-035-149; 
RRID: AB_2340495 
Donkey polyclonal anti-
mouse IgG 1:10,000 
Jackson 
ImmunoResearch, 
Cambridgeshire, UK 
Cat#715-035-150; 
RRID: AB_2340770 
Donkey polyclonal anti-
rabbit IgG 1:10,000 
Jackson 
ImmunoResearch, 
Cambridgeshire, UK 
Cat#711-035-152; 
RRID: AB_10015282 
Donkey polyclonal anti-
rabbit IgG-Cy5 1:500 
Jackson 
ImmunoResearch, 
Cambridgeshire, UK 
Cat#711-175-152; 
RRID: AB_2340607 
Donkey polyclonal anti-
rat IgG 1:10,000 
Jackson 
ImmunoResearch, 
Cambridgeshire, UK 
Cat#112-035-003; 
RRID: AB_2338128 
Donkey polyclonal anti-
sheep IgG 1:10,000 
Jackson 
ImmunoResearch, 
Cambridgeshire, UK 
Cat#713-035-003; 
RRID: AB_2340709 
6.11.3 Stimulatory antibodies 
Antibody Dilution Source Identifier 
Mouse monoclonal anti-
human CD28 [CD28.2] 1 µg in 300 µl 
BD Biosciences, 
Franklin Lakes, USA 
Cat#555725; 
RRID: AB_396068 
Mouse monoclonal anti-
human CD3 [HIT3a] 0.3 µg in 300 µl 
BD Biosciences, 
Franklin Lakes, USA 
Cat# 555336; 
RRID: AB_395742 
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Antibody Dilution Source Identifier 
Rat monoclonal anti-
mouse IgG1 [A85-1] 0.5 µg in 300 µl 
BD Biosciences, 
Franklin Lakes, USA 
Cat#553440; 
RRID: AB_394860 
Rat monoclonal anti-
mouse IgG2a [R19-15]] 0.5 µg in 300 µl 
BD Biosciences, 
Franklin Lakes, USA 
Cat#553387; 
RRID: AB_394825 
 
6.11.4 FACS antibodies 
Antibody Dilution Source Identifier 
Mouse monoclonal anti-
CD2-APC [RPA-2.10] 1:400 
Thermo Fisher 
Scientific, Waltham, 
USA 
Cat# 17-0029-41;  
RRID: AB_10806970 
Mouse monoclonal anti-
human CD28-APC 
[CD28.2] 
1:50 BD Biosciences, Franklin Lakes, USA 
Cat#559770; 
RRID: AB_398666 
Mouse monoclonal anti-
human CD3-FITC 
[OKT3] 
1:100 
Thermo Fisher 
Scientific, Waltham, 
USA 
Cat#11-0037-41; 
RRID: AB_2016601 
6.12 Software 
Software Source 
Adobe Illustrator CS6 (version 16) Adobe Systems, San José, USA 
Adobe Photoshop CS6 (version 16) Adobe Systems, San José, USA 
CLC Main Workbench (version 7.0.3) Qiagen, Hilden 
Endnote X9 Clarivate Analytics, Philadelphia, USA 
FlowJo (version 10) FlowJo LLC, Ashland, USA 
GraphPad Prism (version 5.01) GraphPad, San Diego, USA 
Image J (1.50i) Wayne Rasband, NIH, USA 
Microsoft Office 2010 Microsoft Corp., Redmond, USA 
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7. Methods 
7.1 Molecular biology methods 
7.1.1 Polymerase chain reaction (PCR) 
For the amplification of DNA sequences, samples were prepared as specified in the following 
scheme: 
The following standard PCR program was used for the amplification: 
PCR products were assessed for correct size on agarose gels and purified (section 7.1.4). 
7.1.2 Site-directed mutagenesis 
Mutants were generated by site-directed mutagenesis. In this PCR-based method, the 
desired mutation is introduced by a specifically designed primer, which contains the 
mutation. In a first PCR (megaprimer PCR), a fragment was generated that bears the 
mutation at one end and the flanking restriction site at the other end. This PCR product was 
then purified and used as megaprimer (5 - 15 µl) in a second PCR, together with a primer 
that contains the second restriction site. In the second PCR, the annealing temperature was 
reduced to 50°C. The final PCR product was examined by agarose gel electrophoresis and 
purified (section 7.1.4). 
Component Amount or volume 
Template DNA 50 ng 
5´ primer (25 µM) 0.5 µl 
3´ primer (25 µM) 0.5 µl 
dNTPs (10 mM each) 1.25 µl 
5x Herculase buffer 10 µl 
DNA polymerase (Herculase II) 0.75 µl 
H2O Ad 50 µl 
Step Temperature Time Cycles 
Initialization 95°C 4 min 1 
Denaturation 95°C 1 min 
33 Annealing lowest primer melting temperature – 5°C 40 s 
Elongation 72°C 30 s/kb 
Final elongation 72°C 7 min 1 
Cooling 4°C ? 1 
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7.1.3 DNA restriction digestion 
Amplified inserts and target vectors were digested using restriction enzymes and the 
appropriate buffers. The prepared reaction mixtures were incubated for at least 90 min at 
37°C. Subsequently, samples were separated by agarose gel electrophoresis and DNA 
fragments of correct size were purified (section 7.1.4). 
7.1.4 Agarose gel electrophoresis 
PCR products and digested DNA samples were separated on the basis of size by agarose 
gel electrophoresis. Agarose gels were prepared by dissolving 1 - 2% (w/v) agarose in warm 
TAE buffer. For visualization of DNA molecules ethidium bromide was added to the solution. 
DNA samples were mixed with 6x DNA loading dye and loaded on the hardened gels. For 
sizing of DNA fragments, 5 µl 1 kb plus DNA ladder was loaded. Gels were run in TAE buffer 
at 80-120 V for approximately 1 h. Afterwards, DNA molecules were visualized by UV light 
and extracted from the gel using the “Nucleo-Spin Gel and PCR Clean-up” kit according to 
the manufacturer´s instructions. 
7.1.5 Ligation 
For ligation of digested inserts and corresponding vectors either the T4 DNA ligase or the 
“Rapid DNA Ligation Kit” were used according to the manufacturer´s instructions. The 
prepared reaction batches at a threefold molar ratio of insert to vector were incubated for at 
least 30 min at room temperature (RT). After ligation, a proportion of each of the ligation 
reaction mixtures was transformed into chemically competent E. coli cells. 
7.1.6 Transformation of E. coli 
For the amplification of recombinant plasmids, E. coli Top10 or E. coli Stbl3 cells were 
transformed, whereas the transformation of plasmids into BL21-RIPL chemically competent 
E. coli cells was required for protein production. E. coli cells were mixed with the ligation 
samples (transformation) or with 50-100 ng plasmid DNA (retransformation) and incubated 
on ice for 30 min. Cells were then heated for 45 s at 42°C (heat shock) and immediately 
chilled on ice. 250 µl LB medium was added and the samples were incubated shaking for 1 h 
at 37°C. Afterwards, the cells were plated on LB agar plates containing antibiotic. These 
plates were incubated at 37°C overnight and finally stored in the refrigerator. 
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7.1.7 Minipreparation of plasmid DNA 
Pre-cultures were prepared by inoculating 5 ml LB medium containing antibiotic with a single 
E. coli colony containing the required plasmid from the selection plate. The cultures were 
incubated overnight, shaking at 37°C. The next day, plasmid DNA was isolated from 4 ml of 
the overnight cultures by using the “NucleoSpin Plasmid Kit”, following the manufacturer´s 
protocol.  
7.1.8 Maxipreparation of plasmid DNA 
150 ml LB medium containing antibiotic was inoculated with 350 µl of a fresh pre-culture. The 
culture was incubated overnight, shaking at 37°C. The following large-scale plasmid isolation 
was performed using the “QIAGEN Plasmid Maxi Kit” according to the manufacturer´s 
instructions. 
7.1.9 DNA sequencing 
All newly generated plasmids were sequenced by Eurofins Genomics (Ebersberg) and 
assessed for the right order of nucleotides before they were further processed.  
7.2 Cell culture methods 
7.2.1 Storage of cell lines 
For storage of cells, 1x107 cells were pelleted by centrifugation (350 x g, 4 min), 
resuspended in 1 ml freezing medium (DMEM/RPMI, 20% (v/v) FCS (fetal calf serum), 
10% (v/v) DMSO (dimethyl sulfoxide)) and transferred into cryo vials. Vials were frozen 
at -80°C in isopropanol-containing cryo-freezing containers which reduce the temperature by 
1°C per min. For long-term storage, cell vials were transferred into liquid nitrogen. 
7.2.2 Cultivation of cell lines 
All mammalian cell lines were maintained at 37°C in a humidified atmosphere at 5% CO2. 
Jurkat T cells were cultured in RPMI 1640 Medium supplemented with 10% FCS, 
100 U/ml penicillin and 100 µg/ml streptomycin and kept at a density of 0.5 to 1.5x106 cells 
per ml.  
All adherent cell lines were cultured in DMEM supplemented with 10% FCS, 
100 U/ml penicillin and 100 µg/ml streptomycin and maintained at 30-80% confluency. To 
split or seed cells, the cell layer was washed carefully with PBS and incubated with 0.5-2 ml 
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0.05% trypsin/EDTA solution until cells detached. Trypsinization was stopped by adding 
fresh medium and cells were diluted or seeded as required. 
7.2.3 Transfection of Jurkat T cells by electroporation 
Upon electroporation of cells, electric pulses lead to the temporary formation of pores in the 
cell membrane, which facilitate the uptake of DNA. For the transfection of Jurkat T cells, 
8x106 cells were resuspended in 400 µl medium and mixed with 5 µg DNA in a 4 mm 
electroporation cuvette. Cells were electroporated with a Gene Pulser X System at 220 V 
and 1000 µF (exponential program) and subsequently transferred into pre-warmed RPMI to 
allow them to recover. Cells were analyzed 24 - 72 hrs after electroporation. 
7.2.4 Calcium phosphate transfection of HEK293 cells 
Using this method, calcium cations and phosphate anions are brought together forming 
calcium phosphate [Ca3(PO4)2] crystals. DNA to be transfected is bound by these crystals 
and can that way be absorbed by cells via endocytosis. The day before transfection, HEK293 
cells were washed, trypsinized and counted. 2.5x106 cells were seeded per 10 cm dish in 
9 ml of supplemented DMEM. Prior to transfection, cells were 10 - 30% confluent. 
Transfection samples were prepared by mixing up to 10 µg DNA with 50 µl CaCl2 (2.5 M) and 
450 µl sterile H2O. This mixture was then added dropwise into a 2 ml reaction tube 
containing 500 µl sterile 2x HBS, while constantly vortexing. For precipitate formation 
samples were incubated for 15 min at RT. Subsequently, solutions were distributed dropwise 
on cells. For DNA absorption and transient overexpression of the desired proteins, cells were 
incubated over night at 37°C. 
7.2.5 Generation of OTULIN-, HOIP- and SNX27-deficient cells 
KO cell lines were generated using the CRISPR/Cas9 system (Ran et al., 2013). Single 
guide RNAs (sgRNAs) targeting exon 2 of the OTULIN gene 
(5´-ATACATGAAAGAGGGGCATC-3´) or exon 1 of the SNX27 gene 
(5´-GGCTACGGCTTCAACGTGCG-3´) were designed by means of two online tools 
(http://crispr.mit.edu/ and https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-
design). The sgRNA targeting exon 1 of the RNF31/HOIP gene 
(5´-GAGAGCTGGCTAGTAGCGGC-3´) was adopted from the literature (Yang et al., 2016). 
Two partially complementary oligos carrying overhangs of four nucleotides compatible for 
cloning into the PX458 backbone were synthesized for each KO (sequences listed in section 
6.6.1). Oligo pairs were annealed (5 min at 95°C) and ligated into BbsI-digested 
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pSpCas9(BB)-2A-GFP (PX458) vector. This vector enables simultaneous expression of S. 
pyogenes Cas9, eGFP and sgRNAs targeting the respective gene. 
Jurkat T cells were transfected with the manipulated PX458 vector as described in section 
7.2.3. HEK293 cells were transfected using X-tremeGENE HP DNA Transfection Reagent 
according to the manufacturer’s instructions. After 1-3 days, GFP-positive cells were sorted 
by A. Gewies using a MoFlow Cytometer (Cytomation). Sorted cells were seeded in 96-well 
plates at very low density (0.5 - 5 cells / well) to obtain clonal cell populations. After 
expansion, cell clones were lysed in RIPA buffer and screened for loss of the respective 
protein by WB. In addition, genomic DNA was isolated from cells using the “QIAamp DNA 
Mini Kit”, following the manufacturer´s protocol. The DNA was amplified by PCR around the 
targeted site using the “Taq DNA Polymerase Kit” (primers listed in section 6.6.2) and 
sequenced by Eurofins Genomics in order to verify the KOs on genomic level. Jurkat KO 
clones were additionally checked for the expression of CD3 and CD28 by FACS.  
7.2.6 Lentiviral transduction of KO cells 
To generate cell lines stably expressing OTULIN WT and mutants, OTULIN-deficient cells 
were lentivirally transduced with different pHAGE-h?CD2-T2A-OTULIN constructs. Using this 
construct, both the truncated human surface marker protein CD2 (?CD2) and OTULIN are 
translated from the same mRNA at equimolar levels. The ribosome skips the peptide bond 
formation at the C-terminus of the T2A peptide resulting in the generation of two distinct 
proteins instead of a long fusion protein (Szymczak et al., 2004).  
For virus production, 1.5x106 HEK293T cells were seeded in a 10 cm dish in 8 ml DMEM. 
The day after, cells were transfected with 1.5 ?g of the packaging vector psPAX2, 1 ?g of the 
lentiviral envelope plasmid pMD2.G and 2 µg of the respective pHAGE-h?CD2-T2A 
construct using X-tremeGENE HP DNA Transfection Reagent according to the 
manufacturer’s instructions. 72 hrs after transfection, the virus-containing supernatants were 
collected, sterile filtered (0.45 µm) and added to KO cells in the presence of 8 µg/ml 
polybrene. For lentiviral transduction of OTULIN-deficient Jurkat T cells, 5x105 cells were 
incubated with 500 - 1500 µl supernatant. 24 hrs later, infected cells were washed three 
times with PBS and transferred into fresh RPMI medium. After a recovery phase of about 
one week, transduction efficiency was validated by flow cytometry after anti-CD2 staining of 
the cells. Moreover, cells were lysed in RIPA buffer and OTULIN expression was analyzed 
by WB after SDS-PAGE. 
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7.2.7 Stimulation of cells 
Stimulation of Jurkat T cells was performed in 2 ml reaction tubes on a rotator at 37°C. For 
activation of the Wnt signaling pathway, 3x106 Jurkat T cells were stimulated with 20 ng/ml 
recombinant human Wnt3a protein. Cells were treated with 20 ng/ml recombinant human 
TNF? to induce TNFR signaling. TCR stimulation was mimicked by CD3/CD28 co-ligation. 
3x106 Jurkat T cells were resuspended in 300 µl ‘old’ medium and incubated with 0.3 µg anti-
CD3 and 1 µg anti-CD28 antibodies in the presence of cross-linking secondary antibodies 
(0.5 µg rat anti-mouse IgG1 and IgG2a). After stimulation, cells were lysed in 100 µl High 
Salt buffer and analyzed by WB following SDS-PAGE. 
7.3 Flow cytometry 
Cells were tested for surface protein expression using an Attune Acoustic Focusing 
Cytometer. This cytometer is equipped with a blue laser (488 nm), a red laser (638 nm) and 
different emission filters enabling the detection of different fluorophores.  
7.3.1 Staining of surface molecules 
To analyze surface expression of h?CD2, hCD3 or hCD28, approximately 0.2x106 cells were 
resuspended in 100 µl FACS buffer and incubated with the respective fluorophore-coupled 
antibody (listed in section 6.11.4) for 20 min at 4°C in the dark. Subsequently, cells were 
washed three times with PBS and resuspended in PBS or FACS buffer for the analysis by 
flow cytometry. 
7.3.2 Determination of cell surface GLUT1 levels 
U2OS cells were transfected with the respective pHAGE-h?CD2-T2A construct (mock, 
OTULIN WT, OTULIN ?ETSL) using X-tremeGENE HP DNA Transfection Reagent 
according to the manufacturer’s instructions. 48 hrs after transfection, cells were trypsinized 
and counted. 100,000 cells were resuspended in 95 µl Buffer A (Complete culture medium, 
0.1% NaN3 and 1 mM EDTA) and incubated with 10 µl GLUT1.RBD.GFP and 0.25 µl 
anti-CD2 antibody for 20 min at 37°C. After staining, cells were washed three times with 
Buffer B (PBS, 0.1% NaN3, 1 mM EDTA and 2% FCS) and analyzed for OTULIN 
overexpression (?CD2 positive cells) and GLUT1 surface expression by flow cytometry. In 
order to quantify GLUT1 surface expression, median fluorescence intensities of the 
GLUT1.RBD.GFP signal were determined with the FlowJo software and normalized to mock. 
Data from three independent experiments (n=3) were analyzed and depicted as mean ± 
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standard deviation (SD). Statistical analysis was performed using the unpaired Student´s 
t-test (GraphPad Prism). 
7.4 Synthesis of activity-based probes 
7.4.1 Synthesis of bio-UbG76Dha-Ub (OTULIN ABP) 
Biotin-Ahx-UbG76Dha-Ub (OTULIN ABP) was chemically synthesized by our collaboration 
partner Farid El Oualid (UbiQ). The detailed protocol is published in (Weber et al., 2017). 
7.4.2 Synthesis of His10-UbG76Dha-Ub ?G76 (OTULIN ABP ?G76) 
In contrast to the OTULIN ABP synthesis (section 7.4.1), the synthesis of the 
His10-UbG76Dha-Ub ?G76 (OTULIN ABP ?G76) was not based on solid-phase peptide 
synthesis, but on a recombinant precursor protein. The precursor protein 
His10-UbG76C-Ub ?G76, which carries a G76C substitution in the distal Ub and lacks the 
C-terminal glycine of the proximal Ub, was produced in E. coli BL21-CodonPlus (DE3)-RIPL 
cells and purified via affinity chromatography (see section 7.5.1). Subsequently, the Cys76 in 
the distal Ub moiety was coverted into Dha through oxidative elimination by our collaboration 
partner Farid El Oualid (UbiQ) (Weber et al., 2017). 
7.5 Biochemical and immunological methods 
7.5.1 Production and purification of recombinant proteins 
C-terminally Strep-tag II (Strep)-tagged OTULIN constructs and N-terminally His10 (His)-
tagged diUb variants were expressed in E. coli BL21-CodonPlus (DE3)-RIPL cells and 
purified via affinity chromatography using the ÄKTA Purifier system. Bacteria carrying the 
respective plasmid were grown at 37°C in autoclaved LB medium containing 100 µg/ml 
ampicillin and 25 µg/ml chloramphenicol. At an OD600 of 0.6 - 0.8, protein expression was 
induced by adding 0.5 mM IPTG and 200 ng/ml AHT. Proteins were produced overnight at 
21°C. Cultures (1 l) were harvested by centrifugation (2,100 x g / 20 min / 4°C) and lysed by 
sonification in Strep Lysis buffer or His Binding buffer (10 ml). Lysates were cleared by 
centrifugation (51,000 x g / 20 min / 4°C). Extracts containing Strep-tagged proteins were 
applied on StrepTrap columns and unspecifically bound proteins were removed by rinsing 
the columns with Strep Washing buffer. Proteins were eluted using 1x Strep Elution buffer 
and desalted via HiTrap Desalting columns in Desalting buffer. 
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Cleared lysates containing His-tagged diUb variants were applied on HisTrap columns and 
unspecific proteins were washed away with His Washing buffer. DiUb constructs were eluted 
by a gradient of His Elution buffer and desalted via HiTrap Desalting columns in 50 mM 
sodium phosphate buffer (pH 8). 
The expression and purification of recombinant proteins for crystallography and ITC studies 
was performed by Paul Elliott (MRC, Cambridge; University of Oxford). 
7.5.2 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
The analytical SDS-PAGE technique is used to separate proteins depending on their size by 
an electrical field. Depending on the size of the considered proteins, the acrylamide content 
of the separating gels and therefore their cross-linking level was adjusted (7.5 – 15%). 
Polymerization of the gels was induced by adding APS (ammonium persulfate) and TEMED. 
During polymerization, the separating gel was covered with isopropanol to obtain an even 
surface. 3% stacking gels containing pockets were added on top of fully polymerized 
separating gels.  
All protein samples were treated with SDS-containing sample buffer (Roti-Load 1) and boiled 
at 95°C for 8 min. Thereby the proteins are denatured and covered by negatively charged 
SDS molecules. To estimate the molecular weight of the separated proteins, a prestained 
protein ladder was loaded in a well next to the samples. After loading, electrophoresis was 
performed in SDS Electrophoresis buffer at 90 – 120 V for approximately 2.5 hrs. 
Subsequently, the proteins in the gels were either visualized using Coomassie staining 
solution or the “Pierce Silver Stain Kit” or transferred onto PVDF membranes by Western 
Blotting (see section 7.5.3). 
7.5.3 Western Blot (WB) 
To enable immunodetection of proteins following separation by SDS-PAGE, proteins were 
electrophoretically transferred onto PVDF membranes using a semi-dry Western Blot transfer 
system. Before transfer, PVDF membranes were activated in methanol and subsequently 
equilibrated in Blotting buffer together with Whatman filter papers. The membrane and the 
SDS gel were placed between soaked filter papers in the blotting device, and the transfer 
was carried out for 110 min with a current of 90 mA per gel.  
After WB transfer, membranes were agitated for 1 h in blocking solution to avoid unspecific 
binding of antibodies. Blocked membranes were incubated overnight with a specific primary 
antibody (in PBS-T with 2.5% milk, see section 6.11.1), shaking at 4°C. The next day, 
membranes were washed three times in PBS-T for 10 min to remove unbound antibody. 
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Horseradish peroxidase (HRP)-coupled secondary antibody (in PBS-T with 1.25% milk, 
see section 6.11.2) was added for 1 h at RT and finally, membranes were washed again 
with PBS-T. 
To visualize proteins, membranes were covered with an enhanced chemoluminescence 
(ECL) substrate which is converted by the HRP. This enzymatic reaction is accompanied 
by light emission and can thus be detected using ECL film. 
7.5.4 Labeling recombinant DUBs with OTULIN ABP or Ub-PA 
Recombinant DUBs were diluted in DUB Reaction buffer and incubated for the indicated 
times at 30°C or 37°C with different amounts of OTULIN ABP or Ub-PA (amounts specified 
in the Figure Legends). Reactions were stopped by boiling in reducing SDS sample buffer, 
and proteins were separated by SDS-PAGE (see section 7.5.2). Gels were stained using 
Coomassie-based PageBlue Protein Staining Solution or the “Pierce Silver Stain Kit” in order 
to analyze DUB-diUb (DUB-ABP) or DUB-Ub complex formation. 
7.5.5 Ub chain cleavage assay 
OTULINcat WT (aa 80-352, 500 pM) was diluted in DUB Reaction buffer with 0.03% BSA and 
incubated at 37°C for 25 min with 250 ng of Met1-tetraUb. For inhibition, OTULIN was 
treated with OTULIN ABP or PR-619 at the indicated concentrations (1 h, RT), prior to 
addition of the tetraUb chains. 
In diUb cleavage assays, DUBs (500 nM) were incubated with 500 ng diUb in DUB Reaction 
buffer without BSA (1 h, 30°C). Cleavage reactions were stopped by boiling in 1x SDS 
sample buffer and analyzed by WB or Silver staining after SDS-PAGE. 
7.5.6 Strep-PD 
For Strep-tag II (Strep)-PDs, 20 µg recombinant OTULINcat-Strep (WT, C129A) were mixed 
with equimolar amounts of His10-Ub-Ub WT or His10-UbG76A-Ub in buffer A (total volume 
500 µl) and incubated on the rotator for 2 hrs at 4°C. 20 µl was removed from each sample 
as an Input control (Input). Strep-Tactin Sepharose was pre-equilibrated in buffer A, added to 
the samples (60 µl of 50% slurry per sample) and incubated for 1 h with the protein mixtures 
to enable binding of OTULINcat-Strep to the resin. The resin was pelleted by centrifugation 
(2,500 x g / 4°C / 1 min) and another control sample was removed from each supernatant to 
check whether proteins had been depleted from the solution by the pull-down procedure. 
OTULIN-coupled resin was washed eight times with 1 ml of buffer B to get rid of weaker 
protein interactions and subsequently boiled in 25 µl of 2x reducing SDS sample buffer. 
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Control samples were denatured by boiling in 1x SDS sample buffer and analyzed together 
with the pull-down eluates by WB after SDS-PAGE. 
7.5.7 Treatment of cell extracts with diUb probes 
For the treatment of cell extracts with diUb probes, 2 – 3x106 HEK293 or Jurkat T cells were 
lysed in 250 µl co-IP buffer without protease inhibitors. Cleared extracts were divided into 
aliquots (20 – 50 µl reaction volume / sample). To analyze labeling of cellular DUBs or the 
formation of polyUb chains, different amounts of OTULIN ABP, OTULIN ABP?G76 or 
UbG76A-Ub were added to the samples and incubated at 30 or 37°C for 2 – 60 min (indicated 
in the Figure Legends). Reactions were stopped by boiling in reducing sample buffer and 
analyzed by WB. For ATP depletion, aliquots were treated with 0.5 U Apyrase for 30 min 
before the addition of the OTULIN ABP. For linkage analyses of enriched polyUb chains, 
44 µl aliquots were treated first with 1 µg OTULIN ABP for 30 min at 37°C before adding 5 µl 
of different linkage-specific 10x DUBs (from the “UbiCREST Deubiquitinase Enzyme Set”) 
and incubating for further 30 min at 37°C. 
7.5.8 Strep-PD from cell extracts 
In order to identify the OTULIN interactome by LC-MS/MS, Strep-PDs were performed in 
extracts of OTULIN KO Jurkat T cells reconstituted with either SSF-tagged OTULIN WT or 
mock (SSF-tag only). Every sample was prepared in triplicate. For each sample, 2x108 cells 
were lysed in 1 ml co-IP buffer with phosphatase and protease inhibitors for 1 h at 4°C. Cell 
debris was removed from the lysates by centrifugation (20,000 x g, 20 min, 4°C), 
supernatants were transferred into new reaction tubes and diluted with 500 µl co-IP buffer. 
15 µl was removed from each sample and mixed with SDS sample buffer to later assess by 
WB whether equal cell numbers were used. Strep-Tactin sepharose was pre-equilibrated in 
co-IP buffer and added to each sample (300 µl of 50% slurry / sample). The mixtures were 
incubated on a rotator for 16 hrs at 4°C to ensure efficient binding of SSF-OTULIN to the 
beads. The resin was sedimented by centrifugation (250 x g, 2 min, 4°C) and another 15 µl 
control sample was removed from each supernatant to check whether OTULIN had been 
depleted from the extracts by the PD procedure. Beads were washed three times with 1 ml 
co-IP buffer without inhibitors (250 x g, 2 min, 4°C) and subsequently boiled in 150 µl 2x 
reducing SDS sample buffer. 7.5 µl (5%) was removed for WB analysis, the rest was 
analyzed by LC-MS/MS. 
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7.5.9 His-PD / OTULIN ABP?G76-PD 
For His-PDs, 2x107 Jurkat T cells were lysed in His Lysis buffer without protease inhibitors 
for 20 min at 4°C. Cell debris was removed from the lysate by centrifugation (20,000 x g, 
10 min, 4°C). To check if equal cell numbers were used, 30 µl was removed from each 
sample (Input/lysate). Cell extracts were then incubated with 4 µg His10-UbG76Dha-Ub ?G76 
(OTULIN ABP ?G76) for 60 min at RT, enabling the coupling of active OTULIN and the 
probe. Ni-NTA Agarose was pre-equilibrated in lysis buffer, added to the samples (35 µl of 
50% slurry per sample) and incubated on the turning wheel for 2 hrs at 4°C. By centrifugation 
(500 x g / 2 min / 4°C) beads were sedimented and subsequently washed 3 times with 1 ml 
of washing buffer (300 mM NaCl, 50 mM NaH2PO4, 0.2% NP-40, 10% glycerol, 20 mM 
imidazole, pH 8) to remove unspecifically binding proteins. OTULIN ABP ?G76-bound 
protein complexes were eluted by boiling the beads in 2x reducing SDS sample buffer (25 µl) 
and analyzed by WB after SDS-PAGE. 
7.5.10 Biotin-PD / OTULIN ABP-PD 
For Biotin-PDs, 1x107 HEK293 or 2x107 Jurkat T cells were lysed in 500 µl co-IP buffer 
without protease inhibitors for 20 min at 4°C. Cell debris was removed from the lysate by 
centrifugation (20,000 x g, 10 min, 4°C). To determine if equal cell numbers were used, 30 µl 
was removed from each sample (input/lysate). For a pre-clearing step, cell extracts were 
mixed with 15 µl of High Capacitiy Streptavidin Agarose and incubated on the turning wheel 
for 1 h at 4°C. The beads were sedimented by centrifugation (2,500 x g / 2 min / 4°C) and 
450 µl of the resulting supernatant were transferred into a new reaction tube. The pre-
cleared cell extracts were then incubated at RT with 2 – 4 µg OTULIN ABP (15 – 60 min), 
enabling the covalent coupling of active OTULIN and the probe. To bind and precipitate the 
formed OTULIN-ABP complexes, 25 – 35 µl of streptavidin agarose was added and 
incubated with the samples on the turning wheel for 1 – 2 hrs at 4°C. After a first 
centrifugation step (2,500 x g / 4°C / 2 min), control samples (30 µl) were removed from each 
supernatant to monitor depletion of proteins by the pull-down procedure. Then, beads were 
washed three times with 1 ml co-IP buffer to remove unspecific interactions. Protein 
complexes were eluted by boiling beads in 25 µl 2x SDS sample buffer and analyzed by WB 
after SDS-PAGE. 
To determine protein levels in input (prior to PD) and supernatant (after PD), control samples 
were denatured by boiling in SDS sample buffer and loaded in equal amounts on SDS gels 
for WB analysis. All protein band intensities were quantified using ImageJ software and 
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normalized to ?-actin. The ratio of quantified proteins between the supernatant and input was 
calculated to obtain relative amounts of ‘free’, OTULIN-ABP unbound proteins. 
To identify the OTULIN ABP interactome by LC-MS/MS, we used a larger quantity of cells 
(5x107 cells, lysed in 1 ml co-IP buffer) for the biotin-PDs. Pre-cleared lysates (950 µl) were 
incubated for 30 min at 30°C with (or without) Apyrase (4 U), to deplete cellular ATP. To 
inhibit DUBs, samples were incubated for a further 30 min at 30°C with (or without) PR-619 
(250 µM). Extracts were then treated with (or without) OTULIN ABP (5 µg) for 15 min at RT 
prior to adding 35 µl streptavidin agarose to pull-down protein-ABP complexes (2 hrs, 4°C). 
In order to remove most non-covalent ABP interactors, beads were washed twice with co-IP 
buffer and subsequently twice with high-stringent 1% SDS-containing co-IP buffer. For the 
identification of OTULIN interactors, beads were washed four times with co-IP buffer (no 
SDS). PDs were eluted by boiling the beads in 50 µl 2x SDS sample buffer. 2.5 µl (5%) was 
removed for WB analysis, whereas the rest was analyzed by LC-MS/MS. 
7.5.11 GFP-Trap 
For transient overexpression of proteins, 2.5x106 HEK293 cells were seeded in a 10 cm dish 
and transfected the next day using calcium phosphate transfection. One day after 
transfection, cells were washed with PBS and lysed in 500 µl co-IP buffer (20 min, 4°C). 
Lysates were cleared by centrifugation at 20,000 x g (10 min, 4°C). 30 µl was removed from 
each lysate and mixed with reducing SDS sample buffer (lysate control). Subsequently, 
extracts were incubated with 20 µl GFP-Trap beads (50% suspension), equilibrated in co-IP 
buffer, for 1 - 2 hrs on a rotator at 4°C. To pull down GFP-tagged proteins, samples were 
centrifuged at 2,500 x g (2 min, 4°C). Beads were washed three times in co-IP buffer without 
inhibitors and finally resuspended in 25 µl 2x SDS sample buffer. PD eluates as well as 
lysate control samples were analyzed by antibody detection on WB membranes after 
SDS-PAGE. 
For the analysis of interactions between SNX27 and cargos, cells were lysed in Cargo buffer 
without salt, according to (Gallon et al., 2014). 
7.5.12 Immunoprecipitation (IP) 
For IPs of endogenous proteins, 2.5-5x107 cells were lysed in 500 µl co-IP buffer (20 min, 
4°C). For IPs of overexpressed proteins from HEK293 extracts, fewer cells (~1x107) were 
lysed one day after transfection. Lysates were centrifuged at 20,000 x g (10 min, 4°C) and 
incubated with the respective antibodies on a rotator overnight at 4°C. The next day, 
15 - 25 µl Protein G Sepharose (50% suspension) was added and incubated for another 
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1 - 2 hrs at 4°C. IPs were washed three times with 1 ml co-IP buffer without inhibitors 
(700 x g, 2 min, 4°C) and subsequently denatured by boiling in 25 µl 2x SDS sample buffer. 
IPs and lysate controls were analyzed by WB after SDS-PAGE. 
7.5.13 Size exclusion chromatography analysis of cell extracts 
Gel filtration analyses of cell extracts were performed on an ÄKTApurifier System. 1x108 
Jurkat T cells were washed with PBS and lysed in 400 µl SEC lysis buffer for 30 min at 4°C. 
Lysates were initially centrifuged at 20,000 x g (20 min at 4°C) and subsequently subjected 
to an ultracentrifugation step (125,000 x g, 30 min, 4°C). The resulting supernatants were 
filtered using Proteus Mini Clarification Spin Columns (Generon; 14,000 x g, 2 min, 4°C) to 
get rid of particles that are larger than 0.2 µm. Extracts were loaded onto a Superdex 200 
10/300 GL column equilibrated in SEC buffer. 0.5 ml fractions were collected and mixed with 
SDS sample buffer to analyze the elution profile of the respective proteins by WB after 
SDS-PAGE. 
7.5.14 Confocal microscopy 
U2OS cells were transfected with GFP-SNX27 and RFP-OTULIN constructs using 
X-tremeGENE HP DNA Transfection Reagent according to the manufacturer’s instructions. 
10 hrs after transfection, 30,000 cells per well were seeded in 12-well plates on round cover 
glasses coated with Poly-L-lysine solution. The following day, cells were fixed with 4% Roti-
Histofix (10 min, RT), washed twice with PBS-T and permeabilized in Permeabilization buffer 
for 15 min. Then, cells were washed again with PBS-T, blocked in Blocking solution for 1 h 
and incubated with primary antibody in blocking solution overnight at 4°C. The next day, cells 
were washed three times with PBS-T, incubated with fluorophore-labeled secondary antibody 
in blocking solution (1 h, RT) and washed again twice with PBS-T. After nuclear counterstain 
with DAPI in PBS, cover glasses were washed in PBS and mounted on SuperFrost slides 
using mounting medium (provided by Annalisa Schaub). Images were acquired using a Leica 
SP5 confocal laser scanning microscope (63x magnification) by Annalisa Schaub. 
7.6 X-ray crystallography of the OTULIN-ABP and OTULIN-SNX27 complexes 
The expression and purification of OTULINcat (aa 80-352) and SNXPDZ (aa 40-135) for 
crystallography, as well as the crystallization, structure determination and structure 
refinement, was performed by our collaboration partner Paul Elliott (MRC, Cambridge; 
University of Oxford). The detailed protocol for X-ray crystallograpghy of the OTULIN-ABP 
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complex is published in (Weber et al., 2017). The structure of the OTULIN-ABP complex has 
been deposited with the Protein Data Bank under the accession code PDB ID: 5OE7. 
7.7 LC-MS/MS 
The mass spectrometric analysis including protein digest, LC-MS/MS and data analysis was 
performed by Adan Pinto-Fernandez and Sarah Bonham (Benedikt M. Kessler group, 
University of Oxford). The detailed protocol is published in (Weber et al., 2017). Volcano 
plots were generated using FDR(false discovery rate)=0.01 and s0=2 or s0=0.2 as cutoff 
parameters.  
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE (Vizcaino et al., 2016) partner repository with the dataset identifier 
PXD006868. 
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8. Abbreviations 
°C degree Celsius 
aa amino acid 
ABP activity-based probe 
AHT anhydrotetracycline 
Ahx aminohexanoic 
Ala alanine 
AMC 7-amino-4-methylcoumarin 
AMPA ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AP-1 activator protein 1 
APS ammonium persulfate 
Arp2/3 actin-related protein 2/3 
Asn asparagine 
Asp aspartic acid 
ATP adenosine triphosphate 
BAR Bin/Amphiphysin/Rvs 
bio biotin 
BSA bovine serum albumin 
cIAP1/2 cellular inhibitor of apoptosis 1 and 2 
CO2 carbon dioxide 
CYLD Cylindromatosis 
Cys cysteine 
Da dalton 
DGK? diacylglycerol kinase ? 
Dha dehydroalanine 
DMEM Dulbecco´s Modified Eagle Medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DSB double-strand break 
DSCR3 Down´s syndrome critical region 3 
DTT dithiothreitol 
DUB deubiquitinating enzyme 
DVL2 Dishevelled 2 
E. coli Escherichia coli 
E1, E2, E3 enzymes ubiquitin-activating, ubiquitin-conjugating, ubiquitin-ligating enzyme 
EDTA ethylenediaminetetraacetic acid 
ERK extracellular-signal-regulated kinase 
FCS fetal calf serum 
FDR false discovery rate 
FERM 4.1, ezrin, radixin, moesin 
g gram 
GFP green fluorescent protein 
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Gln glutamine 
Glu glutamic acid 
GLUT1 glucose transporter 1 
Gly glycine 
h, hrs hour, hours 
HCl hydrochloric acid 
HECT Homologous to the E6AP Carboxyl Terminus 
His histidine 
HOIL-1 Heme-oxidized IRP2 Ub ligase-1, also termed RBCK1 or RNF54 
HOIP HOIL-1-interacting protein, also termed RNF31 or ZIBRA 
IKK inhibitor of ?B kinase 
IL-1R interleukin-1 receptor 
Ile isoleucine 
IP immunoprecipitation 
IRAK interleukin-1 receptor-associated kinase 
ITC isothermal calorimetry 
I?B? inhibitor of NF-?B alpha 
KCl potassium chloride 
KD equilibrium dissociation constant 
KO knockout 
l liter 
LB (medium / agar) Lysogeny-Broth (medium / agar) 
LC-MS/MS liquid chromatography–tandem mass spectrometry 
Leu leucine 
LUBAC linear ubiquitin chain assembly complex 
Lys lysine 
m meter 
M molar concentration 
MAPK mitogen-activated protein kinase 
MeOH methanol 
Met methionine 
MilliQ-H2O ultrapure water 
min minute 
MINDY motif interacting with ubiquitin (MIU)- containing novel DUB family 
MW molecular weight 
MYD88 myeloid differentiation primary response 88 
NaCl sodium chloride 
NEMO NF-?B essential modulator 
NF-?B nuclear factor kappa B 
NHEJ non-homologous end joining 
NMDA N-methyl-D-aspartate 
NOD2 nucleotide-binding oligomerization domain-containing protein 2 
NZF nuclear protein localization 4 zinc finger 
O2 oxygen 
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OD optical density 
ORAS OTULIN-related autoinflammatory syndrome 
OTULIN ovarian tumor domain-containing DUB with linear linkage specificity 
PA propargylamide 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PD pull-down 
PDZ post-synaptic density 95/discs large/zonula occludens 
PDZbm PDZ-binding motif 
Phe phenylalanine 
PHLPP1 PH Domain and Leucine Rich Repeat Protein Phosphatase 1 
PI(3)P phosphatidylinositol 3-phosphate 
PIM PUB-interacting motif 
PNGase peptide:N-glycosidase 
PRR pattern recognition receptor 
PUB peptide:N-glycanase/UBA- or UBX-containing proteins 
PX phox-homology 
RBR RING-between-RING 
RFP Red fluorescent protein 
RING Really Interesting New Gene 
RIPK1 receptor-interacting serine/threonine protein kinase 1 
RT room temperature 
s second 
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
sgRNA single guide ribonucleic acid 
SHARPIN Shank-associated RH domain-interacting protein, also termed hSIPL1 
SNX Sorting Nexin 
SPATA2 Spermatogenesis-associated protein 2 
SSF 2xStrep-tag II-Flag 
TAB2/3 TAK1-binding proteins 2 and 3 
TAK1 transforming growth factor ?-activated kinase 1 
TEMED tetramethylethylenediamine 
TGN trans-Golgi network 
Thr threonine 
TLR Toll-like receptor 
TNFR1 tumor necrosis factor receptor 1 
TNF? tumor necrosis factor ? 
TRADD TNFR1-associated death domain protein 
TRAF TNF receptor associated factor 
Tris tris(hydroxymethyl)aminomethane 
Tyr tyrosine 
U enzyme unit 
Ub ubiquitin 
UBA domain ubiquitin-associated domain 
UBAN ubiquitin binding in ABIN and NEMO 
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UBD ubiquitin-binding domain 
UbiCREST Ubiquitin Chain Restriction Analysis 
UBP ubiquitin-binding protein 
UCH ubiquitin C-terminal hydrolase 
USP ubiquitin-specific protease 
UV ultraviolet 
v/v volume per volume 
Val valine 
VME vinyl methyl ester 
VPS vacuolar protein sorting-associated protein 
w/v weight per volume 
WASH Wiskott-Aldrich syndrome protein and SCAR homologue 
WT wild type 
ZnF-UBP zinc-finger ubiquitin-binding protein 
?2-AR beta-2 adrenergic receptor 
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